id	sid	tid	token	lemma	pos
iajs-3387	1	1	255	255	NUM
iajs-3387	1	2	©	©	PROPN
iajs-3387	1	3	2024	2024	NUM
iajs-3387	1	4	the	the	DET
iajs-3387	1	5	author(s	author(s	NOUN
iajs-3387	1	6	)	)	PUNCT
iajs-3387	1	7	.	.	PUNCT
iajs-3387	2	1	published	publish	VERB
iajs-3387	2	2	by	by	ADP
iajs-3387	2	3	college	college	NOUN
iajs-3387	2	4	of	of	ADP
iajs-3387	2	5	education	education	NOUN
iajs-3387	2	6	for	for	ADP
iajs-3387	2	7	pure	pure	ADJ
iajs-3387	2	8	science	science	NOUN
iajs-3387	2	9	(	(	PUNCT
iajs-3387	2	10	ibn	ibn	PROPN
iajs-3387	2	11	al	al	PROPN
iajs-3387	2	12	-	-	PUNCT
iajs-3387	2	13	haitham	haitham	PROPN
iajs-3387	2	14	)	)	PUNCT
iajs-3387	2	15	,	,	PUNCT
iajs-3387	2	16	university	university	NOUN
iajs-3387	2	17	of	of	ADP
iajs-3387	2	18	baghdad	baghdad	PROPN
iajs-3387	2	19	.	.	PUNCT
iajs-3387	3	1	this	this	PRON
iajs-3387	3	2	is	be	AUX
iajs-3387	3	3	an	an	DET
iajs-3387	3	4	open	open	ADJ
iajs-3387	3	5	-	-	PUNCT
iajs-3387	3	6	access	access	NOUN
iajs-3387	3	7	article	article	NOUN
iajs-3387	3	8	distributed	distribute	VERB
iajs-3387	3	9	under	under	ADP
iajs-3387	3	10	the	the	DET
iajs-3387	3	11	terms	term	NOUN
iajs-3387	3	12	of	of	ADP
iajs-3387	3	13	the	the	DET
iajs-3387	3	14	creative	creative	ADJ
iajs-3387	3	15	commons	common	NOUN
iajs-3387	3	16	attribution	attribution	NOUN
iajs-3387	3	17	4.0	4.0	NUM
iajs-3387	3	18	international	international	ADJ
iajs-3387	3	19	license	license	NOUN
iajs-3387	3	20	ibn	ibn	PROPN
iajs-3387	3	21	al	al	PROPN
iajs-3387	3	22	-	-	PUNCT
iajs-3387	3	23	haitham	haitham	PROPN
iajs-3387	3	24	journal	journal	PROPN
iajs-3387	3	25	for	for	ADP
iajs-3387	3	26	pure	pure	ADJ
iajs-3387	3	27	and	and	CCONJ
iajs-3387	3	28	applied	applied	ADJ
iajs-3387	3	29	sciences	sciences	PROPN
iajs-3387	3	30	journal	journal	PROPN
iajs-3387	3	31	homepage	homepage	NOUN
iajs-3387	3	32	:	:	PUNCT
iajs-3387	3	33	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3387	3	34	pissn	pissn	ADJ
iajs-3387	3	35	:	:	PUNCT
iajs-3387	3	36	1609	1609	NUM
iajs-3387	3	37	-	-	SYM
iajs-3387	3	38	4042	4042	NUM
iajs-3387	3	39	,	,	PUNCT
iajs-3387	3	40	eissn	eissn	NOUN
iajs-3387	3	41	:	:	PUNCT
iajs-3387	3	42	2521	2521	NUM
iajs-3387	3	43	-	-	SYM
iajs-3387	3	44	3407	3407	NUM
iajs-3387	3	45	ihjpas	ihjpa	NOUN
iajs-3387	3	46	.	.	PUNCT
iajs-3387	4	1	2024	2024	NUM
iajs-3387	4	2	,	,	PUNCT
iajs-3387	4	3	37(4	37(4	NUM
iajs-3387	4	4	)	)	PUNCT
iajs-3387	4	5	the	the	DET
iajs-3387	4	6	study	study	NOUN
iajs-3387	4	7	of	of	ADP
iajs-3387	4	8	prolidase	prolidase	NOUN
iajs-3387	4	9	level	level	NOUN
iajs-3387	4	10	and	and	CCONJ
iajs-3387	4	11	some	some	DET
iajs-3387	4	12	biochemical	biochemical	ADJ
iajs-3387	4	13	variables	variable	NOUN
iajs-3387	4	14	in	in	ADP
iajs-3387	4	15	iraqi	iraqi	ADJ
iajs-3387	4	16	patients	patient	NOUN
iajs-3387	4	17	with	with	ADP
iajs-3387	4	18	acromegaly	acromegaly	PROPN
iajs-3387	4	19	sara	sara	PROPN
iajs-3387	4	20	a.	a.	PROPN
iajs-3387	4	21	kashash1	kashash1	PROPN
iajs-3387	4	22	,	,	PUNCT
iajs-3387	4	23	*	*	PUNCT
iajs-3387	4	24	and	and	CCONJ
iajs-3387	4	25	areej	areej	VERB
iajs-3387	4	26	sh	sh	PROPN
iajs-3387	4	27	.	.	PROPN
iajs-3387	4	28	hameed	hameed	PROPN
iajs-3387	4	29	2	2	PROPN
iajs-3387	4	30	1department	1department	NUM
iajs-3387	4	31	of	of	ADP
iajs-3387	4	32	chemistry	chemistry	NOUN
iajs-3387	4	33	,	,	PUNCT
iajs-3387	4	34	college	college	NOUN
iajs-3387	4	35	of	of	ADP
iajs-3387	4	36	sciences	science	NOUN
iajs-3387	4	37	for	for	ADP
iajs-3387	4	38	women	woman	NOUN
iajs-3387	4	39	,	,	PUNCT
iajs-3387	4	40	university	university	NOUN
iajs-3387	4	41	of	of	ADP
iajs-3387	4	42	baghdad	baghdad	PROPN
iajs-3387	4	43	,	,	PUNCT
iajs-3387	4	44	baghdad	baghdad	PROPN
iajs-3387	4	45	,	,	PUNCT
iajs-3387	4	46	iraq	iraq	PROPN
iajs-3387	4	47	.	.	PUNCT
iajs-3387	5	1	*	*	PUNCT
iajs-3387	5	2	corresponding	correspond	VERB
iajs-3387	5	3	author	author	NOUN
iajs-3387	5	4	.	.	PUNCT
iajs-3387	6	1	received	receive	VERB
iajs-3387	6	2	:	:	PUNCT
iajs-3387	6	3	6	6	NUM
iajs-3387	6	4	april	april	PROPN
iajs-3387	6	5	2023	2023	NUM
iajs-3387	6	6	accepted	accept	VERB
iajs-3387	6	7	:	:	PUNCT
iajs-3387	6	8	7	7	NUM
iajs-3387	6	9	june	june	PROPN
iajs-3387	6	10	2023	2023	NUM
iajs-3387	6	11	published	publish	VERB
iajs-3387	6	12	:	:	PUNCT
iajs-3387	6	13	20	20	NUM
iajs-3387	6	14	october	october	NOUN
iajs-3387	6	15	2024	2024	NUM
iajs-3387	6	16	doi.org/10.30526/37.4.3387	doi.org/10.30526/37.4.3387	NOUN
iajs-3387	6	17	abstract	abstract	ADJ
iajs-3387	6	18	acromegaly	acromegaly	NOUN
iajs-3387	6	19	is	be	AUX
iajs-3387	6	20	a	a	DET
iajs-3387	6	21	condition	condition	NOUN
iajs-3387	6	22	that	that	PRON
iajs-3387	6	23	results	result	VERB
iajs-3387	6	24	from	from	ADP
iajs-3387	6	25	excessive	excessive	ADJ
iajs-3387	6	26	growth	growth	NOUN
iajs-3387	6	27	hormone	hormone	NOUN
iajs-3387	6	28	production	production	NOUN
iajs-3387	6	29	by	by	ADP
iajs-3387	6	30	the	the	DET
iajs-3387	6	31	anterior	anterior	ADJ
iajs-3387	6	32	pituitary	pituitary	ADJ
iajs-3387	6	33	gland	gland	NOUN
iajs-3387	6	34	.	.	PUNCT
iajs-3387	7	1	prolidase	prolidase	NOUN
iajs-3387	7	2	(	(	PUNCT
iajs-3387	7	3	pld	pld	NOUN
iajs-3387	7	4	)	)	PUNCT
iajs-3387	7	5	is	be	AUX
iajs-3387	7	6	the	the	DET
iajs-3387	7	7	only	only	ADJ
iajs-3387	7	8	known	know	VERB
iajs-3387	7	9	human	human	ADJ
iajs-3387	7	10	enzyme	enzyme	NOUN
iajs-3387	7	11	that	that	PRON
iajs-3387	7	12	can	can	AUX
iajs-3387	7	13	hydrolyze	hydrolyze	VERB
iajs-3387	7	14	dipeptides	dipeptide	NOUN
iajs-3387	7	15	with	with	ADP
iajs-3387	7	16	an	an	DET
iajs-3387	7	17	amino	amino	NOUN
iajs-3387	7	18	acid	acid	NOUN
iajs-3387	7	19	at	at	ADP
iajs-3387	7	20	their	their	PRON
iajs-3387	7	21	c	c	PROPN
iajs-3387	7	22	terminus	terminus	NOUN
iajs-3387	7	23	.	.	PUNCT
iajs-3387	8	1	reports	report	NOUN
iajs-3387	8	2	indicate	indicate	VERB
iajs-3387	8	3	that	that	SCONJ
iajs-3387	8	4	pld	pld	NOUN
iajs-3387	8	5	activity	activity	NOUN
iajs-3387	8	6	serves	serve	VERB
iajs-3387	8	7	as	as	ADP
iajs-3387	8	8	a	a	DET
iajs-3387	8	9	marker	marker	NOUN
iajs-3387	8	10	for	for	ADP
iajs-3387	8	11	oxidative	oxidative	ADJ
iajs-3387	8	12	stress	stress	NOUN
iajs-3387	8	13	in	in	ADP
iajs-3387	8	14	numerous	numerous	ADJ
iajs-3387	8	15	disorders	disorder	NOUN
iajs-3387	8	16	such	such	ADJ
iajs-3387	8	17	as	as	ADP
iajs-3387	8	18	diabetes	diabete	NOUN
iajs-3387	8	19	,	,	PUNCT
iajs-3387	8	20	diabetic	diabetic	ADJ
iajs-3387	8	21	neuropathy	neuropathy	ADJ
iajs-3387	8	22	,	,	PUNCT
iajs-3387	8	23	chronic	chronic	ADJ
iajs-3387	8	24	liver	liver	NOUN
iajs-3387	8	25	diseases	disease	NOUN
iajs-3387	8	26	,	,	PUNCT
iajs-3387	8	27	and	and	CCONJ
iajs-3387	8	28	osteoporosis	osteoporosis	NOUN
iajs-3387	8	29	.	.	PUNCT
iajs-3387	9	1	the	the	DET
iajs-3387	9	2	current	current	ADJ
iajs-3387	9	3	study	study	NOUN
iajs-3387	9	4	aims	aim	VERB
iajs-3387	9	5	to	to	PART
iajs-3387	9	6	estimate	estimate	VERB
iajs-3387	9	7	the	the	DET
iajs-3387	9	8	values	value	NOUN
iajs-3387	9	9	of	of	ADP
iajs-3387	9	10	pld	pld	NOUN
iajs-3387	9	11	,	,	PUNCT
iajs-3387	9	12	its	its	PRON
iajs-3387	9	13	correlation	correlation	NOUN
iajs-3387	9	14	with	with	ADP
iajs-3387	9	15	the	the	DET
iajs-3387	9	16	rest	rest	NOUN
iajs-3387	9	17	of	of	ADP
iajs-3387	9	18	the	the	DET
iajs-3387	9	19	parameters	parameter	NOUN
iajs-3387	9	20	,	,	PUNCT
iajs-3387	9	21	and	and	CCONJ
iajs-3387	9	22	roc	roc	PROPN
iajs-3387	9	23	in	in	ADP
iajs-3387	9	24	acromegaly	acromegaly	PROPN
iajs-3387	9	25	patients	patient	NOUN
iajs-3387	9	26	.	.	PUNCT
iajs-3387	10	1	a	a	DET
iajs-3387	10	2	group	group	NOUN
iajs-3387	10	3	of	of	ADP
iajs-3387	10	4	61	61	NUM
iajs-3387	10	5	patients	patient	NOUN
iajs-3387	10	6	with	with	ADP
iajs-3387	10	7	confirmed	confirm	VERB
iajs-3387	10	8	acromegaly	acromegaly	NOUN
iajs-3387	10	9	were	be	AUX
iajs-3387	10	10	collected	collect	VERB
iajs-3387	10	11	from	from	ADP
iajs-3387	10	12	the	the	DET
iajs-3387	10	13	national	national	ADJ
iajs-3387	10	14	diabetic	diabetic	ADJ
iajs-3387	10	15	center	center	NOUN
iajs-3387	10	16	,	,	PUNCT
iajs-3387	10	17	mustansyrriah	mustansyrriah	PROPN
iajs-3387	10	18	university	university	NOUN
iajs-3387	10	19	,	,	PUNCT
iajs-3387	10	20	and	and	CCONJ
iajs-3387	10	21	60	60	NUM
iajs-3387	10	22	control	control	NOUN
iajs-3387	10	23	groups	group	NOUN
iajs-3387	10	24	were	be	AUX
iajs-3387	10	25	analyzed	analyze	VERB
iajs-3387	10	26	in	in	ADP
iajs-3387	10	27	the	the	DET
iajs-3387	10	28	same	same	ADJ
iajs-3387	10	29	place	place	NOUN
iajs-3387	10	30	for	for	ADP
iajs-3387	10	31	the	the	DET
iajs-3387	10	32	parameters	parameter	NOUN
iajs-3387	10	33	of	of	ADP
iajs-3387	10	34	the	the	DET
iajs-3387	10	35	biochemical	biochemical	ADJ
iajs-3387	10	36	study	study	NOUN
iajs-3387	10	37	.	.	PUNCT
iajs-3387	11	1	acromegalic	acromegalic	ADJ
iajs-3387	11	2	patients	patient	NOUN
iajs-3387	11	3	had	have	VERB
iajs-3387	11	4	changes	change	NOUN
iajs-3387	11	5	in	in	ADP
iajs-3387	11	6	the	the	DET
iajs-3387	11	7	levels	level	NOUN
iajs-3387	11	8	of	of	ADP
iajs-3387	11	9	biochemical	biochemical	ADJ
iajs-3387	11	10	markers	marker	NOUN
iajs-3387	11	11	like	like	ADP
iajs-3387	11	12	pld	pld	NOUN
iajs-3387	11	13	,	,	PUNCT
iajs-3387	11	14	growth	growth	NOUN
iajs-3387	11	15	hormone	hormone	NOUN
iajs-3387	11	16	,	,	PUNCT
iajs-3387	11	17	insulin	insulin	NOUN
iajs-3387	11	18	-	-	PUNCT
iajs-3387	11	19	like	like	ADJ
iajs-3387	11	20	growth	growth	NOUN
iajs-3387	11	21	factor-1	factor-1	PROPN
iajs-3387	11	22	,	,	PUNCT
iajs-3387	11	23	and	and	CCONJ
iajs-3387	11	24	fasting	fast	VERB
iajs-3387	11	25	blood	blood	NOUN
iajs-3387	11	26	glucose	glucose	NOUN
iajs-3387	11	27	.	.	PUNCT
iajs-3387	12	1	there	there	PRON
iajs-3387	12	2	was	be	VERB
iajs-3387	12	3	a	a	DET
iajs-3387	12	4	high	high	ADJ
iajs-3387	12	5	difference	difference	NOUN
iajs-3387	12	6	(	(	PUNCT
iajs-3387	12	7	p	p	X
iajs-3387	12	8	<	<	X
iajs-3387	12	9	0.001	0.001	NUM
iajs-3387	12	10	)	)	PUNCT
iajs-3387	12	11	between	between	ADP
iajs-3387	12	12	the	the	DET
iajs-3387	12	13	patient	patient	NOUN
iajs-3387	12	14	group	group	NOUN
iajs-3387	12	15	and	and	CCONJ
iajs-3387	12	16	the	the	DET
iajs-3387	12	17	healthy	healthy	ADJ
iajs-3387	12	18	control	control	NOUN
iajs-3387	12	19	group	group	NOUN
iajs-3387	12	20	.	.	PUNCT
iajs-3387	13	1	the	the	DET
iajs-3387	13	2	current	current	ADJ
iajs-3387	13	3	study	study	NOUN
iajs-3387	13	4	shows	show	VERB
iajs-3387	13	5	that	that	SCONJ
iajs-3387	13	6	pld	pld	NOUN
iajs-3387	13	7	levels	level	NOUN
iajs-3387	13	8	are	be	AUX
iajs-3387	13	9	higher	high	ADJ
iajs-3387	13	10	in	in	ADP
iajs-3387	13	11	patients	patient	NOUN
iajs-3387	13	12	with	with	ADP
iajs-3387	13	13	acromegaly	acromegaly	NOUN
iajs-3387	13	14	than	than	ADP
iajs-3387	13	15	in	in	ADP
iajs-3387	13	16	the	the	DET
iajs-3387	13	17	healthy	healthy	ADJ
iajs-3387	13	18	control	control	NOUN
iajs-3387	13	19	group	group	NOUN
iajs-3387	13	20	.	.	PUNCT
iajs-3387	14	1	the	the	DET
iajs-3387	14	2	sensitivity	sensitivity	NOUN
iajs-3387	14	3	and	and	CCONJ
iajs-3387	14	4	specificity	specificity	NOUN
iajs-3387	14	5	for	for	ADP
iajs-3387	14	6	pld	pld	NOUN
iajs-3387	14	7	were	be	AUX
iajs-3387	14	8	high	high	ADJ
iajs-3387	14	9	in	in	ADP
iajs-3387	14	10	the	the	DET
iajs-3387	14	11	patient	patient	ADJ
iajs-3387	14	12	group	group	NOUN
iajs-3387	14	13	versus	versus	ADP
iajs-3387	14	14	the	the	DET
iajs-3387	14	15	healthy	healthy	ADJ
iajs-3387	14	16	control	control	NOUN
iajs-3387	14	17	.	.	PUNCT
iajs-3387	15	1	the	the	DET
iajs-3387	15	2	pld	pld	NOUN
iajs-3387	15	3	may	may	AUX
iajs-3387	15	4	be	be	AUX
iajs-3387	15	5	a	a	DET
iajs-3387	15	6	novel	novel	ADJ
iajs-3387	15	7	biomarker	biomarker	NOUN
iajs-3387	15	8	of	of	ADP
iajs-3387	15	9	acromegaly	acromegaly	NOUN
iajs-3387	15	10	activity	activity	NOUN
iajs-3387	15	11	,	,	PUNCT
iajs-3387	15	12	and	and	CCONJ
iajs-3387	15	13	there	there	PRON
iajs-3387	15	14	may	may	AUX
iajs-3387	15	15	be	be	AUX
iajs-3387	15	16	an	an	DET
iajs-3387	15	17	increase	increase	NOUN
iajs-3387	15	18	in	in	ADP
iajs-3387	15	19	fasting	fast	VERB
iajs-3387	15	20	blood	blood	NOUN
iajs-3387	15	21	glucose	glucose	NOUN
iajs-3387	15	22	,	,	PUNCT
iajs-3387	15	23	growth	growth	NOUN
iajs-3387	15	24	hormone	hormone	NOUN
iajs-3387	15	25	,	,	PUNCT
iajs-3387	15	26	and	and	CCONJ
iajs-3387	15	27	igf-1	igf-1	NOUN
iajs-3387	15	28	in	in	ADP
iajs-3387	15	29	acromegaly	acromegaly	NOUN
iajs-3387	15	30	patients	patient	NOUN
iajs-3387	15	31	.	.	PUNCT
iajs-3387	16	1	keywords	keyword	NOUN
iajs-3387	16	2	:	:	PUNCT
iajs-3387	16	3	acromegaly	acromegaly	NOUN
iajs-3387	16	4	,	,	PUNCT
iajs-3387	16	5	growth	growth	NOUN
iajs-3387	16	6	hormone	hormone	NOUN
iajs-3387	16	7	,	,	PUNCT
iajs-3387	16	8	hyperglycemia	hyperglycemia	NOUN
iajs-3387	16	9	,	,	PUNCT
iajs-3387	16	10	insulin	insulin	NOUN
iajs-3387	16	11	like	like	ADP
iajs-3387	16	12	growth	growth	NOUN
iajs-3387	16	13	factor-1	factor-1	PROPN
iajs-3387	16	14	,	,	PUNCT
iajs-3387	16	15	prolidase	prolidase	NOUN
iajs-3387	16	16	.	.	PUNCT
iajs-3387	17	1	1	1	X
iajs-3387	17	2	.	.	X
iajs-3387	17	3	introduction	introduction	NOUN
iajs-3387	17	4	acromegaly	acromegaly	NOUN
iajs-3387	17	5	is	be	AUX
iajs-3387	17	6	an	an	DET
iajs-3387	17	7	uncommon	uncommon	ADJ
iajs-3387	17	8	type	type	NOUN
iajs-3387	17	9	of	of	ADP
iajs-3387	17	10	chronic	chronic	ADJ
iajs-3387	17	11	illness	illness	NOUN
iajs-3387	17	12	marked	mark	VERB
iajs-3387	17	13	by	by	ADP
iajs-3387	17	14	overproduction	overproduction	NOUN
iajs-3387	17	15	of	of	ADP
iajs-3387	17	16	the	the	DET
iajs-3387	17	17	hormones	hormone	NOUN
iajs-3387	17	18	growth	growth	NOUN
iajs-3387	17	19	hormone	hormone	NOUN
iajs-3387	17	20	(	(	PUNCT
iajs-3387	17	21	gh	gh	PROPN
iajs-3387	17	22	)	)	PUNCT
iajs-3387	17	23	and	and	CCONJ
iajs-3387	17	24	insulin	insulin	NOUN
iajs-3387	17	25	-	-	PUNCT
iajs-3387	17	26	like	like	ADJ
iajs-3387	17	27	growth	growth	NOUN
iajs-3387	17	28	factor	factor	NOUN
iajs-3387	17	29	1	1	NUM
iajs-3387	17	30	(	(	PUNCT
iajs-3387	17	31	igf-1	igf-1	NOUN
iajs-3387	17	32	)	)	PUNCT
iajs-3387	17	33	.	.	PUNCT
iajs-3387	18	1	pituitary	pituitary	ADJ
iajs-3387	18	2	adenomas	adenoma	NOUN
iajs-3387	18	3	are	be	AUX
iajs-3387	18	4	the	the	DET
iajs-3387	18	5	root	root	NOUN
iajs-3387	18	6	cause	cause	NOUN
iajs-3387	18	7	of	of	ADP
iajs-3387	18	8	more	more	ADJ
iajs-3387	18	9	than	than	ADP
iajs-3387	18	10	95	95	NUM
iajs-3387	18	11	%	%	NOUN
iajs-3387	18	12	of	of	ADP
iajs-3387	18	13	instances	instance	NOUN
iajs-3387	18	14	of	of	ADP
iajs-3387	18	15	acromegaly	acromegaly	NOUN
iajs-3387	18	16	[	[	X
iajs-3387	18	17	1	1	NUM
iajs-3387	18	18	-	-	SYM
iajs-3387	18	19	3	3	NUM
iajs-3387	18	20	]	]	PUNCT
iajs-3387	18	21	.	.	PUNCT
iajs-3387	19	1	acromegaly	acromegaly	PROPN
iajs-3387	19	2	often	often	ADV
iajs-3387	19	3	develops	develop	VERB
iajs-3387	19	4	slowly	slowly	ADV
iajs-3387	19	5	and	and	CCONJ
iajs-3387	19	6	subtly	subtly	ADV
iajs-3387	20	1	[	[	X
iajs-3387	20	2	4	4	NUM
iajs-3387	20	3	]	]	PUNCT
iajs-3387	20	4	.	.	PUNCT
iajs-3387	21	1	its	its	PRON
iajs-3387	21	2	prevalence	prevalence	NOUN
iajs-3387	21	3	is	be	AUX
iajs-3387	21	4	130	130	NUM
iajs-3387	21	5	cases	case	NOUN
iajs-3387	21	6	per	per	ADP
iajs-3387	21	7	million	million	NUM
iajs-3387	21	8	,	,	PUNCT
iajs-3387	21	9	although	although	SCONJ
iajs-3387	21	10	its	its	PRON
iajs-3387	21	11	annual	annual	ADJ
iajs-3387	21	12	incidence	incidence	NOUN
iajs-3387	21	13	is	be	AUX
iajs-3387	21	14	between	between	ADP
iajs-3387	21	15	4	4	NUM
iajs-3387	21	16	and	and	CCONJ
iajs-3387	21	17	6	6	NUM
iajs-3387	21	18	cases	case	NOUN
iajs-3387	21	19	per	per	ADP
iajs-3387	21	20	million	million	NUM
iajs-3387	21	21	per	per	ADP
iajs-3387	21	22	year	year	NOUN
iajs-3387	21	23	[	[	X
iajs-3387	21	24	5	5	NUM
iajs-3387	21	25	]	]	PUNCT
iajs-3387	21	26	.	.	PUNCT
iajs-3387	22	1	acromegaly	acromegaly	PROPN
iajs-3387	22	2	is	be	AUX
iajs-3387	22	3	linked	link	VERB
iajs-3387	22	4	to	to	ADP
iajs-3387	22	5	a	a	DET
iajs-3387	22	6	variety	variety	NOUN
iajs-3387	22	7	of	of	ADP
iajs-3387	22	8	systemic	systemic	ADJ
iajs-3387	22	9	problems	problem	NOUN
iajs-3387	22	10	,	,	PUNCT
iajs-3387	22	11	including	include	VERB
iajs-3387	22	12	hypopituitarism	hypopituitarism	NOUN
iajs-3387	22	13	,	,	PUNCT
iajs-3387	22	14	osteoarthritis	osteoarthritis	NOUN
iajs-3387	22	15	,	,	PUNCT
iajs-3387	22	16	metabolic	metabolic	NOUN
iajs-3387	22	17	issues	issue	NOUN
iajs-3387	22	18	like	like	ADP
iajs-3387	22	19	respiratory	respiratory	ADJ
iajs-3387	22	20	problems	problem	NOUN
iajs-3387	22	21	,	,	PUNCT
iajs-3387	22	22	perhaps	perhaps	ADV
iajs-3387	22	23	increased	increase	VERB
iajs-3387	22	24	risks	risk	NOUN
iajs-3387	22	25	of	of	ADP
iajs-3387	22	26	certain	certain	ADJ
iajs-3387	22	27	neoplasias	neoplasia	NOUN
iajs-3387	22	28	,	,	PUNCT
iajs-3387	22	29	vertebral	vertebral	ADJ
iajs-3387	22	30	fractures	fracture	NOUN
iajs-3387	22	31	,	,	PUNCT
iajs-3387	22	32	insulin	insulin	NOUN
iajs-3387	22	33	resistance	resistance	NOUN
iajs-3387	22	34	,	,	PUNCT
iajs-3387	22	35	hyperglycemia	hyperglycemia	NOUN
iajs-3387	22	36	,	,	PUNCT
iajs-3387	22	37	and	and	CCONJ
iajs-3387	22	38	hyperlipidemia	hyperlipidemia	NOUN
iajs-3387	22	39	,	,	PUNCT
iajs-3387	22	40	as	as	ADV
iajs-3387	22	41	well	well	ADV
iajs-3387	22	42	as	as	ADP
iajs-3387	22	43	a	a	DET
iajs-3387	22	44	poor	poor	ADJ
iajs-3387	22	45	quality	quality	NOUN
iajs-3387	22	46	of	of	ADP
iajs-3387	22	47	life	life	NOUN
iajs-3387	22	48	.	.	PUNCT
iajs-3387	23	1	vertebral	vertebral	ADJ
iajs-3387	23	2	fractures	fracture	NOUN
iajs-3387	23	3	and	and	CCONJ
iajs-3387	23	4	a	a	DET
iajs-3387	23	5	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3387	23	6	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3387	23	7	https://orcid.org/0009-0001-6718-679x	https://orcid.org/0009-0001-6718-679x	PROPN
iajs-3387	23	8	mailto:sara.kashash1605@csw.uobaghdad.edu.iq	mailto:sara.kashash1605@csw.uobaghdad.edu.iq	PROPN
iajs-3387	23	9	https://orcid.org/0000-0002-7268-3141	https://orcid.org/0000-0002-7268-3141	VERB
iajs-3387	23	10	mailto:areejsh_chem@csw.uobaghdad.edu.iq	mailto:areejsh_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3387	23	11	ihjpas	ihjpa	NOUN
iajs-3387	23	12	.	.	PUNCT
iajs-3387	24	1	2024	2024	NUM
iajs-3387	24	2	,	,	PUNCT
iajs-3387	24	3	37(4	37(4	NOUN
iajs-3387	24	4	)	)	PUNCT
iajs-3387	24	5	256	256	NUM
iajs-3387	24	6	lower	low	ADJ
iajs-3387	24	7	quality	quality	NOUN
iajs-3387	24	8	of	of	ADP
iajs-3387	24	9	life	life	NOUN
iajs-3387	24	10	are	be	AUX
iajs-3387	24	11	two	two	NUM
iajs-3387	24	12	of	of	ADP
iajs-3387	24	13	these	these	DET
iajs-3387	24	14	more	more	ADV
iajs-3387	24	15	recent	recent	ADJ
iajs-3387	24	16	effects	effect	NOUN
iajs-3387	24	17	.	.	PUNCT
iajs-3387	25	1	for	for	ADP
iajs-3387	25	2	many	many	ADJ
iajs-3387	25	3	years	year	NOUN
iajs-3387	25	4	,	,	PUNCT
iajs-3387	25	5	cardiovascular	cardiovascular	ADJ
iajs-3387	25	6	disease	disease	NOUN
iajs-3387	25	7	was	be	AUX
iajs-3387	25	8	thought	think	VERB
iajs-3387	25	9	to	to	PART
iajs-3387	25	10	be	be	AUX
iajs-3387	25	11	the	the	DET
iajs-3387	25	12	primary	primary	ADJ
iajs-3387	25	13	cause	cause	NOUN
iajs-3387	25	14	of	of	ADP
iajs-3387	25	15	mortality	mortality	NOUN
iajs-3387	25	16	[	[	X
iajs-3387	25	17	6	6	NUM
iajs-3387	25	18	-	-	SYM
iajs-3387	25	19	8	8	NUM
iajs-3387	25	20	]	]	PUNCT
iajs-3387	25	21	.	.	PUNCT
iajs-3387	26	1	surgical	surgical	ADJ
iajs-3387	26	2	,	,	PUNCT
iajs-3387	26	3	pharmaceutical	pharmaceutical	NOUN
iajs-3387	26	4	,	,	PUNCT
iajs-3387	26	5	and	and	CCONJ
iajs-3387	26	6	radiotherapeutic	radiotherapeutic	ADJ
iajs-3387	26	7	methods	method	NOUN
iajs-3387	26	8	treat	treat	VERB
iajs-3387	26	9	acromegaly	acromegaly	PROPN
iajs-3387	26	10	.	.	PUNCT
iajs-3387	27	1	multimodal	multimodal	NOUN
iajs-3387	27	2	therapy	therapy	NOUN
iajs-3387	27	3	can	can	AUX
iajs-3387	27	4	usually	usually	ADV
iajs-3387	27	5	control	control	VERB
iajs-3387	27	6	acromegaly	acromegaly	NOUN
iajs-3387	27	7	by	by	ADP
iajs-3387	27	8	stopping	stop	VERB
iajs-3387	27	9	gh	gh	PROPN
iajs-3387	27	10	hypersecretion	hypersecretion	NOUN
iajs-3387	27	11	,	,	PUNCT
iajs-3387	27	12	lowering	lower	VERB
iajs-3387	27	13	igf	igf	PROPN
iajs-3387	27	14	-	-	PUNCT
iajs-3387	27	15	i	i	PROPN
iajs-3387	27	16	levels	level	NOUN
iajs-3387	27	17	,	,	PUNCT
iajs-3387	27	18	and	and	CCONJ
iajs-3387	27	19	stopping	stop	VERB
iajs-3387	27	20	tumor	tumor	NOUN
iajs-3387	27	21	growth	growth	NOUN
iajs-3387	27	22	.	.	PUNCT
iajs-3387	28	1	this	this	PRON
iajs-3387	28	2	can	can	AUX
iajs-3387	28	3	also	also	ADV
iajs-3387	28	4	reduce	reduce	VERB
iajs-3387	28	5	the	the	DET
iajs-3387	28	6	symptoms	symptom	NOUN
iajs-3387	28	7	and	and	CCONJ
iajs-3387	28	8	other	other	ADJ
iajs-3387	28	9	health	health	NOUN
iajs-3387	28	10	problems	problem	NOUN
iajs-3387	28	11	that	that	PRON
iajs-3387	28	12	come	come	VERB
iajs-3387	28	13	with	with	ADP
iajs-3387	28	14	it	it	PRON
iajs-3387	28	15	[	[	X
iajs-3387	28	16	9,10	9,10	NUM
iajs-3387	28	17	]	]	X
iajs-3387	28	18	.	.	PUNCT
iajs-3387	29	1	the	the	DET
iajs-3387	29	2	anterior	anterior	ADJ
iajs-3387	29	3	pituitary	pituitary	ADJ
iajs-3387	29	4	secretes	secrete	NOUN
iajs-3387	29	5	the	the	DET
iajs-3387	29	6	peptide	peptide	ADJ
iajs-3387	29	7	hormone	hormone	NOUN
iajs-3387	29	8	known	know	VERB
iajs-3387	29	9	as	as	ADP
iajs-3387	29	10	human	human	PROPN
iajs-3387	29	11	gh	gh	PROPN
iajs-3387	29	12	.	.	PUNCT
iajs-3387	30	1	its	its	PRON
iajs-3387	30	2	main	main	ADJ
iajs-3387	30	3	function	function	NOUN
iajs-3387	30	4	is	be	AUX
iajs-3387	30	5	the	the	DET
iajs-3387	30	6	regulation	regulation	NOUN
iajs-3387	30	7	of	of	ADP
iajs-3387	30	8	postnatal	postnatal	ADJ
iajs-3387	30	9	growth	growth	NOUN
iajs-3387	30	10	and	and	CCONJ
iajs-3387	30	11	metabolism	metabolism	NOUN
iajs-3387	30	12	,	,	PUNCT
iajs-3387	30	13	and	and	CCONJ
iajs-3387	30	14	it	it	PRON
iajs-3387	30	15	affects	affect	VERB
iajs-3387	30	16	many	many	ADJ
iajs-3387	30	17	different	different	ADJ
iajs-3387	30	18	human	human	ADJ
iajs-3387	30	19	tissues	tissue	NOUN
iajs-3387	30	20	in	in	ADP
iajs-3387	30	21	a	a	DET
iajs-3387	30	22	pleiotropic	pleiotropic	ADJ
iajs-3387	30	23	manner	manner	NOUN
iajs-3387	31	1	[	[	X
iajs-3387	31	2	11	11	NUM
iajs-3387	31	3	]	]	PUNCT
iajs-3387	31	4	.	.	PUNCT
iajs-3387	32	1	the	the	DET
iajs-3387	32	2	somatotroph	somatotroph	PROPN
iajs-3387	32	3	cells	cell	NOUN
iajs-3387	32	4	in	in	ADP
iajs-3387	32	5	the	the	DET
iajs-3387	32	6	proximal	proximal	ADJ
iajs-3387	32	7	portion	portion	NOUN
iajs-3387	32	8	of	of	ADP
iajs-3387	32	9	the	the	DET
iajs-3387	32	10	pituitary	pituitary	ADJ
iajs-3387	32	11	gland	gland	NOUN
iajs-3387	32	12	produce	produce	VERB
iajs-3387	32	13	and	and	CCONJ
iajs-3387	32	14	release	release	VERB
iajs-3387	32	15	growth	growth	NOUN
iajs-3387	32	16	hormone	hormone	NOUN
iajs-3387	32	17	.	.	PUNCT
iajs-3387	33	1	the	the	DET
iajs-3387	33	2	hypothalamus	hypothalamus	PROPN
iajs-3387	33	3	and	and	CCONJ
iajs-3387	33	4	gh	gh	PROPN
iajs-3387	33	5	action	action	NOUN
iajs-3387	33	6	mediators	mediator	NOUN
iajs-3387	33	7	control	control	NOUN
iajs-3387	33	8	gh	gh	PROPN
iajs-3387	33	9	secretion	secretion	PROPN
iajs-3387	33	10	.	.	PUNCT
iajs-3387	34	1	the	the	DET
iajs-3387	34	2	gh	gh	PROPN
iajs-3387	34	3	-	-	PUNCT
iajs-3387	34	4	releasing	release	VERB
iajs-3387	34	5	hormone	hormone	NOUN
iajs-3387	34	6	(	(	PUNCT
iajs-3387	34	7	ghrh	ghrh	PROPN
iajs-3387	34	8	)	)	PUNCT
iajs-3387	34	9	,	,	PUNCT
iajs-3387	34	10	gh	gh	PROPN
iajs-3387	34	11	-	-	PUNCT
iajs-3387	34	12	releasing	releasing	NOUN
iajs-3387	34	13	peptide	peptide	NOUN
iajs-3387	34	14	(	(	PUNCT
iajs-3387	34	15	ghrelin	ghrelin	NOUN
iajs-3387	34	16	)	)	PUNCT
iajs-3387	34	17	,	,	PUNCT
iajs-3387	34	18	igf-1	igf-1	NOUN
iajs-3387	34	19	,	,	PUNCT
iajs-3387	34	20	and	and	CCONJ
iajs-3387	34	21	somatostatin	somatostatin	NOUN
iajs-3387	34	22	are	be	AUX
iajs-3387	34	23	some	some	DET
iajs-3387	34	24	examples	example	NOUN
iajs-3387	34	25	of	of	ADP
iajs-3387	34	26	regulatory	regulatory	ADJ
iajs-3387	34	27	substances	substance	NOUN
iajs-3387	34	28	.	.	PUNCT
iajs-3387	35	1	gh	gh	PROPN
iajs-3387	35	2	/	/	SYM
iajs-3387	35	3	igf1	igf1	PROPN
iajs-3387	35	4	system	system	NOUN
iajs-3387	35	5	disorders	disorder	NOUN
iajs-3387	35	6	are	be	AUX
iajs-3387	35	7	mostly	mostly	ADV
iajs-3387	35	8	caused	cause	VERB
iajs-3387	35	9	by	by	ADP
iajs-3387	35	10	either	either	CCONJ
iajs-3387	35	11	too	too	ADV
iajs-3387	35	12	much	much	ADJ
iajs-3387	35	13	gh	gh	PROPN
iajs-3387	35	14	(	(	PUNCT
iajs-3387	35	15	acromegaly	acromegaly	NOUN
iajs-3387	35	16	or	or	CCONJ
iajs-3387	35	17	gigantism	gigantism	NOUN
iajs-3387	35	18	)	)	PUNCT
iajs-3387	35	19	or	or	CCONJ
iajs-3387	35	20	not	not	PART
iajs-3387	35	21	enough	enough	ADJ
iajs-3387	35	22	gh	gh	PROPN
iajs-3387	36	1	[	[	X
iajs-3387	36	2	12	12	NUM
iajs-3387	36	3	]	]	PUNCT
iajs-3387	36	4	.	.	PUNCT
iajs-3387	37	1	insulin	insulin	NOUN
iajs-3387	37	2	-	-	PUNCT
iajs-3387	37	3	like	like	ADJ
iajs-3387	37	4	growth	growth	NOUN
iajs-3387	37	5	factor	factor	NOUN
iajs-3387	37	6	1	1	NUM
iajs-3387	37	7	(	(	PUNCT
iajs-3387	37	8	igf-1	igf-1	NOUN
iajs-3387	37	9	)	)	PUNCT
iajs-3387	37	10	,	,	PUNCT
iajs-3387	37	11	which	which	PRON
iajs-3387	37	12	can	can	AUX
iajs-3387	37	13	directly	directly	ADV
iajs-3387	37	14	decrease	decrease	VERB
iajs-3387	37	15	growth	growth	NOUN
iajs-3387	37	16	hormone	hormone	NOUN
iajs-3387	37	17	release	release	NOUN
iajs-3387	37	18	from	from	ADP
iajs-3387	37	19	the	the	DET
iajs-3387	37	20	somatotrophins	somatotrophin	NOUN
iajs-3387	37	21	or	or	CCONJ
iajs-3387	37	22	indirectly	indirectly	ADV
iajs-3387	37	23	through	through	ADP
iajs-3387	37	24	an	an	DET
iajs-3387	37	25	increase	increase	NOUN
iajs-3387	37	26	in	in	ADP
iajs-3387	37	27	somatostatin	somatostatin	NOUN
iajs-3387	37	28	,	,	PUNCT
iajs-3387	37	29	also	also	ADV
iajs-3387	37	30	impacts	impact	VERB
iajs-3387	37	31	hormone	hormone	NOUN
iajs-3387	37	32	release	release	NOUN
iajs-3387	37	33	.	.	PUNCT
iajs-3387	38	1	it	it	PRON
iajs-3387	38	2	also	also	ADV
iajs-3387	38	3	reduces	reduce	VERB
iajs-3387	38	4	the	the	DET
iajs-3387	38	5	release	release	NOUN
iajs-3387	38	6	of	of	ADP
iajs-3387	38	7	ghrh	ghrh	NOUN
iajs-3387	38	8	,	,	PUNCT
iajs-3387	38	9	which	which	PRON
iajs-3387	38	10	in	in	ADP
iajs-3387	38	11	turn	turn	NOUN
iajs-3387	38	12	inhibits	inhibit	VERB
iajs-3387	38	13	the	the	DET
iajs-3387	38	14	creation	creation	NOUN
iajs-3387	38	15	of	of	ADP
iajs-3387	38	16	gh	gh	PROPN
iajs-3387	39	1	[	[	X
iajs-3387	39	2	13	13	NUM
iajs-3387	39	3	]	]	PUNCT
iajs-3387	39	4	.	.	PUNCT
iajs-3387	40	1	growth	growth	NOUN
iajs-3387	40	2	hormone	hormone	NOUN
iajs-3387	40	3	(	(	PUNCT
iajs-3387	40	4	gh	gh	PROPN
iajs-3387	40	5	)	)	PUNCT
iajs-3387	40	6	and	and	CCONJ
iajs-3387	40	7	igf1	igf1	PROPN
iajs-3387	40	8	control	control	VERB
iajs-3387	40	9	the	the	DET
iajs-3387	40	10	two	two	NUM
iajs-3387	40	11	most	most	ADV
iajs-3387	40	12	prevalent	prevalent	ADJ
iajs-3387	40	13	proteins	protein	NOUN
iajs-3387	40	14	in	in	ADP
iajs-3387	40	15	musculoskeletal	musculoskeletal	ADJ
iajs-3387	40	16	tissues	tissue	NOUN
iajs-3387	40	17	,	,	PUNCT
iajs-3387	40	18	collagen	collagen	NOUN
iajs-3387	40	19	and	and	CCONJ
iajs-3387	40	20	myofibrillar	myofibrillar	ADJ
iajs-3387	40	21	protein	protein	NOUN
iajs-3387	40	22	[	[	X
iajs-3387	40	23	14	14	NUM
iajs-3387	40	24	]	]	PUNCT
iajs-3387	40	25	.	.	PUNCT
iajs-3387	41	1	prolidase	prolidase	NOUN
iajs-3387	41	2	(	(	PUNCT
iajs-3387	41	3	pld	pld	NOUN
iajs-3387	41	4	)	)	PUNCT
iajs-3387	41	5	is	be	AUX
iajs-3387	41	6	a	a	DET
iajs-3387	41	7	critical	critical	ADJ
iajs-3387	41	8	enzyme	enzyme	NOUN
iajs-3387	41	9	that	that	PRON
iajs-3387	41	10	helps	help	VERB
iajs-3387	41	11	provide	provide	VERB
iajs-3387	41	12	the	the	DET
iajs-3387	41	13	proline	proline	NOUN
iajs-3387	41	14	needed	need	VERB
iajs-3387	41	15	for	for	ADP
iajs-3387	41	16	collagen	collagen	NOUN
iajs-3387	41	17	production	production	NOUN
iajs-3387	41	18	and	and	CCONJ
iajs-3387	41	19	cell	cell	NOUN
iajs-3387	41	20	development	development	NOUN
iajs-3387	41	21	.	.	PUNCT
iajs-3387	42	1	the	the	DET
iajs-3387	42	2	pld	pld	PROPN
iajs-3387	42	3	absence	absence	NOUN
iajs-3387	42	4	causes	cause	VERB
iajs-3387	42	5	clinical	clinical	ADJ
iajs-3387	42	6	signs	sign	NOUN
iajs-3387	42	7	of	of	ADP
iajs-3387	42	8	collagen	collagen	NOUN
iajs-3387	42	9	deficiency	deficiency	NOUN
iajs-3387	42	10	,	,	PUNCT
iajs-3387	42	11	while	while	SCONJ
iajs-3387	42	12	increased	increase	VERB
iajs-3387	42	13	pld	pld	NOUN
iajs-3387	42	14	activity	activity	NOUN
iajs-3387	42	15	is	be	AUX
iajs-3387	42	16	associated	associate	VERB
iajs-3387	42	17	with	with	ADP
iajs-3387	42	18	fibrosis	fibrosis	NOUN
iajs-3387	42	19	.	.	PUNCT
iajs-3387	43	1	therefore	therefore	ADV
iajs-3387	43	2	,	,	PUNCT
iajs-3387	43	3	scientists	scientist	NOUN
iajs-3387	43	4	believe	believe	VERB
iajs-3387	43	5	that	that	SCONJ
iajs-3387	43	6	pld	pld	NOUN
iajs-3387	43	7	constrains	constrain	VERB
iajs-3387	43	8	the	the	DET
iajs-3387	43	9	control	control	NOUN
iajs-3387	43	10	of	of	ADP
iajs-3387	43	11	collagen	collagen	NOUN
iajs-3387	43	12	synthesis	synthesis	NOUN
iajs-3387	43	13	[	[	X
iajs-3387	43	14	15	15	NUM
iajs-3387	43	15	]	]	PUNCT
iajs-3387	43	16	.	.	PUNCT
iajs-3387	44	1	the	the	DET
iajs-3387	44	2	pld	pld	NOUN
iajs-3387	44	3	is	be	AUX
iajs-3387	44	4	the	the	DET
iajs-3387	44	5	sole	sole	ADJ
iajs-3387	44	6	known	know	VERB
iajs-3387	44	7	human	human	ADJ
iajs-3387	44	8	enzyme	enzyme	NOUN
iajs-3387	44	9	capable	capable	ADJ
iajs-3387	44	10	of	of	ADP
iajs-3387	44	11	hydrolyzing	hydrolyzing	NOUN
iajs-3387	44	12	dipeptides	dipeptide	NOUN
iajs-3387	44	13	with	with	ADP
iajs-3387	44	14	an	an	DET
iajs-3387	44	15	amino	amino	NOUN
iajs-3387	44	16	acid	acid	NOUN
iajs-3387	44	17	at	at	ADP
iajs-3387	44	18	their	their	PRON
iajs-3387	44	19	c	c	PROPN
iajs-3387	44	20	terminus	terminus	NOUN
iajs-3387	44	21	.	.	PUNCT
iajs-3387	45	1	this	this	PRON
iajs-3387	45	2	causes	cause	VERB
iajs-3387	45	3	the	the	DET
iajs-3387	45	4	production	production	NOUN
iajs-3387	45	5	of	of	ADP
iajs-3387	45	6	free	free	ADJ
iajs-3387	45	7	proline	proline	NOUN
iajs-3387	45	8	,	,	PUNCT
iajs-3387	45	9	which	which	PRON
iajs-3387	45	10	the	the	DET
iajs-3387	45	11	cell	cell	NOUN
iajs-3387	45	12	may	may	AUX
iajs-3387	45	13	then	then	ADV
iajs-3387	45	14	utilize	utilize	VERB
iajs-3387	45	15	.	.	PUNCT
iajs-3387	46	1	in	in	ADP
iajs-3387	46	2	collagen	collagen	NOUN
iajs-3387	46	3	metabolism	metabolism	NOUN
iajs-3387	46	4	,	,	PUNCT
iajs-3387	46	5	this	this	DET
iajs-3387	46	6	action	action	NOUN
iajs-3387	46	7	is	be	AUX
iajs-3387	46	8	very	very	ADV
iajs-3387	46	9	crucial	crucial	ADJ
iajs-3387	46	10	[	[	X
iajs-3387	46	11	16	16	NUM
iajs-3387	46	12	]	]	PUNCT
iajs-3387	46	13	.	.	PUNCT
iajs-3387	47	1	the	the	DET
iajs-3387	47	2	pld	pld	NOUN
iajs-3387	47	3	is	be	AUX
iajs-3387	47	4	present	present	ADJ
iajs-3387	47	5	in	in	ADP
iajs-3387	47	6	the	the	DET
iajs-3387	47	7	brain	brain	NOUN
iajs-3387	47	8	,	,	PUNCT
iajs-3387	47	9	heart	heart	NOUN
iajs-3387	47	10	tissue	tissue	NOUN
iajs-3387	47	11	,	,	PUNCT
iajs-3387	47	12	uterine	uterine	ADJ
iajs-3387	47	13	tissue	tissue	NOUN
iajs-3387	47	14	cells	cell	NOUN
iajs-3387	47	15	,	,	PUNCT
iajs-3387	47	16	spleen	spleen	NOUN
iajs-3387	47	17	,	,	PUNCT
iajs-3387	47	18	mononuclear	mononuclear	ADJ
iajs-3387	47	19	cells	cell	NOUN
iajs-3387	47	20	,	,	PUNCT
iajs-3387	47	21	neutrophils	neutrophil	NOUN
iajs-3387	47	22	,	,	PUNCT
iajs-3387	47	23	red	red	ADJ
iajs-3387	47	24	blood	blood	NOUN
iajs-3387	47	25	cells	cell	NOUN
iajs-3387	47	26	,	,	PUNCT
iajs-3387	47	27	gut	gut	NOUN
iajs-3387	47	28	,	,	PUNCT
iajs-3387	47	29	and	and	CCONJ
iajs-3387	47	30	red	red	ADJ
iajs-3387	47	31	blood	blood	NOUN
iajs-3387	47	32	cells	cell	NOUN
iajs-3387	47	33	.	.	PUNCT
iajs-3387	48	1	it	it	PRON
iajs-3387	48	2	plays	play	VERB
iajs-3387	48	3	a	a	DET
iajs-3387	48	4	significant	significant	ADJ
iajs-3387	48	5	part	part	NOUN
iajs-3387	48	6	in	in	ADP
iajs-3387	48	7	several	several	ADJ
iajs-3387	48	8	physiological	physiological	ADJ
iajs-3387	48	9	processes	process	NOUN
iajs-3387	48	10	.	.	PUNCT
iajs-3387	49	1	furthermore	furthermore	ADV
iajs-3387	49	2	,	,	PUNCT
iajs-3387	49	3	it	it	PRON
iajs-3387	49	4	contributes	contribute	VERB
iajs-3387	49	5	significantly	significantly	ADV
iajs-3387	49	6	to	to	ADP
iajs-3387	49	7	pathological	pathological	ADJ
iajs-3387	49	8	conditions	condition	NOUN
iajs-3387	49	9	like	like	ADP
iajs-3387	49	10	injury	injury	NOUN
iajs-3387	49	11	and	and	CCONJ
iajs-3387	49	12	infection	infection	NOUN
iajs-3387	49	13	recovery	recovery	NOUN
iajs-3387	49	14	,	,	PUNCT
iajs-3387	49	15	vascular	vascular	ADJ
iajs-3387	49	16	growth	growth	NOUN
iajs-3387	49	17	that	that	PRON
iajs-3387	49	18	fosters	foster	VERB
iajs-3387	49	19	cancer	cancer	NOUN
iajs-3387	49	20	,	,	PUNCT
iajs-3387	49	21	and	and	CCONJ
iajs-3387	49	22	the	the	DET
iajs-3387	49	23	dissemination	dissemination	NOUN
iajs-3387	49	24	of	of	ADP
iajs-3387	49	25	cancer	cancer	NOUN
iajs-3387	49	26	[	[	X
iajs-3387	49	27	17	17	NUM
iajs-3387	49	28	]	]	PUNCT
iajs-3387	49	29	.	.	PUNCT
iajs-3387	50	1	the	the	DET
iajs-3387	50	2	pld	pld	NOUN
iajs-3387	50	3	deficiency	deficiency	NOUN
iajs-3387	50	4	(	(	PUNCT
iajs-3387	50	5	pd	pd	X
iajs-3387	50	6	)	)	PUNCT
iajs-3387	50	7	is	be	AUX
iajs-3387	50	8	characterized	characterize	VERB
iajs-3387	50	9	by	by	ADP
iajs-3387	50	10	a	a	DET
iajs-3387	50	11	variety	variety	NOUN
iajs-3387	50	12	of	of	ADP
iajs-3387	50	13	clinical	clinical	ADJ
iajs-3387	50	14	signs	sign	NOUN
iajs-3387	50	15	,	,	PUNCT
iajs-3387	50	16	the	the	DET
iajs-3387	50	17	most	most	ADV
iajs-3387	50	18	common	common	ADJ
iajs-3387	50	19	of	of	ADP
iajs-3387	50	20	which	which	PRON
iajs-3387	50	21	are	be	AUX
iajs-3387	50	22	persistent	persistent	ADJ
iajs-3387	50	23	respiratory	respiratory	ADJ
iajs-3387	50	24	infections	infection	NOUN
iajs-3387	50	25	,	,	PUNCT
iajs-3387	50	26	mental	mental	ADJ
iajs-3387	50	27	impairment	impairment	NOUN
iajs-3387	50	28	,	,	PUNCT
iajs-3387	50	29	and	and	CCONJ
iajs-3387	50	30	chronic	chronic	ADJ
iajs-3387	50	31	skin	skin	NOUN
iajs-3387	50	32	ulcerations	ulceration	NOUN
iajs-3387	50	33	[	[	X
iajs-3387	50	34	16	16	NUM
iajs-3387	50	35	]	]	PUNCT
iajs-3387	50	36	.	.	PUNCT
iajs-3387	51	1	the	the	DET
iajs-3387	51	2	pld	pld	NOUN
iajs-3387	51	3	activity	activity	NOUN
iajs-3387	51	4	frequently	frequently	ADV
iajs-3387	51	5	triggers	trigger	VERB
iajs-3387	51	6	this	this	DET
iajs-3387	51	7	condition	condition	NOUN
iajs-3387	51	8	.	.	PUNCT
iajs-3387	52	1	to	to	ADP
iajs-3387	52	2	date	date	NOUN
iajs-3387	52	3	,	,	PUNCT
iajs-3387	52	4	researchers	researcher	NOUN
iajs-3387	52	5	have	have	AUX
iajs-3387	52	6	identified	identify	VERB
iajs-3387	52	7	only	only	ADV
iajs-3387	52	8	a	a	DET
iajs-3387	52	9	little	little	ADJ
iajs-3387	52	10	over	over	ADP
iajs-3387	52	11	one	one	NUM
iajs-3387	52	12	hundred	hundred	NUM
iajs-3387	52	13	people	people	NOUN
iajs-3387	52	14	with	with	ADP
iajs-3387	52	15	pd	pd	PROPN
iajs-3387	52	16	,	,	PUNCT
iajs-3387	52	17	a	a	DET
iajs-3387	52	18	rare	rare	ADJ
iajs-3387	52	19	recessive	recessive	ADJ
iajs-3387	52	20	genetic	genetic	ADJ
iajs-3387	52	21	condition	condition	NOUN
iajs-3387	52	22	.	.	PUNCT
iajs-3387	53	1	the	the	DET
iajs-3387	53	2	pld	pld	PROPN
iajs-3387	53	3	gene	gene	NOUN
iajs-3387	53	4	has	have	VERB
iajs-3387	53	5	35	35	NUM
iajs-3387	53	6	variants	variant	NOUN
iajs-3387	53	7	in	in	ADP
iajs-3387	53	8	pd	pd	PROPN
iajs-3387	53	9	patients	patient	NOUN
iajs-3387	53	10	,	,	PUNCT
iajs-3387	53	11	including	include	VERB
iajs-3387	53	12	9	9	NUM
iajs-3387	53	13	insertions	insertion	NOUN
iajs-3387	53	14	and	and	CCONJ
iajs-3387	53	15	deletions	deletion	NOUN
iajs-3387	53	16	and	and	CCONJ
iajs-3387	53	17	16	16	NUM
iajs-3387	53	18	missense	missense	NOUN
iajs-3387	53	19	mutations	mutation	NOUN
iajs-3387	53	20	[	[	X
iajs-3387	53	21	18	18	NUM
iajs-3387	53	22	]	]	PUNCT
iajs-3387	53	23	.	.	PUNCT
iajs-3387	54	1	furthermore	furthermore	ADV
iajs-3387	54	2	,	,	PUNCT
iajs-3387	54	3	various	various	ADJ
iajs-3387	54	4	clinical	clinical	ADJ
iajs-3387	54	5	states	state	NOUN
iajs-3387	54	6	have	have	AUX
iajs-3387	54	7	observed	observe	VERB
iajs-3387	54	8	changes	change	NOUN
iajs-3387	54	9	in	in	ADP
iajs-3387	54	10	pld	pld	NOUN
iajs-3387	54	11	enzyme	enzyme	NOUN
iajs-3387	54	12	activity	activity	NOUN
iajs-3387	54	13	,	,	PUNCT
iajs-3387	54	14	making	make	VERB
iajs-3387	54	15	it	it	PRON
iajs-3387	54	16	a	a	DET
iajs-3387	54	17	valuable	valuable	ADJ
iajs-3387	54	18	biochemical	biochemical	ADJ
iajs-3387	54	19	marker	marker	NOUN
iajs-3387	54	20	for	for	ADP
iajs-3387	54	21	evaluating	evaluate	VERB
iajs-3387	54	22	the	the	DET
iajs-3387	54	23	severity	severity	NOUN
iajs-3387	54	24	of	of	ADP
iajs-3387	54	25	the	the	DET
iajs-3387	54	26	disease	disease	NOUN
iajs-3387	54	27	[	[	X
iajs-3387	54	28	19	19	NUM
iajs-3387	54	29	]	]	PUNCT
iajs-3387	54	30	.	.	PUNCT
iajs-3387	55	1	the	the	DET
iajs-3387	55	2	study	study	NOUN
iajs-3387	55	3	's	's	PART
iajs-3387	55	4	goal	goal	NOUN
iajs-3387	55	5	is	be	AUX
iajs-3387	55	6	to	to	PART
iajs-3387	55	7	estimate	estimate	VERB
iajs-3387	55	8	the	the	DET
iajs-3387	55	9	values	value	NOUN
iajs-3387	55	10	of	of	ADP
iajs-3387	55	11	pld	pld	NOUN
iajs-3387	55	12	,	,	PUNCT
iajs-3387	55	13	correlation	correlation	NOUN
iajs-3387	55	14	,	,	PUNCT
iajs-3387	55	15	and	and	CCONJ
iajs-3387	55	16	roc	roc	PROPN
iajs-3387	55	17	in	in	ADP
iajs-3387	55	18	acromegaly	acromegaly	PROPN
iajs-3387	55	19	patients	patient	NOUN
iajs-3387	55	20	.	.	PUNCT
iajs-3387	56	1	2	2	X
iajs-3387	56	2	.	.	X
iajs-3387	56	3	materials	material	NOUN
iajs-3387	56	4	and	and	CCONJ
iajs-3387	56	5	methods	method	NOUN
iajs-3387	56	6	2.1	2.1	NUM
iajs-3387	56	7	patients	patient	NOUN
iajs-3387	56	8	selection	selection	NOUN
iajs-3387	56	9	sixty	sixty	NUM
iajs-3387	56	10	-	-	PUNCT
iajs-3387	56	11	one	one	NUM
iajs-3387	56	12	acromegalic	acromegalic	ADJ
iajs-3387	56	13	patients	patient	NOUN
iajs-3387	56	14	were	be	AUX
iajs-3387	56	15	enrolled	enrol	VERB
iajs-3387	56	16	in	in	ADP
iajs-3387	56	17	the	the	DET
iajs-3387	56	18	study	study	NOUN
iajs-3387	56	19	,	,	PUNCT
iajs-3387	56	20	plus	plus	CCONJ
iajs-3387	56	21	sixty	sixty	NUM
iajs-3387	56	22	non	non	ADJ
iajs-3387	56	23	-	-	ADJ
iajs-3387	56	24	acromegalic	acromegalic	ADJ
iajs-3387	56	25	patients	patient	NOUN
iajs-3387	56	26	as	as	ADP
iajs-3387	56	27	the	the	DET
iajs-3387	56	28	control	control	NOUN
iajs-3387	56	29	group	group	NOUN
iajs-3387	56	30	.	.	PUNCT
iajs-3387	57	1	they	they	PRON
iajs-3387	57	2	were	be	AUX
iajs-3387	57	3	studied	study	VERB
iajs-3387	57	4	during	during	ADP
iajs-3387	57	5	the	the	DET
iajs-3387	57	6	period	period	NOUN
iajs-3387	57	7	from	from	ADP
iajs-3387	57	8	november	november	PROPN
iajs-3387	57	9	2022	2022	NUM
iajs-3387	57	10	to	to	ADP
iajs-3387	57	11	february	february	PROPN
iajs-3387	57	12	2023	2023	NUM
iajs-3387	57	13	.	.	PUNCT
iajs-3387	58	1	they	they	PRON
iajs-3387	58	2	attend	attend	VERB
iajs-3387	58	3	the	the	DET
iajs-3387	58	4	national	national	ADJ
iajs-3387	58	5	diabetic	diabetic	ADJ
iajs-3387	58	6	center	center	NOUN
iajs-3387	58	7	at	at	ADP
iajs-3387	58	8	mustansyrriah	mustansyrriah	PROPN
iajs-3387	58	9	university	university	PROPN
iajs-3387	58	10	monthly	monthly	ADV
iajs-3387	58	11	for	for	ADP
iajs-3387	58	12	follow	follow	NOUN
iajs-3387	58	13	-	-	PUNCT
iajs-3387	58	14	up	up	NOUN
iajs-3387	58	15	and	and	CCONJ
iajs-3387	58	16	to	to	PART
iajs-3387	58	17	receive	receive	VERB
iajs-3387	58	18	their	their	PRON
iajs-3387	58	19	monthly	monthly	ADJ
iajs-3387	58	20	injection	injection	NOUN
iajs-3387	58	21	of	of	ADP
iajs-3387	58	22	long	long	ADV
iajs-3387	58	23	-	-	PUNCT
iajs-3387	58	24	acting	act	VERB
iajs-3387	58	25	repeatable	repeatable	ADJ
iajs-3387	58	26	octreotide	octreotide	NOUN
iajs-3387	58	27	(	(	PUNCT
iajs-3387	58	28	sandostatin	sandostatin	NOUN
iajs-3387	58	29	-	-	PUNCT
iajs-3387	58	30	lar	lar	NOUN
iajs-3387	58	31	)	)	PUNCT
iajs-3387	58	32	after	after	ADP
iajs-3387	58	33	ethical	ethical	ADJ
iajs-3387	58	34	consent	consent	NOUN
iajs-3387	58	35	obtained	obtain	VERB
iajs-3387	58	36	from	from	ADP
iajs-3387	58	37	the	the	DET
iajs-3387	58	38	review	review	NOUN
iajs-3387	58	39	board	board	NOUN
iajs-3387	58	40	and	and	CCONJ
iajs-3387	58	41	verbal	verbal	ADJ
iajs-3387	58	42	consent	consent	NOUN
iajs-3387	58	43	of	of	ADP
iajs-3387	58	44	participation	participation	NOUN
iajs-3387	58	45	from	from	ADP
iajs-3387	58	46	the	the	DET
iajs-3387	58	47	subjects	subject	NOUN
iajs-3387	58	48	.	.	PUNCT
iajs-3387	59	1	2.2	2.2	NUM
iajs-3387	59	2	inclusion	inclusion	NOUN
iajs-3387	59	3	and	and	CCONJ
iajs-3387	59	4	exclusion	exclusion	NOUN
iajs-3387	59	5	criteria	criterion	NOUN
iajs-3387	59	6	ihjpas	ihjpa	VERB
iajs-3387	59	7	.	.	PUNCT
iajs-3387	60	1	2024	2024	NUM
iajs-3387	60	2	,	,	PUNCT
iajs-3387	60	3	37(4	37(4	PROPN
iajs-3387	60	4	)	)	PUNCT
iajs-3387	60	5	257	257	NUM
iajs-3387	60	6	the	the	DET
iajs-3387	60	7	inclusion	inclusion	NOUN
iajs-3387	60	8	criteria	criterion	NOUN
iajs-3387	60	9	included	include	VERB
iajs-3387	60	10	patients	patient	NOUN
iajs-3387	60	11	with	with	ADP
iajs-3387	60	12	acromegaly	acromegaly	NOUN
iajs-3387	60	13	aged	age	VERB
iajs-3387	60	14	30	30	NUM
iajs-3387	60	15	-	-	SYM
iajs-3387	60	16	65	65	NUM
iajs-3387	60	17	years	year	NOUN
iajs-3387	60	18	old	old	ADJ
iajs-3387	60	19	,	,	PUNCT
iajs-3387	60	20	and	and	CCONJ
iajs-3387	60	21	the	the	DET
iajs-3387	60	22	exclusion	exclusion	NOUN
iajs-3387	60	23	criteria	criterion	NOUN
iajs-3387	60	24	are	be	AUX
iajs-3387	60	25	thyroid	thyroid	NOUN
iajs-3387	60	26	disease	disease	NOUN
iajs-3387	60	27	,	,	PUNCT
iajs-3387	60	28	heart	heart	NOUN
iajs-3387	60	29	disease	disease	NOUN
iajs-3387	60	30	,	,	PUNCT
iajs-3387	60	31	and	and	CCONJ
iajs-3387	60	32	kidney	kidney	NOUN
iajs-3387	60	33	disease	disease	NOUN
iajs-3387	60	34	,	,	PUNCT
iajs-3387	60	35	as	as	ADV
iajs-3387	60	36	well	well	ADV
iajs-3387	60	37	as	as	ADP
iajs-3387	60	38	pregnant	pregnant	ADJ
iajs-3387	60	39	women	woman	NOUN
iajs-3387	60	40	.	.	PUNCT
iajs-3387	61	1	the	the	DET
iajs-3387	61	2	study	study	NOUN
iajs-3387	61	3	measured	measure	VERB
iajs-3387	61	4	the	the	DET
iajs-3387	61	5	following	follow	VERB
iajs-3387	61	6	parameters	parameter	NOUN
iajs-3387	61	7	:	:	PUNCT
iajs-3387	61	8	pld	pld	NOUN
iajs-3387	61	9	,	,	PUNCT
iajs-3387	61	10	gh	gh	PROPN
iajs-3387	61	11	,	,	PUNCT
iajs-3387	61	12	and	and	CCONJ
iajs-3387	61	13	igf-1	igf-1	NOUN
iajs-3387	61	14	.	.	NOUN
iajs-3387	62	1	2.3	2.3	NUM
iajs-3387	62	2	biochemical	biochemical	ADJ
iajs-3387	62	3	assay	assay	VERB
iajs-3387	62	4	the	the	DET
iajs-3387	62	5	pld	pld	NOUN
iajs-3387	62	6	level	level	NOUN
iajs-3387	62	7	was	be	AUX
iajs-3387	62	8	measured	measure	VERB
iajs-3387	62	9	from	from	ADP
iajs-3387	62	10	a	a	DET
iajs-3387	62	11	serum	serum	NOUN
iajs-3387	62	12	sample	sample	NOUN
iajs-3387	62	13	by	by	ADP
iajs-3387	62	14	the	the	DET
iajs-3387	62	15	(	(	PUNCT
iajs-3387	62	16	enzyme	enzyme	NOUN
iajs-3387	62	17	-	-	PUNCT
iajs-3387	62	18	linked	link	VERB
iajs-3387	62	19	immunosorbent	immunosorbent	NOUN
iajs-3387	62	20	assay	assay	PROPN
iajs-3387	62	21	(	(	PUNCT
iajs-3387	62	22	elisa	elisa	NOUN
iajs-3387	62	23	)	)	PUNCT
iajs-3387	62	24	)	)	PUNCT
iajs-3387	62	25	using	use	VERB
iajs-3387	62	26	a	a	DET
iajs-3387	62	27	kit	kit	NOUN
iajs-3387	62	28	(	(	PUNCT
iajs-3387	62	29	my	my	PRON
iajs-3387	62	30	biosource	biosource	NOUN
iajs-3387	62	31	,	,	PUNCT
iajs-3387	62	32	usa	usa	PROPN
iajs-3387	62	33	)	)	PUNCT
iajs-3387	62	34	,	,	PUNCT
iajs-3387	62	35	while	while	SCONJ
iajs-3387	62	36	gh	gh	PROPN
iajs-3387	62	37	and	and	CCONJ
iajs-3387	62	38	igf-1	igf-1	ADV
iajs-3387	62	39	were	be	AUX
iajs-3387	62	40	measured	measure	VERB
iajs-3387	62	41	using	use	VERB
iajs-3387	62	42	the	the	DET
iajs-3387	62	43	sandwich	sandwich	NOUN
iajs-3387	62	44	chemiluminescence	chemiluminescence	NOUN
iajs-3387	62	45	immunoassay	immunoassay	PROPN
iajs-3387	62	46	technique	technique	NOUN
iajs-3387	62	47	(	(	PUNCT
iajs-3387	62	48	elisa	elisa	NOUN
iajs-3387	62	49	)	)	PUNCT
iajs-3387	62	50	blood	blood	NOUN
iajs-3387	62	51	samples	sample	NOUN
iajs-3387	62	52	(	(	PUNCT
iajs-3387	62	53	5	5	NUM
iajs-3387	62	54	ml	ml	NOUN
iajs-3387	62	55	)	)	PUNCT
iajs-3387	62	56	were	be	AUX
iajs-3387	62	57	collected	collect	VERB
iajs-3387	62	58	from	from	ADP
iajs-3387	62	59	acromegalic	acromegalic	ADJ
iajs-3387	62	60	patients	patient	NOUN
iajs-3387	62	61	and	and	CCONJ
iajs-3387	62	62	healthy	healthy	ADJ
iajs-3387	62	63	subjects	subject	NOUN
iajs-3387	62	64	,	,	PUNCT
iajs-3387	62	65	then	then	ADV
iajs-3387	62	66	centrifuged	centrifuge	VERB
iajs-3387	62	67	at	at	ADP
iajs-3387	62	68	3000	3000	NUM
iajs-3387	62	69	rpm	rpm	NOUN
iajs-3387	62	70	for	for	ADP
iajs-3387	62	71	10	10	NUM
iajs-3387	62	72	min	min	NOUN
iajs-3387	62	73	.	.	PROPN
iajs-3387	62	74	,	,	PUNCT
iajs-3387	62	75	and	and	CCONJ
iajs-3387	62	76	kept	keep	VERB
iajs-3387	62	77	at	at	ADP
iajs-3387	62	78	a	a	DET
iajs-3387	62	79	temperature	temperature	NOUN
iajs-3387	62	80	of	of	ADP
iajs-3387	62	81	-20	-20	NUM
iajs-3387	62	82	̊	̊	PROPN
iajs-3387	62	83	c.	c.	NOUN
iajs-3387	62	84	2.4	2.4	NUM
iajs-3387	62	85	statistical	statistical	ADJ
iajs-3387	62	86	analysis	analysis	NOUN
iajs-3387	62	87	the	the	DET
iajs-3387	62	88	significance	significance	NOUN
iajs-3387	62	89	of	of	ADP
iajs-3387	62	90	the	the	DET
iajs-3387	62	91	results	result	NOUN
iajs-3387	62	92	was	be	AUX
iajs-3387	62	93	evaluated	evaluate	VERB
iajs-3387	62	94	using	use	VERB
iajs-3387	62	95	spss	spss	PROPN
iajs-3387	62	96	(	(	PUNCT
iajs-3387	62	97	version	version	NOUN
iajs-3387	62	98	25.0	25.0	NUM
iajs-3387	62	99	,	,	PUNCT
iajs-3387	62	100	spss	spss	PROPN
iajs-3387	62	101	inc	inc	PROPN
iajs-3387	62	102	.	.	PROPN
iajs-3387	62	103	,	,	PUNCT
iajs-3387	62	104	chicago	chicago	PROPN
iajs-3387	62	105	,	,	PUNCT
iajs-3387	62	106	il	il	PROPN
iajs-3387	62	107	,	,	PUNCT
iajs-3387	62	108	usa	usa	PROPN
iajs-3387	62	109	)	)	PUNCT
iajs-3387	62	110	.	.	PUNCT
iajs-3387	63	1	summary	summary	NOUN
iajs-3387	63	2	data	datum	NOUN
iajs-3387	63	3	are	be	AUX
iajs-3387	63	4	presented	present	VERB
iajs-3387	63	5	as	as	SCONJ
iajs-3387	63	6	means	mean	VERB
iajs-3387	63	7	±	±	NUM
iajs-3387	63	8	sd	sd	NOUN
iajs-3387	63	9	.	.	PUNCT
iajs-3387	64	1	the	the	DET
iajs-3387	64	2	statistical	statistical	ADJ
iajs-3387	64	3	differences	difference	NOUN
iajs-3387	64	4	between	between	ADP
iajs-3387	64	5	continuous	continuous	ADJ
iajs-3387	64	6	variables	variable	NOUN
iajs-3387	64	7	were	be	AUX
iajs-3387	64	8	analyzed	analyze	VERB
iajs-3387	64	9	using	use	VERB
iajs-3387	64	10	an	an	DET
iajs-3387	64	11	independent	independent	ADJ
iajs-3387	64	12	sample	sample	NOUN
iajs-3387	64	13	student	student	NOUN
iajs-3387	64	14	's	's	PART
iajs-3387	64	15	t	t	NOUN
iajs-3387	64	16	-	-	PUNCT
iajs-3387	64	17	test	test	NOUN
iajs-3387	64	18	.	.	PUNCT
iajs-3387	65	1	other	other	ADJ
iajs-3387	65	2	tests	test	NOUN
iajs-3387	65	3	have	have	AUX
iajs-3387	65	4	been	be	AUX
iajs-3387	65	5	used	use	VERB
iajs-3387	65	6	.	.	PUNCT
iajs-3387	66	1	a	a	DET
iajs-3387	66	2	graphical	graphical	ADJ
iajs-3387	66	3	plot	plot	NOUN
iajs-3387	66	4	known	know	VERB
iajs-3387	66	5	as	as	ADP
iajs-3387	66	6	the	the	DET
iajs-3387	66	7	receiver	receiver	NOUN
iajs-3387	66	8	operating	operate	VERB
iajs-3387	66	9	characteristic	characteristic	NOUN
iajs-3387	66	10	(	(	PUNCT
iajs-3387	66	11	roc	roc	PROPN
iajs-3387	66	12	)	)	PUNCT
iajs-3387	66	13	illustrates	illustrate	VERB
iajs-3387	66	14	the	the	DET
iajs-3387	66	15	diagnostic	diagnostic	ADJ
iajs-3387	66	16	ability	ability	NOUN
iajs-3387	66	17	of	of	ADP
iajs-3387	66	18	a	a	DET
iajs-3387	66	19	binary	binary	ADJ
iajs-3387	66	20	classifier	classifier	NOUN
iajs-3387	66	21	system	system	NOUN
iajs-3387	66	22	as	as	ADP
iajs-3387	66	23	its	its	PRON
iajs-3387	66	24	discrimination	discrimination	NOUN
iajs-3387	66	25	threshold	threshold	NOUN
iajs-3387	66	26	varies	vary	VERB
iajs-3387	66	27	.	.	PUNCT
iajs-3387	67	1	3	3	X
iajs-3387	67	2	.	.	NOUN
iajs-3387	67	3	results	result	NOUN
iajs-3387	67	4	table	table	NOUN
iajs-3387	67	5	1	1	NUM
iajs-3387	67	6	shows	show	VERB
iajs-3387	67	7	the	the	DET
iajs-3387	67	8	baseline	baseline	PROPN
iajs-3387	67	9	characteristics	characteristic	NOUN
iajs-3387	67	10	of	of	ADP
iajs-3387	67	11	the	the	DET
iajs-3387	67	12	patients	patient	NOUN
iajs-3387	67	13	and	and	CCONJ
iajs-3387	67	14	their	their	PRON
iajs-3387	67	15	healthy	healthy	ADJ
iajs-3387	67	16	control	control	NOUN
iajs-3387	67	17	counterparts	counterpart	NOUN
iajs-3387	67	18	.	.	PUNCT
iajs-3387	68	1	the	the	DET
iajs-3387	68	2	patient	patient	ADJ
iajs-3387	68	3	group	group	NOUN
iajs-3387	68	4	has	have	VERB
iajs-3387	68	5	a	a	DET
iajs-3387	68	6	higher	high	ADJ
iajs-3387	68	7	level	level	NOUN
iajs-3387	68	8	of	of	ADP
iajs-3387	68	9	pld	pld	NOUN
iajs-3387	68	10	than	than	ADP
iajs-3387	68	11	the	the	DET
iajs-3387	68	12	healthy	healthy	ADJ
iajs-3387	68	13	control	control	NOUN
iajs-3387	68	14	group	group	NOUN
iajs-3387	68	15	.	.	PUNCT
iajs-3387	69	1	the	the	DET
iajs-3387	69	2	pld	pld	NOUN
iajs-3387	69	3	is	be	AUX
iajs-3387	69	4	694.57±122.12	694.57±122.12	NUM
iajs-3387	69	5	in	in	ADP
iajs-3387	69	6	the	the	DET
iajs-3387	69	7	patient	patient	NOUN
iajs-3387	69	8	group	group	NOUN
iajs-3387	69	9	and	and	CCONJ
iajs-3387	69	10	411.64±62.86	411.64±62.86	NOUN
iajs-3387	69	11	in	in	ADP
iajs-3387	69	12	the	the	DET
iajs-3387	69	13	control	control	NOUN
iajs-3387	69	14	group	group	NOUN
iajs-3387	69	15	(	(	PUNCT
iajs-3387	69	16	p	p	X
iajs-3387	69	17	<	<	X
iajs-3387	69	18	0.001	0.001	NUM
iajs-3387	69	19	)	)	PUNCT
iajs-3387	69	20	.	.	PUNCT
iajs-3387	70	1	fasting	fast	VERB
iajs-3387	70	2	blood	blood	NOUN
iajs-3387	70	3	glucose	glucose	NOUN
iajs-3387	70	4	(	(	PUNCT
iajs-3387	70	5	fbg	fbg	PROPN
iajs-3387	70	6	)	)	PUNCT
iajs-3387	70	7	is	be	AUX
iajs-3387	70	8	143.84±83.02	143.84±83.02	NUM
iajs-3387	70	9	in	in	ADP
iajs-3387	70	10	acromegalic	acromegalic	ADJ
iajs-3387	70	11	patients	patient	NOUN
iajs-3387	70	12	and	and	CCONJ
iajs-3387	70	13	93.58±11.56	93.58±11.56	NUM
iajs-3387	70	14	in	in	ADP
iajs-3387	70	15	healthy	healthy	ADJ
iajs-3387	70	16	controls	control	NOUN
iajs-3387	70	17	;	;	PUNCT
iajs-3387	70	18	the	the	DET
iajs-3387	70	19	difference	difference	NOUN
iajs-3387	70	20	is	be	AUX
iajs-3387	70	21	highly	highly	ADV
iajs-3387	70	22	significant	significant	ADJ
iajs-3387	70	23	.	.	PUNCT
iajs-3387	71	1	the	the	DET
iajs-3387	71	2	gh	gh	PROPN
iajs-3387	71	3	in	in	ADP
iajs-3387	71	4	acromegalic	acromegalic	ADJ
iajs-3387	71	5	patients	patient	NOUN
iajs-3387	71	6	is	be	AUX
iajs-3387	71	7	7.05±3.53	7.05±3.53	NOUN
iajs-3387	71	8	,	,	PUNCT
iajs-3387	71	9	whereas	whereas	SCONJ
iajs-3387	71	10	in	in	ADP
iajs-3387	71	11	the	the	DET
iajs-3387	71	12	control	control	NOUN
iajs-3387	71	13	it	it	PRON
iajs-3387	71	14	is	be	AUX
iajs-3387	71	15	0.70±0.29	0.70±0.29	NOUN
iajs-3387	71	16	,	,	PUNCT
iajs-3387	71	17	and	and	CCONJ
iajs-3387	71	18	the	the	DET
iajs-3387	71	19	difference	difference	NOUN
iajs-3387	71	20	is	be	AUX
iajs-3387	71	21	highly	highly	ADV
iajs-3387	71	22	significant	significant	ADJ
iajs-3387	71	23	(	(	PUNCT
iajs-3387	71	24	p	p	X
iajs-3387	71	25	<	<	X
iajs-3387	71	26	0.001	0.001	NUM
iajs-3387	71	27	)	)	PUNCT
iajs-3387	71	28	.	.	PUNCT
iajs-3387	72	1	moreover	moreover	ADV
iajs-3387	72	2	,	,	PUNCT
iajs-3387	72	3	igf-1	igf-1	ADV
iajs-3387	72	4	is	be	AUX
iajs-3387	72	5	482.96±238.28	482.96±238.28	PROPN
iajs-3387	72	6	in	in	ADP
iajs-3387	72	7	patients	patient	NOUN
iajs-3387	72	8	and	and	CCONJ
iajs-3387	72	9	105.28±6.5	105.28±6.5	NUM
iajs-3387	72	10	in	in	ADP
iajs-3387	72	11	healthy	healthy	ADJ
iajs-3387	72	12	controls	control	NOUN
iajs-3387	72	13	;	;	PUNCT
iajs-3387	72	14	the	the	DET
iajs-3387	72	15	difference	difference	NOUN
iajs-3387	72	16	is	be	AUX
iajs-3387	72	17	highly	highly	ADV
iajs-3387	72	18	significant	significant	ADJ
iajs-3387	72	19	.	.	PUNCT
iajs-3387	73	1	table	table	NOUN
iajs-3387	73	2	1	1	NUM
iajs-3387	73	3	.	.	PUNCT
iajs-3387	74	1	the	the	DET
iajs-3387	74	2	baseline	baseline	PROPN
iajs-3387	74	3	characteristics	characteristic	NOUN
iajs-3387	74	4	of	of	ADP
iajs-3387	74	5	the	the	DET
iajs-3387	74	6	acromegalic	acromegalic	ADJ
iajs-3387	74	7	patients	patient	NOUN
iajs-3387	74	8	and	and	CCONJ
iajs-3387	74	9	healthy	healthy	ADJ
iajs-3387	74	10	control	control	NOUN
iajs-3387	74	11	group	group	NOUN
iajs-3387	74	12	.	.	PUNCT
iajs-3387	75	1	parameters	parameter	NOUN
iajs-3387	75	2	acromegaly	acromegaly	PROPN
iajs-3387	75	3	control	control	PROPN
iajs-3387	75	4	p	p	NOUN
iajs-3387	75	5	value	value	NOUN
iajs-3387	75	6	number	number	NOUN
iajs-3387	75	7	61	61	NUM
iajs-3387	75	8	60	60	NUM
iajs-3387	75	9	male	male	ADJ
iajs-3387	75	10	/	/	SYM
iajs-3387	75	11	female	female	NOUN
iajs-3387	75	12	35/26	35/26	NUM
iajs-3387	75	13	30/30	30/30	NUM
iajs-3387	75	14	age	age	NOUN
iajs-3387	75	15	(	(	PUNCT
iajs-3387	75	16	years	year	NOUN
iajs-3387	75	17	)	)	PUNCT
iajs-3387	75	18	49.57±10.38	49.57±10.38	NUM
iajs-3387	75	19	46.98±5.64	46.98±5.64	NUM
iajs-3387	75	20	>	>	X
iajs-3387	75	21	0.05	0.05	NUM
iajs-3387	75	22	pld	pld	NOUN
iajs-3387	75	23	(	(	PUNCT
iajs-3387	75	24	u	u	NOUN
iajs-3387	75	25	/	/	SYM
iajs-3387	75	26	l	l	NOUN
iajs-3387	75	27	)	)	PUNCT
iajs-3387	75	28	694.57±122.12	694.57±122.12	NUM
iajs-3387	75	29	411.64±62.86	411.64±62.86	NOUN
iajs-3387	75	30	<	<	X
iajs-3387	75	31	0.001	0.001	NUM
iajs-3387	75	32	fbg	fbg	NOUN
iajs-3387	75	33	(	(	PUNCT
iajs-3387	75	34	mg	mg	PROPN
iajs-3387	75	35	/	/	SYM
iajs-3387	75	36	dl	dl	NOUN
iajs-3387	75	37	)	)	PUNCT
iajs-3387	75	38	143.84±83.02	143.84±83.02	NUM
iajs-3387	75	39	93.58±11.56	93.58±11.56	NUM
iajs-3387	75	40	<	<	X
iajs-3387	75	41	0.001	0.001	NUM
iajs-3387	75	42	gh	gh	PROPN
iajs-3387	75	43	(	(	PUNCT
iajs-3387	75	44	ng	ng	PROPN
iajs-3387	75	45	/	/	SYM
iajs-3387	75	46	ml	ml	NOUN
iajs-3387	75	47	)	)	PUNCT
iajs-3387	75	48	7.05±3.53	7.05±3.53	NOUN
iajs-3387	75	49	0.70±0.29	0.70±0.29	NOUN
iajs-3387	75	50	<	<	X
iajs-3387	75	51	0.001	0.001	NUM
iajs-3387	75	52	igf-1	igf-1	PRON
iajs-3387	75	53	(	(	PUNCT
iajs-3387	75	54	ng	ng	PROPN
iajs-3387	75	55	/	/	SYM
iajs-3387	75	56	ml	ml	NOUN
iajs-3387	75	57	)	)	PUNCT
iajs-3387	75	58	482.96±238.28	482.96±238.28	PROPN
iajs-3387	75	59	105.28±6.5	105.28±6.5	NUM
iajs-3387	75	60	<	<	SYM
iajs-3387	75	61	0.001	0.001	NUM
iajs-3387	75	62	table	table	NOUN
iajs-3387	75	63	2	2	NUM
iajs-3387	75	64	shows	show	VERB
iajs-3387	75	65	the	the	DET
iajs-3387	75	66	biochemical	biochemical	ADJ
iajs-3387	75	67	variables	variable	NOUN
iajs-3387	75	68	(	(	PUNCT
iajs-3387	75	69	pld	pld	NOUN
iajs-3387	75	70	,	,	PUNCT
iajs-3387	75	71	fbg	fbg	PROPN
iajs-3387	75	72	,	,	PUNCT
iajs-3387	75	73	g	g	NOUN
iajs-3387	75	74	-	-	PUNCT
iajs-3387	75	75	h	h	NOUN
iajs-3387	75	76	,	,	PUNCT
iajs-3387	75	77	and	and	CCONJ
iajs-3387	75	78	igf-1	igf-1	PRON
iajs-3387	75	79	)	)	PUNCT
iajs-3387	75	80	in	in	ADP
iajs-3387	75	81	patients	patient	NOUN
iajs-3387	75	82	and	and	CCONJ
iajs-3387	75	83	the	the	DET
iajs-3387	75	84	control	control	NOUN
iajs-3387	75	85	group	group	NOUN
iajs-3387	75	86	according	accord	VERB
iajs-3387	75	87	to	to	ADP
iajs-3387	75	88	their	their	PRON
iajs-3387	75	89	gender	gender	NOUN
iajs-3387	75	90	.	.	PUNCT
iajs-3387	76	1	in	in	ADP
iajs-3387	76	2	the	the	DET
iajs-3387	76	3	patient	patient	ADJ
iajs-3387	76	4	groups	group	NOUN
iajs-3387	76	5	,	,	PUNCT
iajs-3387	76	6	the	the	DET
iajs-3387	76	7	difference	difference	NOUN
iajs-3387	76	8	between	between	ADP
iajs-3387	76	9	males	male	NOUN
iajs-3387	76	10	and	and	CCONJ
iajs-3387	76	11	females	female	NOUN
iajs-3387	76	12	did	do	AUX
iajs-3387	76	13	not	not	PART
iajs-3387	76	14	reach	reach	VERB
iajs-3387	76	15	statistical	statistical	ADJ
iajs-3387	76	16	significance	significance	NOUN
iajs-3387	76	17	,	,	PUNCT
iajs-3387	76	18	as	as	SCONJ
iajs-3387	76	19	evidenced	evidence	VERB
iajs-3387	76	20	by	by	ADP
iajs-3387	76	21	the	the	DET
iajs-3387	76	22	p	p	NOUN
iajs-3387	76	23	-	-	PUNCT
iajs-3387	76	24	values	value	NOUN
iajs-3387	76	25	of	of	ADP
iajs-3387	76	26	0.378	0.378	NUM
iajs-3387	76	27	,	,	PUNCT
iajs-3387	76	28	0.839	0.839	NUM
iajs-3387	76	29	,	,	PUNCT
iajs-3387	76	30	0.188	0.188	NUM
iajs-3387	76	31	,	,	PUNCT
iajs-3387	76	32	and	and	CCONJ
iajs-3387	76	33	0.301	0.301	NUM
iajs-3387	76	34	for	for	ADP
iajs-3387	76	35	gh	gh	PROPN
iajs-3387	76	36	,	,	PUNCT
iajs-3387	76	37	igf-1	igf-1	NOUN
iajs-3387	76	38	,	,	PUNCT
iajs-3387	76	39	fbg	fbg	NOUN
iajs-3387	76	40	,	,	PUNCT
iajs-3387	76	41	and	and	CCONJ
iajs-3387	76	42	pld	pld	NOUN
iajs-3387	76	43	,	,	PUNCT
iajs-3387	76	44	respectively	respectively	ADV
iajs-3387	76	45	.	.	PUNCT
iajs-3387	77	1	however	however	ADV
iajs-3387	77	2	,	,	PUNCT
iajs-3387	77	3	in	in	ADP
iajs-3387	77	4	the	the	DET
iajs-3387	77	5	healthy	healthy	ADJ
iajs-3387	77	6	controls	control	NOUN
iajs-3387	77	7	,	,	PUNCT
iajs-3387	77	8	there	there	PRON
iajs-3387	77	9	was	be	VERB
iajs-3387	77	10	a	a	DET
iajs-3387	77	11	highly	highly	ADV
iajs-3387	77	12	significant	significant	ADJ
iajs-3387	77	13	difference	difference	NOUN
iajs-3387	77	14	in	in	ADP
iajs-3387	77	15	growth	growth	NOUN
iajs-3387	77	16	hormone	hormone	NOUN
iajs-3387	77	17	between	between	ADP
iajs-3387	77	18	male	male	NOUN
iajs-3387	77	19	and	and	CCONJ
iajs-3387	77	20	females	female	NOUN
iajs-3387	77	21	.	.	PUNCT
iajs-3387	78	1	ihjpas	ihjpas	PROPN
iajs-3387	78	2	.	.	PUNCT
iajs-3387	79	1	2024	2024	NUM
iajs-3387	79	2	,	,	PUNCT
iajs-3387	79	3	37(4	37(4	NOUN
iajs-3387	79	4	)	)	PUNCT
iajs-3387	79	5	258	258	NUM
iajs-3387	79	6	table	table	NOUN
iajs-3387	79	7	2	2	NUM
iajs-3387	79	8	.	.	PUNCT
iajs-3387	80	1	the	the	DET
iajs-3387	80	2	biochemical	biochemical	ADJ
iajs-3387	80	3	variables	variable	NOUN
iajs-3387	80	4	in	in	ADP
iajs-3387	80	5	patients	patient	NOUN
iajs-3387	80	6	and	and	CCONJ
iajs-3387	80	7	control	control	NOUN
iajs-3387	80	8	group	group	NOUN
iajs-3387	80	9	according	accord	VERB
iajs-3387	80	10	to	to	ADP
iajs-3387	80	11	their	their	PRON
iajs-3387	80	12	gender	gender	NOUN
iajs-3387	80	13	.	.	PUNCT
iajs-3387	81	1	parameters	parameter	NOUN
iajs-3387	81	2	acromegaly	acromegaly	VERB
iajs-3387	81	3	healthy	healthy	ADJ
iajs-3387	81	4	control	control	NOUN
iajs-3387	81	5	male	male	ADJ
iajs-3387	81	6	female	female	ADJ
iajs-3387	81	7	p	p	NOUN
iajs-3387	81	8	value	value	NOUN
iajs-3387	81	9	male	male	ADJ
iajs-3387	81	10	female	female	ADJ
iajs-3387	81	11	p	p	NOUN
iajs-3387	81	12	value	value	NOUN
iajs-3387	81	13	pld	pld	NOUN
iajs-3387	81	14	(	(	PUNCT
iajs-3387	81	15	u	u	NOUN
iajs-3387	81	16	/	/	SYM
iajs-3387	81	17	l	l	NOUN
iajs-3387	81	18	)	)	PUNCT
iajs-3387	82	1	680.51±118.21	680.51±118.21	PROPN
iajs-3387	82	2	714.49±127.30	714.49±127.30	NUM
iajs-3387	82	3	0.301	0.301	NUM
iajs-3387	82	4	414.81±63.28	414.81±63.28	NUM
iajs-3387	82	5	408.24±63.3	408.24±63.3	NUM
iajs-3387	82	6	8	8	NUM
iajs-3387	82	7	0.695	0.695	NUM
iajs-3387	82	8	fbg	fbg	NOUN
iajs-3387	82	9	(	(	PUNCT
iajs-3387	82	10	mg	mg	PROPN
iajs-3387	82	11	/	/	SYM
iajs-3387	82	12	dl	dl	PROPN
iajs-3387	82	13	)	)	PUNCT
iajs-3387	82	14	131.71±75.94	131.71±75.94	PROPN
iajs-3387	82	15	160.15±90.65	160.15±90.65	NUM
iajs-3387	82	16	0.188	0.188	NUM
iajs-3387	82	17	93.13±10.65	93.13±10.65	NUM
iajs-3387	82	18	94.03±12.57	94.03±12.57	NOUN
iajs-3387	83	1	0.766	0.766	NUM
iajs-3387	83	2	gh	gh	PROPN
iajs-3387	83	3	(	(	PUNCT
iajs-3387	83	4	ng	ng	PROPN
iajs-3387	83	5	/	/	SYM
iajs-3387	83	6	ml	ml	NOUN
iajs-3387	83	7	)	)	PUNCT
iajs-3387	83	8	7.40±3.65	7.40±3.65	PROPN
iajs-3387	83	9	6.59±3.38	6.59±3.38	NUM
iajs-3387	83	10	0.378	0.378	NUM
iajs-3387	83	11	0.62±0.19	0.62±0.19	NOUN
iajs-3387	83	12	0.79±0.34	0.79±0.34	NOUN
iajs-3387	83	13	0.019	0.019	NUM
iajs-3387	83	14	igf1(ng	igf1(ng	PROPN
iajs-3387	83	15	/	/	SYM
iajs-3387	83	16	ml	ml	NOUN
iajs-3387	83	17	)	)	PUNCT
iajs-3387	83	18	477.54±206.98	477.54±206.98	NUM
iajs-3387	83	19	490.26±279.11	490.26±279.11	NOUN
iajs-3387	83	20	0.839	0.839	NUM
iajs-3387	83	21	105.67±6.16	105.67±6.16	NUM
iajs-3387	83	22	104.90±6.99	104.90±6.99	NUM
iajs-3387	83	23	0.654	0.654	NUM
iajs-3387	83	24	table	table	NOUN
iajs-3387	83	25	3	3	NUM
iajs-3387	83	26	shows	show	VERB
iajs-3387	83	27	the	the	DET
iajs-3387	83	28	correlation	correlation	NOUN
iajs-3387	83	29	of	of	ADP
iajs-3387	83	30	the	the	DET
iajs-3387	83	31	studied	study	VERB
iajs-3387	83	32	molecules	molecule	NOUN
iajs-3387	83	33	with	with	ADP
iajs-3387	83	34	age	age	NOUN
iajs-3387	83	35	,	,	PUNCT
iajs-3387	83	36	pld	pld	NOUN
iajs-3387	83	37	,	,	PUNCT
iajs-3387	83	38	gh	gh	PROPN
iajs-3387	83	39	,	,	PUNCT
iajs-3387	83	40	and	and	CCONJ
iajs-3387	83	41	igf-1	igf-1	NOUN
iajs-3387	83	42	.	.	PUNCT
iajs-3387	84	1	the	the	DET
iajs-3387	84	2	relationship	relationship	NOUN
iajs-3387	84	3	is	be	AUX
iajs-3387	84	4	negative	negative	ADJ
iajs-3387	84	5	with	with	ADP
iajs-3387	84	6	age	age	NOUN
iajs-3387	84	7	for	for	ADP
iajs-3387	84	8	pld	pld	NOUN
iajs-3387	84	9	,	,	PUNCT
iajs-3387	84	10	fbg	fbg	PROPN
iajs-3387	84	11	,	,	PUNCT
iajs-3387	84	12	gh	gh	PROPN
iajs-3387	84	13	,	,	PUNCT
iajs-3387	84	14	and	and	CCONJ
iajs-3387	84	15	igf-1	igf-1	NOUN
iajs-3387	84	16	.	.	PUNCT
iajs-3387	85	1	we	we	PRON
iajs-3387	85	2	find	find	VERB
iajs-3387	85	3	a	a	DET
iajs-3387	85	4	statistically	statistically	ADV
iajs-3387	85	5	significant	significant	ADJ
iajs-3387	85	6	correlation	correlation	NOUN
iajs-3387	85	7	between	between	ADP
iajs-3387	85	8	age	age	NOUN
iajs-3387	85	9	and	and	CCONJ
iajs-3387	85	10	the	the	DET
iajs-3387	85	11	following	following	ADJ
iajs-3387	85	12	variables	variable	NOUN
iajs-3387	85	13	:	:	PUNCT
iajs-3387	85	14	gh	gh	PROPN
iajs-3387	85	15	and	and	CCONJ
iajs-3387	85	16	igf-1	igf-1	PRON
iajs-3387	85	17	(	(	PUNCT
iajs-3387	85	18	p	p	NOUN
iajs-3387	85	19	-	-	PUNCT
iajs-3387	85	20	values	value	NOUN
iajs-3387	85	21	of	of	ADP
iajs-3387	85	22	0.005	0.005	NUM
iajs-3387	85	23	and	and	CCONJ
iajs-3387	85	24	0.001	0.001	NUM
iajs-3387	85	25	,	,	PUNCT
iajs-3387	85	26	respectively	respectively	ADV
iajs-3387	85	27	)	)	PUNCT
iajs-3387	85	28	.	.	PUNCT
iajs-3387	86	1	the	the	DET
iajs-3387	86	2	pld	pld	PROPN
iajs-3387	86	3	has	have	VERB
iajs-3387	86	4	a	a	DET
iajs-3387	86	5	negative	negative	ADJ
iajs-3387	86	6	correlation	correlation	NOUN
iajs-3387	86	7	only	only	ADV
iajs-3387	86	8	with	with	ADP
iajs-3387	86	9	age	age	NOUN
iajs-3387	86	10	,	,	PUNCT
iajs-3387	86	11	but	but	CCONJ
iajs-3387	86	12	its	its	PRON
iajs-3387	86	13	correlation	correlation	NOUN
iajs-3387	86	14	with	with	ADP
iajs-3387	86	15	the	the	DET
iajs-3387	86	16	other	other	ADJ
iajs-3387	86	17	variables	variable	NOUN
iajs-3387	86	18	is	be	AUX
iajs-3387	86	19	positive	positive	ADJ
iajs-3387	86	20	;	;	PUNCT
iajs-3387	86	21	however	however	ADV
iajs-3387	86	22	,	,	PUNCT
iajs-3387	86	23	those	those	PRON
iajs-3387	86	24	who	who	PRON
iajs-3387	86	25	reach	reach	VERB
iajs-3387	86	26	statistical	statistical	ADJ
iajs-3387	86	27	significance	significance	NOUN
iajs-3387	86	28	are	be	AUX
iajs-3387	86	29	with	with	ADP
iajs-3387	86	30	gh	gh	PROPN
iajs-3387	86	31	(	(	PUNCT
iajs-3387	86	32	p	p	NOUN
iajs-3387	86	33	-	-	PUNCT
iajs-3387	86	34	value	value	NOUN
iajs-3387	86	35	0.037	0.037	NUM
iajs-3387	86	36	)	)	PUNCT
iajs-3387	86	37	.	.	PUNCT
iajs-3387	87	1	fasting	fast	VERB
iajs-3387	87	2	blood	blood	NOUN
iajs-3387	87	3	glucose	glucose	NOUN
iajs-3387	87	4	correlates	correlate	VERB
iajs-3387	87	5	negatively	negatively	ADV
iajs-3387	87	6	only	only	ADV
iajs-3387	87	7	with	with	ADP
iajs-3387	87	8	age	age	NOUN
iajs-3387	87	9	and	and	CCONJ
iajs-3387	87	10	positively	positively	ADV
iajs-3387	87	11	with	with	ADP
iajs-3387	87	12	other	other	ADJ
iajs-3387	87	13	markers	marker	NOUN
iajs-3387	87	14	;	;	PUNCT
iajs-3387	87	15	however	however	ADV
iajs-3387	87	16	,	,	PUNCT
iajs-3387	87	17	the	the	DET
iajs-3387	87	18	relation	relation	NOUN
iajs-3387	87	19	reaches	reach	VERB
iajs-3387	87	20	statistical	statistical	ADJ
iajs-3387	87	21	significance	significance	NOUN
iajs-3387	87	22	with	with	ADP
iajs-3387	87	23	gh	gh	PROPN
iajs-3387	87	24	only	only	ADV
iajs-3387	87	25	(	(	PUNCT
iajs-3387	87	26	p	p	X
iajs-3387	87	27	-	-	PUNCT
iajs-3387	87	28	value	value	NOUN
iajs-3387	87	29	is	be	AUX
iajs-3387	87	30	0.001	0.001	NUM
iajs-3387	87	31	)	)	PUNCT
iajs-3387	87	32	.	.	PUNCT
iajs-3387	88	1	growth	growth	NOUN
iajs-3387	88	2	hormone	hormone	NOUN
iajs-3387	88	3	correlates	correlate	VERB
iajs-3387	88	4	negatively	negatively	ADV
iajs-3387	88	5	with	with	ADP
iajs-3387	88	6	age	age	NOUN
iajs-3387	88	7	and	and	CCONJ
iajs-3387	88	8	fbg	fbg	NOUN
iajs-3387	88	9	,	,	PUNCT
iajs-3387	88	10	while	while	SCONJ
iajs-3387	88	11	its	its	PRON
iajs-3387	88	12	correlation	correlation	NOUN
iajs-3387	88	13	with	with	ADP
iajs-3387	88	14	the	the	DET
iajs-3387	88	15	others	other	NOUN
iajs-3387	88	16	is	be	AUX
iajs-3387	88	17	positive	positive	ADJ
iajs-3387	88	18	;	;	PUNCT
iajs-3387	88	19	however	however	ADV
iajs-3387	88	20	,	,	PUNCT
iajs-3387	88	21	the	the	DET
iajs-3387	88	22	correlation	correlation	NOUN
iajs-3387	88	23	reaches	reach	VERB
iajs-3387	88	24	statistical	statistical	ADJ
iajs-3387	88	25	significance	significance	NOUN
iajs-3387	88	26	between	between	ADP
iajs-3387	88	27	igf-1	igf-1	NOUN
iajs-3387	88	28	and	and	CCONJ
iajs-3387	88	29	pld	pld	NOUN
iajs-3387	88	30	(	(	PUNCT
iajs-3387	88	31	p	p	NOUN
iajs-3387	88	32	-	-	PUNCT
iajs-3387	88	33	values	value	NOUN
iajs-3387	88	34	of	of	ADP
iajs-3387	88	35	0.001	0.001	NUM
iajs-3387	88	36	and	and	CCONJ
iajs-3387	88	37	0.037	0.037	NUM
iajs-3387	88	38	,	,	PUNCT
iajs-3387	88	39	respectively	respectively	ADV
iajs-3387	88	40	)	)	PUNCT
iajs-3387	88	41	.	.	PUNCT
iajs-3387	89	1	insulin	insulin	NOUN
iajs-3387	89	2	,	,	PUNCT
iajs-3387	89	3	like	like	ADP
iajs-3387	89	4	growth	growth	NOUN
iajs-3387	89	5	factor-1	factor-1	PROPN
iajs-3387	89	6	,	,	PUNCT
iajs-3387	89	7	correlates	correlate	VERB
iajs-3387	89	8	negatively	negatively	ADV
iajs-3387	89	9	with	with	ADP
iajs-3387	89	10	age	age	NOUN
iajs-3387	89	11	,	,	PUNCT
iajs-3387	89	12	but	but	CCONJ
iajs-3387	89	13	positively	positively	ADV
iajs-3387	89	14	with	with	ADP
iajs-3387	89	15	fbg	fbg	PROPN
iajs-3387	89	16	,	,	PUNCT
iajs-3387	89	17	gh	gh	PROPN
iajs-3387	89	18	,	,	PUNCT
iajs-3387	89	19	and	and	CCONJ
iajs-3387	89	20	pld	pld	NOUN
iajs-3387	89	21	.	.	PUNCT
iajs-3387	90	1	these	these	DET
iajs-3387	90	2	correlations	correlation	NOUN
iajs-3387	90	3	between	between	ADP
iajs-3387	90	4	igf-1	igf-1	NOUN
iajs-3387	90	5	and	and	CCONJ
iajs-3387	90	6	age	age	NOUN
iajs-3387	90	7	and	and	CCONJ
iajs-3387	90	8	gh	gh	PROPN
iajs-3387	90	9	reach	reach	VERB
iajs-3387	90	10	statistical	statistical	ADJ
iajs-3387	90	11	significance	significance	NOUN
iajs-3387	90	12	(	(	PUNCT
iajs-3387	90	13	pvalues	pvalue	NOUN
iajs-3387	90	14	of	of	ADP
iajs-3387	90	15	0.001	0.001	NUM
iajs-3387	90	16	and	and	CCONJ
iajs-3387	90	17	0.001	0.001	NUM
iajs-3387	90	18	,	,	PUNCT
iajs-3387	90	19	respectively	respectively	ADV
iajs-3387	90	20	)	)	PUNCT
iajs-3387	90	21	.	.	PUNCT
iajs-3387	91	1	table	table	NOUN
iajs-3387	91	2	3	3	NUM
iajs-3387	91	3	.	.	PUNCT
iajs-3387	92	1	the	the	DET
iajs-3387	92	2	correlations	correlation	NOUN
iajs-3387	92	3	between	between	ADP
iajs-3387	92	4	the	the	DET
iajs-3387	92	5	parameters	parameter	NOUN
iajs-3387	92	6	in	in	ADP
iajs-3387	92	7	acromegalic	acromegalic	ADJ
iajs-3387	92	8	patients	patient	NOUN
iajs-3387	92	9	.	.	PUNCT
iajs-3387	93	1	correlations	correlation	NOUN
iajs-3387	93	2	age	age	NOUN
iajs-3387	93	3	fbg	fbg	PROPN
iajs-3387	93	4	gh	gh	PROPN
iajs-3387	93	5	igf-1	igf-1	NOUN
iajs-3387	93	6	pld	pld	PROPN
iajs-3387	93	7	age	age	NOUN
iajs-3387	93	8	pearson	pearson	NOUN
iajs-3387	93	9	correlation	correlation	NOUN
iajs-3387	93	10	1	1	NUM
iajs-3387	93	11	-0.174	-0.174	NOUN
iajs-3387	93	12	*	*	PUNCT
iajs-3387	93	13	*	*	NOUN
iajs-3387	93	14	0.360**0.398	0.360**0.398	NOUN
iajs-3387	93	15	-	-	PUNCT
iajs-3387	93	16	0.045	0.045	NUM
iajs-3387	93	17	sig	sig	NOUN
iajs-3387	93	18	.	.	PUNCT
iajs-3387	94	1	(	(	PUNCT
iajs-3387	94	2	2	2	NUM
iajs-3387	94	3	-	-	PUNCT
iajs-3387	94	4	tailed	tailed	ADJ
iajs-3387	94	5	)	)	PUNCT
iajs-3387	95	1	0.181	0.181	NUM
iajs-3387	95	2	0.005	0.005	NUM
iajs-3387	95	3	0.001	0.001	NUM
iajs-3387	95	4	0.735	0.735	NUM
iajs-3387	95	5	n	n	PRON
iajs-3387	95	6	61	61	NUM
iajs-3387	95	7	61	61	NUM
iajs-3387	95	8	61	61	NUM
iajs-3387	95	9	61	61	NUM
iajs-3387	95	10	61	61	NUM
iajs-3387	95	11	pld	pld	NOUN
iajs-3387	95	12	pearson	pearson	NOUN
iajs-3387	95	13	correlation	correlation	NOUN
iajs-3387	95	14	-0.045	-0.045	PUNCT
iajs-3387	95	15	0.075	0.075	NUM
iajs-3387	95	16	*	*	NOUN
iajs-3387	95	17	0.279	0.279	NUM
iajs-3387	95	18	0.162	0.162	NUM
iajs-3387	95	19	1	1	NUM
iajs-3387	95	20	sig	sig	NOUN
iajs-3387	95	21	.	.	PUNCT
iajs-3387	96	1	(	(	PUNCT
iajs-3387	96	2	2	2	NUM
iajs-3387	96	3	-	-	PUNCT
iajs-3387	96	4	tailed	tailed	ADJ
iajs-3387	96	5	)	)	PUNCT
iajs-3387	96	6	0.735	0.735	NUM
iajs-3387	96	7	0.575	0.575	NUM
iajs-3387	96	8	0.037	0.037	NUM
iajs-3387	96	9	0.225	0.225	NUM
iajs-3387	96	10	n	n	ADP
iajs-3387	96	11	61	61	NUM
iajs-3387	96	12	61	61	NUM
iajs-3387	96	13	61	61	NUM
iajs-3387	96	14	61	61	NUM
iajs-3387	96	15	61	61	NUM
iajs-3387	96	16	fbg	fbg	NOUN
iajs-3387	96	17	pearson	pearson	NOUN
iajs-3387	96	18	correlation	correlation	NOUN
iajs-3387	96	19	-0.174	-0.174	PUNCT
iajs-3387	96	20	1	1	NUM
iajs-3387	96	21	*	*	PUNCT
iajs-3387	96	22	*	*	NUM
iajs-3387	96	23	0.467	0.467	NUM
iajs-3387	96	24	0.174	0.174	NUM
iajs-3387	96	25	0.075	0.075	NUM
iajs-3387	96	26	sig	sig	NOUN
iajs-3387	96	27	.	.	PUNCT
iajs-3387	97	1	(	(	PUNCT
iajs-3387	97	2	2	2	NUM
iajs-3387	97	3	-	-	PUNCT
iajs-3387	97	4	tailed	tailed	ADJ
iajs-3387	97	5	)	)	PUNCT
iajs-3387	97	6	.181	.181	NUM
iajs-3387	98	1	0.001	0.001	NUM
iajs-3387	98	2	0.180	0.180	NUM
iajs-3387	98	3	0.575	0.575	NUM
iajs-3387	98	4	n	n	NUM
iajs-3387	98	5	61	61	NUM
iajs-3387	98	6	61	61	NUM
iajs-3387	98	7	61	61	NUM
iajs-3387	98	8	61	61	NUM
iajs-3387	98	9	61	61	NUM
iajs-3387	98	10	gh	gh	PROPN
iajs-3387	98	11	pearson	pearson	PROPN
iajs-3387	98	12	correlation	correlation	NOUN
iajs-3387	98	13	-0.071	-0.071	PUNCT
iajs-3387	98	14	-0.011	-0.011	PUNCT
iajs-3387	98	15	1	1	NUM
iajs-3387	98	16	*	*	PUNCT
iajs-3387	98	17	*	*	NUM
iajs-3387	98	18	0.351	0.351	NUM
iajs-3387	98	19	*	*	SYM
iajs-3387	98	20	0.279	0.279	NUM
iajs-3387	98	21	sig	sig	NOUN
iajs-3387	98	22	.	.	PUNCT
iajs-3387	99	1	(	(	PUNCT
iajs-3387	99	2	2	2	NUM
iajs-3387	99	3	-	-	PUNCT
iajs-3387	99	4	tailed	tailed	ADJ
iajs-3387	99	5	)	)	PUNCT
iajs-3387	99	6	0.585	0.585	NUM
iajs-3387	99	7	0.930	0.930	NUM
iajs-3387	99	8	0.006	0.006	NUM
iajs-3387	99	9	0.037	0.037	NUM
iajs-3387	99	10	n	n	PRON
iajs-3387	99	11	61	61	NUM
iajs-3387	99	12	61	61	NUM
iajs-3387	99	13	61	61	NUM
iajs-3387	99	14	61	61	NUM
iajs-3387	99	15	61	61	NUM
iajs-3387	99	16	igf-1	igf-1	NUM
iajs-3387	99	17	pearson	pearson	NOUN
iajs-3387	99	18	correlation	correlation	NOUN
iajs-3387	99	19	*	*	PUNCT
iajs-3387	100	1	*	*	PUNCT
iajs-3387	100	2	0.3980.174	0.3980.174	NUM
iajs-3387	100	3	*	*	PUNCT
iajs-3387	100	4	*	*	PUNCT
iajs-3387	100	5	0.525	0.525	NUM
iajs-3387	100	6	1	1	NUM
iajs-3387	100	7	0.162	0.162	NUM
iajs-3387	100	8	sig	sig	NOUN
iajs-3387	100	9	.	.	PUNCT
iajs-3387	101	1	(	(	PUNCT
iajs-3387	101	2	2	2	NUM
iajs-3387	101	3	-	-	PUNCT
iajs-3387	101	4	tailed	tailed	ADJ
iajs-3387	101	5	)	)	PUNCT
iajs-3387	101	6	0.001	0.001	NUM
iajs-3387	101	7	0.180	0.180	NUM
iajs-3387	101	8	0.001	0.001	NUM
iajs-3387	101	9	0.225	0.225	NUM
iajs-3387	101	10	n	n	NUM
iajs-3387	101	11	61	61	NUM
iajs-3387	101	12	61	61	NUM
iajs-3387	101	13	61	61	NUM
iajs-3387	101	14	61	61	NUM
iajs-3387	101	15	61	61	NUM
iajs-3387	101	16	the	the	DET
iajs-3387	101	17	roc	roc	PROPN
iajs-3387	101	18	curve	curve	NOUN
iajs-3387	101	19	indicates	indicate	VERB
iajs-3387	101	20	a	a	DET
iajs-3387	101	21	pld	pld	NOUN
iajs-3387	101	22	area	area	NOUN
iajs-3387	101	23	under	under	ADP
iajs-3387	101	24	the	the	DET
iajs-3387	101	25	curve	curve	NOUN
iajs-3387	101	26	(	(	PUNCT
iajs-3387	101	27	auc	auc	NOUN
iajs-3387	101	28	)	)	PUNCT
iajs-3387	101	29	of	of	ADP
iajs-3387	101	30	0.976	0.976	NUM
iajs-3387	101	31	,	,	PUNCT
iajs-3387	101	32	a	a	DET
iajs-3387	101	33	95	95	NUM
iajs-3387	101	34	%	%	NOUN
iajs-3387	101	35	confidence	confidence	NOUN
iajs-3387	101	36	interval	interval	NOUN
iajs-3387	101	37	(	(	PUNCT
iajs-3387	101	38	ci	ci	NOUN
iajs-3387	101	39	)	)	PUNCT
iajs-3387	101	40	with	with	ADP
iajs-3387	101	41	sensitivity	sensitivity	NOUN
iajs-3387	101	42	and	and	CCONJ
iajs-3387	101	43	specificity	specificity	NOUN
iajs-3387	101	44	of	of	ADP
iajs-3387	101	45	93.4	93.4	NUM
iajs-3387	101	46	and	and	CCONJ
iajs-3387	101	47	91.7	91.7	NUM
iajs-3387	101	48	,	,	PUNCT
iajs-3387	101	49	respectively	respectively	ADV
iajs-3387	101	50	,	,	PUNCT
iajs-3387	101	51	with	with	ADP
iajs-3387	101	52	a	a	DET
iajs-3387	101	53	p	p	NOUN
iajs-3387	101	54	-	-	PUNCT
iajs-3387	101	55	value	value	NOUN
iajs-3387	101	56	of	of	ADP
iajs-3387	101	57	less	less	ADJ
iajs-3387	101	58	than	than	ADP
iajs-3387	101	59	0.001	0.001	NUM
iajs-3387	101	60	,	,	PUNCT
iajs-3387	101	61	and	and	CCONJ
iajs-3387	101	62	a	a	DET
iajs-3387	101	63	best	good	ADJ
iajs-3387	101	64	cut	cut	NOUN
iajs-3387	101	65	-	-	PUNCT
iajs-3387	101	66	off	off	ADP
iajs-3387	101	67	point	point	NOUN
iajs-3387	101	68	of	of	ADP
iajs-3387	101	69	528.598	528.598	NUM
iajs-3387	101	70	pg	pg	NOUN
iajs-3387	101	71	/	/	SYM
iajs-3387	101	72	ml	ml	NOUN
iajs-3387	101	73	.	.	PUNCT
iajs-3387	102	1	that	that	PRON
iajs-3387	102	2	means	mean	VERB
iajs-3387	102	3	the	the	DET
iajs-3387	102	4	test	test	NOUN
iajs-3387	102	5	value	value	NOUN
iajs-3387	102	6	less	less	ADJ
iajs-3387	102	7	than	than	ADP
iajs-3387	102	8	(	(	PUNCT
iajs-3387	102	9	528.598	528.598	NUM
iajs-3387	102	10	pg	pg	NOUN
iajs-3387	102	11	/	/	SYM
iajs-3387	102	12	ml	ml	VERB
iajs-3387	102	13	)	)	PUNCT
iajs-3387	102	14	is	be	AUX
iajs-3387	102	15	considered	consider	VERB
iajs-3387	102	16	healthy	healthy	ADJ
iajs-3387	102	17	,	,	PUNCT
iajs-3387	102	18	whereas	whereas	SCONJ
iajs-3387	102	19	the	the	DET
iajs-3387	102	20	value	value	NOUN
iajs-3387	102	21	greater	great	ADJ
iajs-3387	102	22	than	than	ADP
iajs-3387	102	23	(	(	PUNCT
iajs-3387	102	24	528.598	528.598	NUM
iajs-3387	102	25	pg	pg	NOUN
iajs-3387	102	26	/	/	SYM
iajs-3387	102	27	ml	ml	NOUN
iajs-3387	102	28	)	)	PUNCT
iajs-3387	102	29	represents	represent	VERB
iajs-3387	102	30	the	the	DET
iajs-3387	102	31	unusual	unusual	ADJ
iajs-3387	102	32	case	case	NOUN
iajs-3387	102	33	,	,	PUNCT
iajs-3387	102	34	as	as	SCONJ
iajs-3387	102	35	shown	show	VERB
iajs-3387	102	36	in	in	ADP
iajs-3387	102	37	figure	figure	NOUN
iajs-3387	102	38	1	1	NUM
iajs-3387	103	1	.	.	PUNCT
iajs-3387	103	2	ihjpas	ihjpas	PROPN
iajs-3387	103	3	.	.	PUNCT
iajs-3387	104	1	2024	2024	NUM
iajs-3387	104	2	,	,	PUNCT
iajs-3387	104	3	37(4	37(4	NOUN
iajs-3387	104	4	)	)	PUNCT
iajs-3387	104	5	259	259	NUM
iajs-3387	104	6	figure	figure	NOUN
iajs-3387	104	7	1	1	NUM
iajs-3387	104	8	.	.	PUNCT
iajs-3387	105	1	the	the	DET
iajs-3387	105	2	roc	roc	PROPN
iajs-3387	105	3	curve	curve	NOUN
iajs-3387	105	4	of	of	ADP
iajs-3387	105	5	pld	pld	PROPN
iajs-3387	105	6	.	.	PROPN
iajs-3387	105	7	4	4	NUM
iajs-3387	105	8	.	.	X
iajs-3387	105	9	discussion	discussion	NOUN
iajs-3387	105	10	this	this	DET
iajs-3387	105	11	study	study	NOUN
iajs-3387	105	12	conducted	conduct	VERB
iajs-3387	105	13	on	on	ADP
iajs-3387	105	14	sixty	sixty	NUM
iajs-3387	105	15	-	-	PUNCT
iajs-3387	105	16	one	one	NUM
iajs-3387	105	17	patients	patient	NOUN
iajs-3387	105	18	with	with	ADP
iajs-3387	105	19	acromegaly	acromegaly	NOUN
iajs-3387	105	20	and	and	CCONJ
iajs-3387	105	21	sixty	sixty	NUM
iajs-3387	105	22	with	with	ADP
iajs-3387	105	23	non	non	ADJ
iajs-3387	105	24	-	-	NOUN
iajs-3387	105	25	acromegaly	acromegaly	ADJ
iajs-3387	105	26	.	.	PUNCT
iajs-3387	106	1	to	to	ADP
iajs-3387	106	2	our	our	PRON
iajs-3387	106	3	knowledge	knowledge	NOUN
iajs-3387	106	4	,	,	PUNCT
iajs-3387	106	5	only	only	ADV
iajs-3387	106	6	one	one	NUM
iajs-3387	106	7	study	study	NOUN
iajs-3387	106	8	has	have	AUX
iajs-3387	106	9	reported	report	VERB
iajs-3387	106	10	higher	high	ADJ
iajs-3387	106	11	levels	level	NOUN
iajs-3387	106	12	of	of	ADP
iajs-3387	106	13	pld	pld	PROPN
iajs-3387	106	14	in	in	ADP
iajs-3387	106	15	acromegaly	acromegaly	PROPN
iajs-3387	106	16	.	.	PUNCT
iajs-3387	107	1	the	the	DET
iajs-3387	107	2	results	result	NOUN
iajs-3387	107	3	are	be	AUX
iajs-3387	107	4	in	in	ADP
iajs-3387	107	5	agreement	agreement	NOUN
iajs-3387	107	6	with	with	ADP
iajs-3387	107	7	the	the	DET
iajs-3387	107	8	tabur	tabur	PROPN
iajs-3387	107	9	et	et	PROPN
iajs-3387	107	10	al	al	PROPN
iajs-3387	107	11	.	.	PROPN
iajs-3387	107	12	,	,	PUNCT
iajs-3387	107	13	study	study	VERB
iajs-3387	107	14	[	[	X
iajs-3387	107	15	15	15	NUM
iajs-3387	107	16	]	]	PUNCT
iajs-3387	107	17	.	.	PUNCT
iajs-3387	108	1	patients	patient	NOUN
iajs-3387	108	2	with	with	ADP
iajs-3387	108	3	acromegaly	acromegaly	PROPN
iajs-3387	108	4	and	and	CCONJ
iajs-3387	108	5	gh	gh	PROPN
iajs-3387	108	6	insufficiency	insufficiency	NOUN
iajs-3387	108	7	frequently	frequently	ADV
iajs-3387	108	8	experience	experience	VERB
iajs-3387	108	9	morbidity	morbidity	NOUN
iajs-3387	108	10	due	due	ADP
iajs-3387	108	11	to	to	ADP
iajs-3387	108	12	the	the	DET
iajs-3387	108	13	disproportionate	disproportionate	ADJ
iajs-3387	108	14	expansion	expansion	NOUN
iajs-3387	108	15	of	of	ADP
iajs-3387	108	16	their	their	PRON
iajs-3387	108	17	muscles	muscle	NOUN
iajs-3387	108	18	and	and	CCONJ
iajs-3387	108	19	bones	bone	NOUN
iajs-3387	108	20	[	[	X
iajs-3387	108	21	20	20	NUM
iajs-3387	108	22	,	,	PUNCT
iajs-3387	108	23	21	21	NUM
iajs-3387	108	24	]	]	PUNCT
iajs-3387	108	25	,	,	PUNCT
iajs-3387	108	26	and	and	CCONJ
iajs-3387	108	27	symptoms	symptom	NOUN
iajs-3387	108	28	affecting	affect	VERB
iajs-3387	108	29	bone	bone	NOUN
iajs-3387	108	30	,	,	PUNCT
iajs-3387	108	31	joints	joint	NOUN
iajs-3387	108	32	,	,	PUNCT
iajs-3387	108	33	muscles	muscle	NOUN
iajs-3387	108	34	,	,	PUNCT
iajs-3387	108	35	tendons	tendon	NOUN
iajs-3387	108	36	,	,	PUNCT
iajs-3387	108	37	and	and	CCONJ
iajs-3387	108	38	joints	joint	NOUN
iajs-3387	108	39	have	have	VERB
iajs-3387	108	40	a	a	DET
iajs-3387	108	41	significant	significant	ADJ
iajs-3387	108	42	influence	influence	NOUN
iajs-3387	108	43	on	on	ADP
iajs-3387	108	44	both	both	CCONJ
iajs-3387	108	45	patient	patient	ADJ
iajs-3387	108	46	groups	group	NOUN
iajs-3387	108	47	'	'	PART
iajs-3387	108	48	quality	quality	NOUN
iajs-3387	108	49	of	of	ADP
iajs-3387	108	50	life	life	NOUN
iajs-3387	108	51	[	[	X
iajs-3387	108	52	22	22	NUM
iajs-3387	108	53	]	]	PUNCT
iajs-3387	108	54	.	.	PUNCT
iajs-3387	109	1	the	the	DET
iajs-3387	109	2	gh	gh	PROPN
iajs-3387	109	3	/	/	SYM
iajs-3387	109	4	igf-1	igf-1	NOUN
iajs-3387	109	5	axis	axis	NOUN
iajs-3387	109	6	also	also	ADV
iajs-3387	109	7	significantly	significantly	ADV
iajs-3387	109	8	influences	influence	VERB
iajs-3387	109	9	collagen	collagen	NOUN
iajs-3387	109	10	modulation	modulation	NOUN
iajs-3387	109	11	[	[	X
iajs-3387	109	12	23	23	NUM
iajs-3387	109	13	,	,	PUNCT
iajs-3387	109	14	24	24	NUM
iajs-3387	109	15	]	]	PUNCT
iajs-3387	109	16	.	.	PUNCT
iajs-3387	110	1	the	the	DET
iajs-3387	110	2	acromegaly	acromegaly	PROPN
iajs-3387	110	3	group	group	NOUN
iajs-3387	110	4	had	have	VERB
iajs-3387	110	5	considerably	considerably	ADV
iajs-3387	110	6	greater	great	ADJ
iajs-3387	110	7	pld	pld	NOUN
iajs-3387	110	8	activity	activity	NOUN
iajs-3387	110	9	than	than	ADP
iajs-3387	110	10	the	the	DET
iajs-3387	110	11	healthy	healthy	ADJ
iajs-3387	110	12	control	control	NOUN
iajs-3387	110	13	group	group	NOUN
iajs-3387	110	14	,	,	PUNCT
iajs-3387	110	15	according	accord	VERB
iajs-3387	110	16	to	to	ADP
iajs-3387	110	17	the	the	DET
iajs-3387	110	18	current	current	ADJ
iajs-3387	110	19	study	study	NOUN
iajs-3387	110	20	.	.	PUNCT
iajs-3387	111	1	the	the	DET
iajs-3387	111	2	higher	high	ADJ
iajs-3387	111	3	pld	pld	NOUN
iajs-3387	111	4	activity	activity	NOUN
iajs-3387	111	5	suggests	suggest	VERB
iajs-3387	111	6	that	that	SCONJ
iajs-3387	111	7	collagen	collagen	NOUN
iajs-3387	111	8	management	management	NOUN
iajs-3387	111	9	remains	remain	VERB
iajs-3387	111	10	unattainable	unattainable	ADJ
iajs-3387	111	11	,	,	PUNCT
iajs-3387	111	12	even	even	ADV
iajs-3387	111	13	when	when	SCONJ
iajs-3387	111	14	the	the	DET
iajs-3387	111	15	condition	condition	NOUN
iajs-3387	111	16	is	be	AUX
iajs-3387	111	17	under	under	ADP
iajs-3387	111	18	control	control	NOUN
iajs-3387	111	19	[	[	X
iajs-3387	111	20	25	25	NUM
iajs-3387	111	21	]	]	PUNCT
iajs-3387	111	22	.	.	PUNCT
iajs-3387	112	1	growth	growth	NOUN
iajs-3387	112	2	hormone	hormone	NOUN
iajs-3387	112	3	and	and	CCONJ
iajs-3387	112	4	igf-1	igf-1	NOUN
iajs-3387	112	5	regulate	regulate	VERB
iajs-3387	112	6	collagen	collagen	NOUN
iajs-3387	112	7	and	and	CCONJ
iajs-3387	112	8	myofibrillar	myofibrillar	ADJ
iajs-3387	112	9	protein	protein	NOUN
iajs-3387	112	10	,	,	PUNCT
iajs-3387	112	11	the	the	DET
iajs-3387	112	12	two	two	NUM
iajs-3387	112	13	most	most	ADV
iajs-3387	112	14	prevalent	prevalent	ADJ
iajs-3387	112	15	proteins	protein	NOUN
iajs-3387	112	16	in	in	ADP
iajs-3387	112	17	joint	joint	ADJ
iajs-3387	112	18	tissues	tissue	NOUN
iajs-3387	112	19	.	.	PUNCT
iajs-3387	113	1	the	the	DET
iajs-3387	113	2	coarsened	coarsen	VERB
iajs-3387	113	3	facial	facial	ADJ
iajs-3387	113	4	features	feature	NOUN
iajs-3387	113	5	and	and	CCONJ
iajs-3387	113	6	acral	acral	ADJ
iajs-3387	113	7	overgrowth	overgrowth	NOUN
iajs-3387	113	8	of	of	ADP
iajs-3387	113	9	the	the	DET
iajs-3387	113	10	hands	hand	NOUN
iajs-3387	113	11	and	and	CCONJ
iajs-3387	113	12	feet	foot	NOUN
iajs-3387	113	13	in	in	ADP
iajs-3387	113	14	acromegaly	acromegaly	NOUN
iajs-3387	113	15	patients	patient	NOUN
iajs-3387	113	16	suggest	suggest	VERB
iajs-3387	113	17	a	a	DET
iajs-3387	113	18	correlation	correlation	NOUN
iajs-3387	113	19	between	between	ADP
iajs-3387	113	20	gh	gh	PROPN
iajs-3387	113	21	/	/	SYM
iajs-3387	113	22	igf1	igf1	PROPN
iajs-3387	113	23	and	and	CCONJ
iajs-3387	113	24	collagen	collagen	NOUN
iajs-3387	113	25	production	production	NOUN
iajs-3387	113	26	.	.	PUNCT
iajs-3387	114	1	moreover	moreover	ADV
iajs-3387	114	2	,	,	PUNCT
iajs-3387	114	3	collagen	collagen	NOUN
iajs-3387	114	4	synthesis	synthesis	NOUN
iajs-3387	114	5	appears	appear	VERB
iajs-3387	114	6	to	to	PART
iajs-3387	114	7	be	be	AUX
iajs-3387	114	8	susceptible	susceptible	ADJ
iajs-3387	114	9	to	to	ADP
iajs-3387	114	10	hormone	hormone	NOUN
iajs-3387	114	11	-	-	PUNCT
iajs-3387	114	12	regulatory	regulatory	ADJ
iajs-3387	114	13	treatment	treatment	NOUN
iajs-3387	114	14	as	as	ADV
iajs-3387	114	15	well	well	ADV
iajs-3387	114	16	as	as	ADP
iajs-3387	114	17	circulating	circulate	VERB
iajs-3387	114	18	gh	gh	PROPN
iajs-3387	114	19	and	and	CCONJ
iajs-3387	114	20	igf1	igf1	PROPN
iajs-3387	114	21	levels	level	NOUN
iajs-3387	114	22	[	[	X
iajs-3387	114	23	22	22	NUM
iajs-3387	114	24	]	]	PUNCT
iajs-3387	114	25	.	.	PUNCT
iajs-3387	115	1	the	the	DET
iajs-3387	115	2	onset	onset	NOUN
iajs-3387	115	3	of	of	ADP
iajs-3387	115	4	osteoarthritis	osteoarthritis	NOUN
iajs-3387	115	5	has	have	AUX
iajs-3387	115	6	been	be	AUX
iajs-3387	115	7	associated	associate	VERB
iajs-3387	115	8	with	with	ADP
iajs-3387	115	9	pld	pld	NOUN
iajs-3387	115	10	activity	activity	NOUN
iajs-3387	115	11	and	and	CCONJ
iajs-3387	115	12	oxidative	oxidative	ADJ
iajs-3387	115	13	stress	stress	NOUN
iajs-3387	115	14	[	[	X
iajs-3387	115	15	26	26	NUM
iajs-3387	115	16	,	,	PUNCT
iajs-3387	115	17	27	27	NUM
iajs-3387	115	18	]	]	PUNCT
iajs-3387	115	19	.	.	PUNCT
iajs-3387	116	1	there	there	PRON
iajs-3387	116	2	are	be	VERB
iajs-3387	116	3	few	few	ADJ
iajs-3387	116	4	studies	study	NOUN
iajs-3387	116	5	examining	examine	VERB
iajs-3387	116	6	the	the	DET
iajs-3387	116	7	levels	level	NOUN
iajs-3387	116	8	of	of	ADP
iajs-3387	116	9	oxidative	oxidative	ADJ
iajs-3387	116	10	stress	stress	NOUN
iajs-3387	116	11	in	in	ADP
iajs-3387	116	12	individuals	individual	NOUN
iajs-3387	116	13	with	with	ADP
iajs-3387	116	14	acromegaly	acromegaly	PROPN
iajs-3387	116	15	.	.	PUNCT
iajs-3387	117	1	according	accord	VERB
iajs-3387	117	2	to	to	ADP
iajs-3387	117	3	nishizawa	nishizawa	PROPN
iajs-3387	117	4	et	et	PROPN
iajs-3387	117	5	al	al	PROPN
iajs-3387	117	6	.	.	PROPN
iajs-3387	117	7	,	,	PUNCT
iajs-3387	117	8	individuals	individual	NOUN
iajs-3387	117	9	with	with	ADP
iajs-3387	117	10	acromegaly	acromegaly	NOUN
iajs-3387	117	11	have	have	VERB
iajs-3387	117	12	higher	high	ADJ
iajs-3387	117	13	levels	level	NOUN
iajs-3387	117	14	of	of	ADP
iajs-3387	117	15	reactive	reactive	ADJ
iajs-3387	117	16	stress	stress	NOUN
iajs-3387	117	17	[	[	X
iajs-3387	117	18	28	28	NUM
iajs-3387	117	19	]	]	PUNCT
iajs-3387	117	20	.	.	PUNCT
iajs-3387	118	1	a	a	DET
iajs-3387	118	2	recent	recent	ADJ
iajs-3387	118	3	study	study	NOUN
iajs-3387	118	4	by	by	ADP
iajs-3387	118	5	anagnostis	anagnostis	PROPN
iajs-3387	118	6	et	et	PROPN
iajs-3387	118	7	al	al	PROPN
iajs-3387	118	8	.	.	PROPN
iajs-3387	118	9	compared	compare	VERB
iajs-3387	118	10	15	15	NUM
iajs-3387	118	11	people	people	NOUN
iajs-3387	118	12	with	with	ADP
iajs-3387	118	13	acromegaly	acromegaly	NOUN
iajs-3387	118	14	to	to	ADP
iajs-3387	118	15	controls	control	NOUN
iajs-3387	118	16	of	of	ADP
iajs-3387	118	17	the	the	DET
iajs-3387	118	18	same	same	ADJ
iajs-3387	118	19	age	age	NOUN
iajs-3387	118	20	and	and	CCONJ
iajs-3387	118	21	gender	gender	NOUN
iajs-3387	118	22	and	and	CCONJ
iajs-3387	118	23	found	find	VERB
iajs-3387	118	24	that	that	SCONJ
iajs-3387	118	25	the	the	DET
iajs-3387	118	26	acromegaly	acromegaly	NOUN
iajs-3387	118	27	patients	patient	NOUN
iajs-3387	118	28	had	have	VERB
iajs-3387	118	29	higher	high	ADJ
iajs-3387	118	30	levels	level	NOUN
iajs-3387	118	31	of	of	ADP
iajs-3387	118	32	oxidative	oxidative	ADJ
iajs-3387	118	33	stress	stress	NOUN
iajs-3387	118	34	and	and	CCONJ
iajs-3387	118	35	lower	low	ADJ
iajs-3387	118	36	antioxidant	antioxidant	ADJ
iajs-3387	118	37	capacity	capacity	NOUN
iajs-3387	118	38	[	[	X
iajs-3387	118	39	29	29	NUM
iajs-3387	118	40	]	]	PUNCT
iajs-3387	118	41	.	.	PUNCT
iajs-3387	119	1	additionally	additionally	ADV
iajs-3387	119	2	,	,	PUNCT
iajs-3387	119	3	joint	joint	ADJ
iajs-3387	119	4	disease	disease	NOUN
iajs-3387	119	5	in	in	ADP
iajs-3387	119	6	acromegaly	acromegaly	NOUN
iajs-3387	119	7	patients	patient	NOUN
iajs-3387	119	8	persists	persist	VERB
iajs-3387	119	9	even	even	ADV
iajs-3387	119	10	after	after	ADP
iajs-3387	119	11	the	the	DET
iajs-3387	119	12	condition	condition	NOUN
iajs-3387	119	13	's	's	PART
iajs-3387	119	14	pharmacologic	pharmacologic	ADJ
iajs-3387	119	15	management	management	NOUN
iajs-3387	119	16	[	[	X
iajs-3387	119	17	30	30	NUM
iajs-3387	119	18	,	,	PUNCT
iajs-3387	119	19	31	31	NUM
iajs-3387	119	20	]	]	PUNCT
iajs-3387	119	21	.	.	PUNCT
iajs-3387	120	1	as	as	ADP
iajs-3387	120	2	a	a	DET
iajs-3387	120	3	result	result	NOUN
iajs-3387	120	4	,	,	PUNCT
iajs-3387	120	5	pld	pld	NOUN
iajs-3387	120	6	may	may	AUX
iajs-3387	120	7	play	play	VERB
iajs-3387	120	8	a	a	DET
iajs-3387	120	9	part	part	NOUN
iajs-3387	120	10	in	in	ADP
iajs-3387	120	11	the	the	DET
iajs-3387	120	12	development	development	NOUN
iajs-3387	120	13	of	of	ADP
iajs-3387	120	14	this	this	DET
iajs-3387	120	15	degenerative	degenerative	ADJ
iajs-3387	120	16	joint	joint	ADJ
iajs-3387	120	17	disease	disease	NOUN
iajs-3387	120	18	in	in	ADP
iajs-3387	120	19	people	people	NOUN
iajs-3387	120	20	who	who	PRON
iajs-3387	120	21	are	be	AUX
iajs-3387	120	22	acromegalic	acromegalic	ADJ
iajs-3387	120	23	,	,	PUNCT
iajs-3387	120	24	since	since	SCONJ
iajs-3387	120	25	it	it	PRON
iajs-3387	120	26	is	be	AUX
iajs-3387	120	27	a	a	DET
iajs-3387	120	28	key	key	ADJ
iajs-3387	120	29	biomarker	biomarker	NOUN
iajs-3387	120	30	for	for	ADP
iajs-3387	120	31	controlling	control	VERB
iajs-3387	120	32	this	this	DET
iajs-3387	120	33	process	process	NOUN
iajs-3387	120	34	.	.	PUNCT
iajs-3387	121	1	5	5	X
iajs-3387	121	2	.	.	X
iajs-3387	121	3	conclusion	conclusion	NOUN
iajs-3387	121	4	the	the	DET
iajs-3387	121	5	current	current	ADJ
iajs-3387	121	6	study	study	NOUN
iajs-3387	121	7	shows	show	VERB
iajs-3387	121	8	that	that	SCONJ
iajs-3387	121	9	pld	pld	NOUN
iajs-3387	121	10	levels	level	NOUN
iajs-3387	121	11	are	be	AUX
iajs-3387	121	12	higher	high	ADJ
iajs-3387	121	13	in	in	ADP
iajs-3387	121	14	patients	patient	NOUN
iajs-3387	121	15	with	with	ADP
iajs-3387	121	16	acromegaly	acromegaly	NOUN
iajs-3387	121	17	than	than	ADP
iajs-3387	121	18	in	in	ADP
iajs-3387	121	19	the	the	DET
iajs-3387	121	20	healthy	healthy	ADJ
iajs-3387	121	21	control	control	NOUN
iajs-3387	121	22	group	group	NOUN
iajs-3387	121	23	.	.	PUNCT
iajs-3387	122	1	the	the	DET
iajs-3387	122	2	sensitivity	sensitivity	NOUN
iajs-3387	122	3	and	and	CCONJ
iajs-3387	122	4	specificity	specificity	NOUN
iajs-3387	122	5	for	for	ADP
iajs-3387	122	6	pld	pld	NOUN
iajs-3387	122	7	were	be	AUX
iajs-3387	122	8	high	high	ADJ
iajs-3387	122	9	in	in	ADP
iajs-3387	122	10	the	the	DET
iajs-3387	122	11	patient	patient	NOUN
iajs-3387	122	12	group	group	NOUN
iajs-3387	122	13	ihjpas	ihjpa	VERB
iajs-3387	122	14	.	.	PUNCT
iajs-3387	123	1	2024	2024	NUM
iajs-3387	123	2	,	,	PUNCT
iajs-3387	123	3	37(4	37(4	NOUN
iajs-3387	123	4	)	)	PUNCT
iajs-3387	123	5	260	260	NUM
iajs-3387	123	6	versus	versus	ADP
iajs-3387	123	7	the	the	DET
iajs-3387	123	8	healthy	healthy	ADJ
iajs-3387	123	9	control	control	NOUN
iajs-3387	123	10	.	.	PUNCT
iajs-3387	124	1	the	the	DET
iajs-3387	124	2	pld	pld	NOUN
iajs-3387	124	3	may	may	AUX
iajs-3387	124	4	be	be	AUX
iajs-3387	124	5	a	a	DET
iajs-3387	124	6	novel	novel	ADJ
iajs-3387	124	7	biomarker	biomarker	NOUN
iajs-3387	124	8	of	of	ADP
iajs-3387	124	9	acromegaly	acromegaly	NOUN
iajs-3387	124	10	activity	activity	NOUN
iajs-3387	124	11	,	,	PUNCT
iajs-3387	124	12	and	and	CCONJ
iajs-3387	124	13	there	there	PRON
iajs-3387	124	14	may	may	AUX
iajs-3387	124	15	be	be	AUX
iajs-3387	124	16	an	an	DET
iajs-3387	124	17	increase	increase	NOUN
iajs-3387	124	18	in	in	ADP
iajs-3387	124	19	fasting	fast	VERB
iajs-3387	124	20	blood	blood	NOUN
iajs-3387	124	21	glucose	glucose	NOUN
iajs-3387	124	22	,	,	PUNCT
iajs-3387	124	23	growth	growth	NOUN
iajs-3387	124	24	hormone	hormone	NOUN
iajs-3387	124	25	,	,	PUNCT
iajs-3387	124	26	and	and	CCONJ
iajs-3387	124	27	igf-1	igf-1	NOUN
iajs-3387	124	28	in	in	ADP
iajs-3387	124	29	acromegalic	acromegalic	ADJ
iajs-3387	124	30	patients	patient	NOUN
iajs-3387	124	31	.	.	PUNCT
iajs-3387	125	1	acknowledgment	acknowledgment	NOUN
iajs-3387	125	2	the	the	DET
iajs-3387	125	3	authors	author	NOUN
iajs-3387	125	4	extend	extend	VERB
iajs-3387	125	5	their	their	PRON
iajs-3387	125	6	thanks	thank	NOUN
iajs-3387	125	7	and	and	CCONJ
iajs-3387	125	8	appreciation	appreciation	NOUN
iajs-3387	125	9	to	to	ADP
iajs-3387	125	10	the	the	DET
iajs-3387	125	11	national	national	ADJ
iajs-3387	125	12	center	center	NOUN
iajs-3387	125	13	for	for	ADP
iajs-3387	125	14	diabetics	diabetic	NOUN
iajs-3387	125	15	for	for	ADP
iajs-3387	125	16	treatment	treatment	NOUN
iajs-3387	125	17	and	and	CCONJ
iajs-3387	125	18	research	research	NOUN
iajs-3387	125	19	at	at	ADP
iajs-3387	125	20	al	al	PROPN
iajs-3387	125	21	-	-	PUNCT
iajs-3387	125	22	mustansiriya	mustansiriya	PROPN
iajs-3387	125	23	university	university	NOUN
iajs-3387	125	24	in	in	ADP
iajs-3387	125	25	baghdad	baghdad	PROPN
iajs-3387	125	26	,	,	PUNCT
iajs-3387	125	27	iraq	iraq	PROPN
iajs-3387	125	28	,	,	PUNCT
iajs-3387	125	29	and	and	CCONJ
iajs-3387	125	30	in	in	ADP
iajs-3387	125	31	particular	particular	ADJ
iajs-3387	125	32	to	to	PART
iajs-3387	125	33	prof	prof	PROPN
iajs-3387	125	34	.	.	PUNCT
iajs-3387	126	1	dr	dr	PROPN
iajs-3387	126	2	.	.	PROPN
iajs-3387	126	3	abbas	abbas	PROPN
iajs-3387	126	4	mahdi	mahdi	PROPN
iajs-3387	126	5	rahma	rahma	PROPN
iajs-3387	126	6	for	for	ADP
iajs-3387	126	7	his	his	PRON
iajs-3387	126	8	assistance	assistance	NOUN
iajs-3387	126	9	during	during	ADP
iajs-3387	126	10	this	this	DET
iajs-3387	126	11	study	study	NOUN
iajs-3387	126	12	and	and	CCONJ
iajs-3387	126	13	for	for	ADP
iajs-3387	126	14	being	be	AUX
iajs-3387	126	15	the	the	DET
iajs-3387	126	16	first	first	ADJ
iajs-3387	126	17	responsible	responsible	ADJ
iajs-3387	126	18	for	for	ADP
iajs-3387	126	19	acromegalic	acromegalic	ADJ
iajs-3387	126	20	patients	patient	NOUN
iajs-3387	126	21	.	.	PUNCT
iajs-3387	127	1	conflict	conflict	NOUN
iajs-3387	127	2	of	of	ADP
iajs-3387	127	3	interest	interest	NOUN
iajs-3387	127	4	the	the	DET
iajs-3387	127	5	authors	author	NOUN
iajs-3387	127	6	declare	declare	VERB
iajs-3387	127	7	there	there	PRON
iajs-3387	127	8	is	be	VERB
iajs-3387	127	9	no	no	DET
iajs-3387	127	10	conflict	conflict	NOUN
iajs-3387	127	11	of	of	ADP
iajs-3387	127	12	interest	interest	NOUN
iajs-3387	127	13	.	.	PUNCT
iajs-3387	128	1	funding	fund	VERB
iajs-3387	128	2	none	none	NOUN
iajs-3387	128	3	.	.	PUNCT
iajs-3387	129	1	ethical	ethical	ADJ
iajs-3387	129	2	clearance	clearance	NOUN
iajs-3387	129	3	this	this	DET
iajs-3387	129	4	study	study	NOUN
iajs-3387	129	5	was	be	AUX
iajs-3387	129	6	approved	approve	VERB
iajs-3387	129	7	by	by	ADP
iajs-3387	129	8	the	the	DET
iajs-3387	129	9	scientific	scientific	ADJ
iajs-3387	129	10	committee	committee	NOUN
iajs-3387	129	11	in	in	ADP
iajs-3387	129	12	the	the	DET
iajs-3387	129	13	college	college	NOUN
iajs-3387	129	14	of	of	ADP
iajs-3387	129	15	science	science	NOUN
iajs-3387	129	16	for	for	ADP
iajs-3387	129	17	women	woman	NOUN
iajs-3387	129	18	,	,	PUNCT
iajs-3387	129	19	and	and	CCONJ
iajs-3387	129	20	a	a	DET
iajs-3387	129	21	verbal	verbal	ADJ
iajs-3387	129	22	consent	consent	NOUN
iajs-3387	129	23	from	from	ADP
iajs-3387	129	24	was	be	AUX
iajs-3387	129	25	obtained	obtain	VERB
iajs-3387	129	26	from	from	ADP
iajs-3387	129	27	each	each	DET
iajs-3387	129	28	participant	participant	NOUN
iajs-3387	129	29	enrolled	enrol	VERB
iajs-3387	129	30	in	in	ADP
iajs-3387	129	31	the	the	DET
iajs-3387	129	32	study	study	NOUN
iajs-3387	129	33	.	.	PUNCT
iajs-3387	130	1	references	reference	NOUN
iajs-3387	130	2	1	1	NUM
iajs-3387	130	3	.	.	PUNCT
iajs-3387	130	4	wu	wu	PROPN
iajs-3387	130	5	,	,	PUNCT
iajs-3387	130	6	t.e	t.e	PROPN
iajs-3387	130	7	;	;	PUNCT
iajs-3387	130	8	chen	chen	PROPN
iajs-3387	130	9	,	,	PUNCT
iajs-3387	130	10	h.s	h.s	PROPN
iajs-3387	130	11	.	.	PUNCT
iajs-3387	131	1	the	the	DET
iajs-3387	131	2	role	role	NOUN
iajs-3387	131	3	of	of	ADP
iajs-3387	131	4	growth	growth	NOUN
iajs-3387	131	5	hormone	hormone	NOUN
iajs-3387	131	6	and	and	CCONJ
iajs-3387	131	7	igf-1	igf-1	NOUN
iajs-3387	131	8	in	in	ADP
iajs-3387	131	9	retinopathy	retinopathy	ADJ
iajs-3387	131	10	:	:	PUNCT
iajs-3387	131	11	a	a	DET
iajs-3387	131	12	prospective	prospective	ADJ
iajs-3387	131	13	study	study	NOUN
iajs-3387	131	14	of	of	ADP
iajs-3387	131	15	retinopathy	retinopathy	ADJ
iajs-3387	131	16	in	in	ADP
iajs-3387	131	17	patients	patient	NOUN
iajs-3387	131	18	with	with	ADP
iajs-3387	131	19	acromegaly	acromegaly	NOUN
iajs-3387	131	20	and	and	CCONJ
iajs-3387	131	21	impaired	impaired	ADJ
iajs-3387	131	22	fasting	fasting	NOUN
iajs-3387	131	23	glucose	glucose	NOUN
iajs-3387	131	24	.	.	PUNCT
iajs-3387	132	1	diabetology	diabetology	PROPN
iajs-3387	132	2	&	&	CCONJ
iajs-3387	132	3	metabolic	metabolic	PROPN
iajs-3387	132	4	syndrome	syndrome	PROPN
iajs-3387	132	5	2022	2022	NUM
iajs-3387	132	6	,	,	PUNCT
iajs-3387	132	7	14(1	14(1	NUM
iajs-3387	132	8	)	)	PUNCT
iajs-3387	132	9	,	,	PUNCT
iajs-3387	132	10	38	38	NUM
iajs-3387	132	11	.	.	PUNCT
iajs-3387	133	1	https://doi.org/10.1186/s13098-022-00806-z	https://doi.org/10.1186/s13098-022-00806-z	NOUN
iajs-3387	133	2	.	.	PUNCT
iajs-3387	134	1	2	2	X
iajs-3387	134	2	.	.	X
iajs-3387	134	3	mohammad	mohammad	PROPN
iajs-3387	134	4	,	,	PUNCT
iajs-3387	134	5	t.u	t.u	PROPN
iajs-3387	134	6	.	.	PROPN
iajs-3387	134	7	partial	partial	ADJ
iajs-3387	134	8	purification	purification	NOUN
iajs-3387	134	9	of	of	ADP
iajs-3387	134	10	leucine	leucine	NOUN
iajs-3387	134	11	aminopeptidase	aminopeptidase	NOUN
iajs-3387	134	12	(	(	PUNCT
iajs-3387	134	13	lap	lap	NOUN
iajs-3387	134	14	)	)	PUNCT
iajs-3387	134	15	in	in	ADP
iajs-3387	134	16	acromegalic	acromegalic	ADJ
iajs-3387	134	17	sample	sample	NOUN
iajs-3387	134	18	of	of	ADP
iajs-3387	134	19	iraqi	iraqi	ADJ
iajs-3387	134	20	patients	patient	NOUN
iajs-3387	134	21	.	.	PUNCT
iajs-3387	135	1	journal	journal	PROPN
iajs-3387	135	2	of	of	ADP
iajs-3387	135	3	physics	physics	PROPN
iajs-3387	135	4	2018	2018	NUM
iajs-3387	135	5	,	,	PUNCT
iajs-3387	135	6	1003(1	1003(1	NUM
iajs-3387	135	7	)	)	PUNCT
iajs-3387	135	8	,	,	PUNCT
iajs-3387	135	9	12	12	NUM
iajs-3387	135	10	-	-	SYM
iajs-3387	135	11	15	15	NUM
iajs-3387	135	12	.	.	PUNCT
iajs-3387	136	1	https://doi.org/10.1088/17426596/1003/1/012015	https://doi.org/10.1088/17426596/1003/1/012015	X
iajs-3387	136	2	.	.	PROPN
iajs-3387	137	1	3	3	X
iajs-3387	137	2	.	.	X
iajs-3387	137	3	abass	abass	PROPN
iajs-3387	137	4	,	,	PUNCT
iajs-3387	137	5	e.a	e.a	PROPN
iajs-3387	137	6	.	.	PROPN
iajs-3387	137	7	;	;	PUNCT
iajs-3387	137	8	abed	abe	VERB
iajs-3387	137	9	,	,	PUNCT
iajs-3387	137	10	b.a	b.a	PROPN
iajs-3387	137	11	.	.	PROPN
iajs-3387	137	12	;	;	PUNCT
iajs-3387	137	13	mohsin	mohsin	PROPN
iajs-3387	137	14	,	,	PUNCT
iajs-3387	137	15	s.n	s.n	PROPN
iajs-3387	137	16	.	.	PROPN
iajs-3387	137	17	determination	determination	NOUN
iajs-3387	137	18	of	of	ADP
iajs-3387	137	19	osteocalcin	osteocalcin	PROPN
iajs-3387	137	20	,	,	PUNCT
iajs-3387	137	21	bone	bone	NOUN
iajs-3387	137	22	alkaline	alkaline	NOUN
iajs-3387	137	23	phosphatase	phosphatase	NOUN
iajs-3387	137	24	,	,	PUNCT
iajs-3387	137	25	and	and	CCONJ
iajs-3387	137	26	lysyl	lysyl	NOUN
iajs-3387	137	27	oxidase	oxidase	NOUN
iajs-3387	137	28	in	in	ADP
iajs-3387	137	29	iraqi	iraqi	ADJ
iajs-3387	137	30	acromegalic	acromegalic	ADJ
iajs-3387	137	31	patients	patient	NOUN
iajs-3387	137	32	.	.	PUNCT
iajs-3387	138	1	ibn	ibn	PROPN
iajs-3387	138	2	al	al	PROPN
iajs-3387	138	3	-	-	PUNCT
iajs-3387	138	4	haitham	haitham	PROPN
iajs-3387	138	5	journal	journal	PROPN
iajs-3387	138	6	for	for	ADP
iajs-3387	138	7	pure	pure	ADJ
iajs-3387	138	8	and	and	CCONJ
iajs-3387	138	9	applied	applied	ADJ
iajs-3387	138	10	sciences	science	NOUN
iajs-3387	138	11	2018	2018	NUM
iajs-3387	138	12	,	,	PUNCT
iajs-3387	138	13	31(1	31(1	NUM
iajs-3387	138	14	)	)	PUNCT
iajs-3387	138	15	,	,	PUNCT
iajs-3387	138	16	172	172	NUM
iajs-3387	138	17	-	-	SYM
iajs-3387	138	18	179	179	NUM
iajs-3387	138	19	.	.	PUNCT
iajs-3387	139	1	https://doi.org/10.30526/31.1.1864	https://doi.org/10.30526/31.1.1864	X
iajs-3387	139	2	.	.	NOUN
iajs-3387	139	3	4	4	NUM
iajs-3387	139	4	.	.	X
iajs-3387	139	5	crisafulli	crisafulli	PROPN
iajs-3387	139	6	,	,	PUNCT
iajs-3387	139	7	s.	s.	PROPN
iajs-3387	139	8	;	;	PUNCT
iajs-3387	139	9	fontana	fontana	PROPN
iajs-3387	139	10	,	,	PUNCT
iajs-3387	139	11	a.	a.	NOUN
iajs-3387	139	12	;	;	PUNCT
iajs-3387	139	13	l’abbate	l’abbate	PROPN
iajs-3387	139	14	,	,	PUNCT
iajs-3387	139	15	l.	l.	PROPN
iajs-3387	139	16	;	;	PUNCT
iajs-3387	139	17	ientile	ientile	ADJ
iajs-3387	139	18	,	,	PUNCT
iajs-3387	139	19	v.	v.	ADV
iajs-3387	139	20	;	;	PUNCT
iajs-3387	139	21	gianfrilli	gianfrilli	PROPN
iajs-3387	139	22	,	,	PUNCT
iajs-3387	139	23	d.	d.	PROPN
iajs-3387	139	24	;	;	PUNCT
iajs-3387	139	25	cozzolino	cozzolino	PROPN
iajs-3387	139	26	,	,	PUNCT
iajs-3387	139	27	a.	a.	NOUN
iajs-3387	139	28	;	;	PUNCT
iajs-3387	139	29	de	de	X
iajs-3387	139	30	martino	martino	PROPN
iajs-3387	139	31	,	,	PUNCT
iajs-3387	139	32	m.c	m.c	PROPN
iajs-3387	139	33	.	.	PROPN
iajs-3387	139	34	;	;	PUNCT
iajs-3387	139	35	ragonese	ragonese	PROPN
iajs-3387	139	36	,	,	PUNCT
iajs-3387	139	37	m.	m.	NOUN
iajs-3387	139	38	;	;	PUNCT
iajs-3387	139	39	sultana	sultana	NOUN
iajs-3387	139	40	,	,	PUNCT
iajs-3387	139	41	j.	j.	PROPN
iajs-3387	139	42	;	;	PUNCT
iajs-3387	139	43	barone	barone	PROPN
iajs-3387	139	44	-	-	PUNCT
iajs-3387	139	45	adesi	adesi	PROPN
iajs-3387	139	46	,	,	PUNCT
iajs-3387	139	47	f.	f.	PROPN
iajs-3387	139	48	;	;	PUNCT
iajs-3387	139	49	trifirò	trifirò	ADV
iajs-3387	139	50	,	,	PUNCT
iajs-3387	139	51	g.	g.	PROPN
iajs-3387	139	52	development	development	NOUN
iajs-3387	139	53	and	and	CCONJ
iajs-3387	139	54	testing	testing	NOUN
iajs-3387	139	55	of	of	ADP
iajs-3387	139	56	diagnostic	diagnostic	ADJ
iajs-3387	139	57	algorithms	algorithm	NOUN
iajs-3387	139	58	to	to	PART
iajs-3387	139	59	identify	identify	VERB
iajs-3387	139	60	patients	patient	NOUN
iajs-3387	139	61	with	with	ADP
iajs-3387	139	62	acromegaly	acromegaly	NOUN
iajs-3387	139	63	in	in	ADP
iajs-3387	139	64	southern	southern	ADJ
iajs-3387	139	65	italian	italian	ADJ
iajs-3387	139	66	claims	claim	NOUN
iajs-3387	139	67	databases	database	NOUN
iajs-3387	139	68	.	.	PUNCT
iajs-3387	140	1	scientific	scientific	ADJ
iajs-3387	140	2	reports	report	NOUN
iajs-3387	140	3	2022	2022	NUM
iajs-3387	140	4	,	,	PUNCT
iajs-3387	140	5	12(1),15843	12(1),15843	NUM
iajs-3387	140	6	.	.	PUNCT
iajs-3387	141	1	https://doi.org/10.1038/s41598-022-20295-4	https://doi.org/10.1038/s41598-022-20295-4	NUM
iajs-3387	141	2	.	.	PUNCT
iajs-3387	142	1	5	5	NUM
iajs-3387	142	2	.	.	X
iajs-3387	142	3	hameed	hameed	PROPN
iajs-3387	142	4	,	,	PUNCT
iajs-3387	142	5	a.s	a.s	PROPN
iajs-3387	142	6	.	.	PROPN
iajs-3387	142	7	;	;	PUNCT
iajs-3387	142	8	khaleel	khaleel	PROPN
iajs-3387	142	9	,	,	PUNCT
iajs-3387	142	10	f.m	f.m	PROPN
iajs-3387	142	11	.	.	PROPN
iajs-3387	142	12	;	;	PUNCT
iajs-3387	142	13	rahma	rahma	PROPN
iajs-3387	142	14	,	,	PUNCT
iajs-3387	142	15	a.m.	a.m.	PROPN
iajs-3387	143	1	the	the	DET
iajs-3387	143	2	response	response	NOUN
iajs-3387	143	3	of	of	ADP
iajs-3387	143	4	acromegalic	acromegalic	ADJ
iajs-3387	143	5	patients	patient	NOUN
iajs-3387	143	6	(	(	PUNCT
iajs-3387	143	7	diabetic	diabetic	ADJ
iajs-3387	143	8	versus	versus	ADP
iajs-3387	143	9	non	non	ADJ
iajs-3387	143	10	-	-	ADJ
iajs-3387	143	11	diabetic	diabetic	ADJ
iajs-3387	143	12	)	)	PUNCT
iajs-3387	143	13	to	to	ADP
iajs-3387	143	14	long	long	ADV
iajs-3387	143	15	-	-	PUNCT
iajs-3387	143	16	acting	act	VERB
iajs-3387	143	17	-	-	PUNCT
iajs-3387	143	18	repeatable	repeatable	ADJ
iajs-3387	143	19	octreotide	octreotide	NOUN
iajs-3387	143	20	(	(	PUNCT
iajs-3387	143	21	lar	lar	ADJ
iajs-3387	143	22	)	)	PUNCT
iajs-3387	143	23	in	in	ADP
iajs-3387	143	24	the	the	DET
iajs-3387	143	25	presence	presence	NOUN
iajs-3387	143	26	or	or	CCONJ
iajs-3387	143	27	absence	absence	NOUN
iajs-3387	143	28	of	of	ADP
iajs-3387	143	29	glutathion	glutathion	NOUN
iajs-3387	143	30	s	s	PART
iajs-3387	143	31	transferase	transferase	NOUN
iajs-3387	143	32	(	(	PUNCT
iajs-3387	143	33	gstm1	gstm1	NOUN
iajs-3387	143	34	,	,	PUNCT
iajs-3387	143	35	gstt1	gstt1	NOUN
iajs-3387	143	36	)	)	PUNCT
iajs-3387	143	37	genes	gene	NOUN
iajs-3387	143	38	.	.	PUNCT
iajs-3387	144	1	journal	journal	NOUN
iajs-3387	144	2	of	of	ADP
iajs-3387	144	3	pharmaceutical	pharmaceutical	NOUN
iajs-3387	144	4	sciences	science	NOUN
iajs-3387	144	5	and	and	CCONJ
iajs-3387	144	6	research	research	NOUN
iajs-3387	144	7	2019	2019	NUM
iajs-3387	144	8	,	,	PUNCT
iajs-3387	144	9	11(2	11(2	NUM
iajs-3387	144	10	)	)	PUNCT
iajs-3387	144	11	,	,	PUNCT
iajs-3387	144	12	495	495	NUM
iajs-3387	144	13	-	-	SYM
iajs-3387	144	14	500	500	NUM
iajs-3387	144	15	.	.	PUNCT
iajs-3387	145	1	https://www.jpsr.pharmainfo.in/documents/volumes/vol10issue12/jpsr10121814.pdf	https://www.jpsr.pharmainfo.in/documents/volumes/vol10issue12/jpsr10121814.pdf	NOUN
iajs-3387	145	2	.	.	PROPN
iajs-3387	145	3	6	6	NUM
iajs-3387	145	4	.	.	NUM
iajs-3387	145	5	gadelha	gadelha	NOUN
iajs-3387	145	6	,	,	PUNCT
iajs-3387	145	7	m.r	m.r	PROPN
iajs-3387	145	8	.	.	PROPN
iajs-3387	145	9	;	;	PUNCT
iajs-3387	145	10	kasuki	kasuki	PROPN
iajs-3387	145	11	,	,	PUNCT
iajs-3387	145	12	l.	l.	PROPN
iajs-3387	145	13	;	;	PUNCT
iajs-3387	145	14	lim	lim	PROPN
iajs-3387	145	15	,	,	PUNCT
iajs-3387	145	16	d.s	d.s	PROPN
iajs-3387	145	17	.	.	PROPN
iajs-3387	145	18	;	;	PUNCT
iajs-3387	145	19	fleseriu	fleseriu	PROPN
iajs-3387	145	20	,	,	PUNCT
iajs-3387	145	21	m.	m.	NOUN
iajs-3387	145	22	systemic	systemic	ADJ
iajs-3387	145	23	complications	complication	NOUN
iajs-3387	145	24	of	of	ADP
iajs-3387	145	25	acromegaly	acromegaly	PROPN
iajs-3387	145	26	and	and	CCONJ
iajs-3387	145	27	the	the	DET
iajs-3387	145	28	impact	impact	NOUN
iajs-3387	145	29	of	of	ADP
iajs-3387	145	30	the	the	DET
iajs-3387	145	31	current	current	ADJ
iajs-3387	145	32	treatment	treatment	NOUN
iajs-3387	145	33	landscape	landscape	NOUN
iajs-3387	145	34	:	:	PUNCT
iajs-3387	145	35	an	an	DET
iajs-3387	145	36	update	update	NOUN
iajs-3387	145	37	.	.	PUNCT
iajs-3387	146	1	endocrine	endocrine	ADJ
iajs-3387	146	2	reviews	review	NOUN
iajs-3387	146	3	2019	2019	NUM
iajs-3387	146	4	,	,	PUNCT
iajs-3387	146	5	40(1	40(1	NUM
iajs-3387	146	6	)	)	PUNCT
iajs-3387	146	7	,	,	PUNCT
iajs-3387	146	8	268	268	NUM
iajs-3387	146	9	-	-	SYM
iajs-3387	146	10	332	332	NUM
iajs-3387	146	11	.	.	PUNCT
iajs-3387	147	1	https://doi.org/10.1210/er.2018-00115	https://doi.org/10.1210/er.2018-00115	NOUN
iajs-3387	147	2	.	.	PUNCT
iajs-3387	148	1	7	7	X
iajs-3387	148	2	.	.	X
iajs-3387	148	3	tahir	tahir	PROPN
iajs-3387	148	4	,	,	PUNCT
iajs-3387	148	5	n.t	n.t	PROPN
iajs-3387	148	6	.	.	PROPN
iajs-3387	148	7	;	;	PUNCT
iajs-3387	148	8	abdulsattar	abdulsattar	PROPN
iajs-3387	148	9	,	,	PUNCT
iajs-3387	148	10	s.a	s.a	PROPN
iajs-3387	148	11	.	.	PROPN
iajs-3387	148	12	;	;	PUNCT
iajs-3387	148	13	alkazzaz	alkazzaz	PROPN
iajs-3387	148	14	,	,	PUNCT
iajs-3387	148	15	f.f	f.f	PROPN
iajs-3387	148	16	.	.	PROPN
iajs-3387	148	17	assessment	assessment	NOUN
iajs-3387	148	18	of	of	ADP
iajs-3387	148	19	obesity	obesity	NOUN
iajs-3387	148	20	,	,	PUNCT
iajs-3387	148	21	dyslipidemia	dyslipidemia	NOUN
iajs-3387	148	22	,	,	PUNCT
iajs-3387	148	23	hyperglycemia	hyperglycemia	NOUN
iajs-3387	148	24	,	,	PUNCT
iajs-3387	148	25	and	and	CCONJ
iajs-3387	148	26	pro	pro	ADJ
iajs-3387	148	27	-	-	ADJ
iajs-3387	148	28	inflammatory	inflammatory	ADJ
iajs-3387	148	29	cytokines	cytokine	NOUN
iajs-3387	148	30	as	as	ADP
iajs-3387	148	31	cardiovascular	cardiovascular	ADJ
iajs-3387	148	32	disease	disease	NOUN
iajs-3387	148	33	risk	risk	NOUN
iajs-3387	148	34	factors	factor	NOUN
iajs-3387	148	35	in	in	ADP
iajs-3387	148	36	acromegaly	acromegaly	NOUN
iajs-3387	148	37	patients	patient	NOUN
iajs-3387	148	38	.	.	PUNCT
iajs-3387	149	1	baghdad	baghdad	PROPN
iajs-3387	149	2	science	science	PROPN
iajs-3387	149	3	journal	journal	PROPN
iajs-3387	149	4	2022	2022	NUM
iajs-3387	149	5	,	,	PUNCT
iajs-3387	149	6	19(5),0976	19(5),0976	NUM
iajs-3387	149	7	.	.	PUNCT
iajs-3387	150	1	http://dx.doi.org/10.21123/bsj.2022.6002	http://dx.doi.org/10.21123/bsj.2022.6002	X
iajs-3387	150	2	.	.	PROPN
iajs-3387	150	3	8	8	NUM
iajs-3387	150	4	.	.	X
iajs-3387	151	1	hameed	hameed	PROPN
iajs-3387	151	2	,	,	PUNCT
iajs-3387	151	3	a.s	a.s	PROPN
iajs-3387	151	4	.	.	PROPN
iajs-3387	151	5	;	;	PUNCT
iajs-3387	151	6	khaleel	khaleel	PROPN
iajs-3387	151	7	,	,	PUNCT
iajs-3387	151	8	f.m	f.m	PROPN
iajs-3387	151	9	.	.	PROPN
iajs-3387	151	10	;	;	PUNCT
iajs-3387	151	11	rahma	rahma	PROPN
iajs-3387	151	12	,	,	PUNCT
iajs-3387	151	13	a.m.	a.m.	ADV
iajs-3387	151	14	superoxide	superoxide	NOUN
iajs-3387	151	15	dismutase	dismutase	NOUN
iajs-3387	151	16	and	and	CCONJ
iajs-3387	151	17	glutathione	glutathione	NOUN
iajs-3387	151	18	s	s	PART
iajs-3387	151	19	transferase	transferase	NOUN
iajs-3387	151	20	enzymes	enzyme	NOUN
iajs-3387	151	21	levels	level	NOUN
iajs-3387	151	22	in	in	ADP
iajs-3387	151	23	diabetic	diabetic	ADJ
iajs-3387	151	24	iraqi	iraqi	ADJ
iajs-3387	151	25	acromegalic	acromegalic	ADJ
iajs-3387	151	26	patients	patient	NOUN
iajs-3387	151	27	.	.	PUNCT
iajs-3387	152	1	biochemical	biochemical	ADJ
iajs-3387	152	2	and	and	CCONJ
iajs-3387	152	3	cellular	cellular	ADJ
iajs-3387	152	4	archives	archive	NOUN
iajs-3387	152	5	2019	2019	NUM
iajs-3387	152	6	,	,	PUNCT
iajs-3387	152	7	2097	2097	NUM
iajs-3387	152	8	-	-	SYM
iajs-3387	152	9	2100	2100	NUM
iajs-3387	152	10	.	.	PUNCT
iajs-3387	153	1	https://doi.org/10.35124/bca.2019.19.s1.2097	https://doi.org/10.35124/bca.2019.19.s1.2097	PROPN
iajs-3387	153	2	.	.	PUNCT
iajs-3387	154	1	https://doi.org/10.1186/s13098-022-00806-z	https://doi.org/10.1186/s13098-022-00806-z	NOUN
iajs-3387	154	2	https://doi.org/10.1088/1742-6596/1003/1/012015	https://doi.org/10.1088/1742-6596/1003/1/012015	PROPN
iajs-3387	154	3	https://doi.org/10.1088/1742-6596/1003/1/012015	https://doi.org/10.1088/1742-6596/1003/1/012015	PROPN
iajs-3387	155	1	https://doi.org/10.30526/31.1.1864	https://doi.org/10.30526/31.1.1864	PROPN
iajs-3387	155	2	https://doi.org/10.1038/s41598-022-20295-4	https://doi.org/10.1038/s41598-022-20295-4	NUM
iajs-3387	156	1	https://www.jpsr.pharmainfo.in/documents/volumes/vol10issue12/jpsr10121814.pdf	https://www.jpsr.pharmainfo.in/documents/volumes/vol10issue12/jpsr10121814.pdf	NUM
iajs-3387	156	2	https://doi.org/10.1210/er.2018-00115	https://doi.org/10.1210/er.2018-00115	NOUN
iajs-3387	156	3	http://dx.doi.org/10.21123/bsj.2022.6002	http://dx.doi.org/10.21123/bsj.2022.6002	NUM
iajs-3387	156	4	https://doi.org/10.35124/bca.2019.19.s1.2097	https://doi.org/10.35124/bca.2019.19.s1.2097	PROPN
iajs-3387	156	5	ihjpas	ihjpas	PROPN
iajs-3387	156	6	.	.	PUNCT
iajs-3387	157	1	2024	2024	NUM
iajs-3387	157	2	,	,	PUNCT
iajs-3387	157	3	37(4	37(4	NOUN
iajs-3387	157	4	)	)	PUNCT
iajs-3387	157	5	261	261	NUM
iajs-3387	157	6	9	9	NUM
iajs-3387	157	7	.	.	PUNCT
iajs-3387	157	8	giustina	giustina	PROPN
iajs-3387	157	9	,	,	PUNCT
iajs-3387	157	10	a.	a.	NOUN
iajs-3387	157	11	;	;	PUNCT
iajs-3387	157	12	chanson	chanson	PROPN
iajs-3387	157	13	,	,	PUNCT
iajs-3387	157	14	p.	p.	PROPN
iajs-3387	157	15	;	;	PUNCT
iajs-3387	157	16	kleinberg	kleinberg	PROPN
iajs-3387	157	17	,	,	PUNCT
iajs-3387	157	18	d.	d.	PROPN
iajs-3387	157	19	;	;	PUNCT
iajs-3387	158	1	bronstein	bronstein	PROPN
iajs-3387	158	2	,	,	PUNCT
iajs-3387	158	3	m.d	m.d	PROPN
iajs-3387	158	4	.	.	PROPN
iajs-3387	158	5	;	;	PUNCT
iajs-3387	158	6	clemmons	clemmons	PROPN
iajs-3387	158	7	,	,	PUNCT
iajs-3387	158	8	d.r	d.r	PROPN
iajs-3387	158	9	.	.	PROPN
iajs-3387	158	10	;	;	PUNCT
iajs-3387	158	11	klibanski	klibanski	PROPN
iajs-3387	158	12	,	,	PUNCT
iajs-3387	158	13	a.	a.	NOUN
iajs-3387	158	14	;	;	PUNCT
iajs-3387	158	15	van	van	PROPN
iajs-3387	158	16	der	der	PROPN
iajs-3387	158	17	lely	lely	PROPN
iajs-3387	158	18	,	,	PUNCT
iajs-3387	158	19	a.j	a.j	PROPN
iajs-3387	158	20	.	.	PROPN
iajs-3387	158	21	;	;	PUNCT
iajs-3387	158	22	strasburger	strasburger	NOUN
iajs-3387	158	23	,	,	PUNCT
iajs-3387	158	24	c.j	c.j	PROPN
iajs-3387	158	25	.	.	PROPN
iajs-3387	158	26	;	;	PUNCT
iajs-3387	158	27	lamberts	lamberts	PROPN
iajs-3387	158	28	,	,	PUNCT
iajs-3387	158	29	s.w	s.w	PROPN
iajs-3387	158	30	.	.	PROPN
iajs-3387	158	31	;	;	PUNCT
iajs-3387	158	32	ho	ho	PROPN
iajs-3387	158	33	,	,	PUNCT
iajs-3387	158	34	k.k	k.k	PROPN
iajs-3387	158	35	.	.	PROPN
iajs-3387	158	36	;	;	PUNCT
iajs-3387	158	37	casanueva	casanueva	PROPN
iajs-3387	158	38	,	,	PUNCT
iajs-3387	158	39	f.f	f.f	PROPN
iajs-3387	158	40	.	.	PROPN
iajs-3387	158	41	expert	expert	PROPN
iajs-3387	158	42	consensus	consensus	NOUN
iajs-3387	158	43	document	document	NOUN
iajs-3387	158	44	:	:	PUNCT
iajs-3387	158	45	a	a	DET
iajs-3387	158	46	consensus	consensus	NOUN
iajs-3387	158	47	on	on	ADP
iajs-3387	158	48	the	the	DET
iajs-3387	158	49	medical	medical	ADJ
iajs-3387	158	50	treatment	treatment	NOUN
iajs-3387	158	51	of	of	ADP
iajs-3387	158	52	acromegaly	acromegaly	PROPN
iajs-3387	158	53	.	.	PUNCT
iajs-3387	159	1	nature	nature	NOUN
iajs-3387	159	2	reviews	review	VERB
iajs-3387	159	3	endocrinology	endocrinology	NOUN
iajs-3387	159	4	2014	2014	NUM
iajs-3387	159	5	,	,	PUNCT
iajs-3387	159	6	10(4	10(4	NUM
iajs-3387	159	7	)	)	PUNCT
iajs-3387	159	8	,	,	PUNCT
iajs-3387	159	9	243	243	NUM
iajs-3387	159	10	-	-	SYM
iajs-3387	159	11	248	248	NUM
iajs-3387	159	12	.	.	PUNCT
iajs-3387	160	1	https://doi.org/10.1038/nrendo.2014.21	https://doi.org/10.1038/nrendo.2014.21	PROPN
iajs-3387	160	2	.	.	PUNCT
iajs-3387	161	1	10	10	NUM
iajs-3387	161	2	.	.	X
iajs-3387	162	1	tönjes	tönje	NOUN
iajs-3387	162	2	,	,	PUNCT
iajs-3387	162	3	a.	a.	NOUN
iajs-3387	162	4	;	;	PUNCT
iajs-3387	162	5	quinkler	quinkler	NOUN
iajs-3387	162	6	,	,	PUNCT
iajs-3387	162	7	m.	m.	NOUN
iajs-3387	162	8	;	;	PUNCT
iajs-3387	162	9	knappe	knappe	PROPN
iajs-3387	162	10	,	,	PUNCT
iajs-3387	162	11	u.	u.	PROPN
iajs-3387	162	12	;	;	PUNCT
iajs-3387	162	13	störmann	störmann	PROPN
iajs-3387	162	14	,	,	PUNCT
iajs-3387	162	15	s.	s.	PROPN
iajs-3387	162	16	;	;	PUNCT
iajs-3387	162	17	schöfl	schöfl	PROPN
iajs-3387	162	18	,	,	PUNCT
iajs-3387	162	19	c.	c.	NOUN
iajs-3387	162	20	;	;	PUNCT
iajs-3387	162	21	schopohl	schopohl	NOUN
iajs-3387	162	22	,	,	PUNCT
iajs-3387	162	23	j.	j.	PROPN
iajs-3387	162	24	;	;	PUNCT
iajs-3387	162	25	meyhöfer	meyhöfer	PROPN
iajs-3387	162	26	,	,	PUNCT
iajs-3387	162	27	s.m	s.m	PROPN
iajs-3387	162	28	.	.	PROPN
iajs-3387	162	29	treatment	treatment	NOUN
iajs-3387	162	30	of	of	ADP
iajs-3387	162	31	acromegaly	acromegaly	NOUN
iajs-3387	162	32	-	-	PUNCT
iajs-3387	162	33	data	data	NOUN
iajs-3387	162	34	from	from	ADP
iajs-3387	162	35	the	the	DET
iajs-3387	162	36	german	german	ADJ
iajs-3387	162	37	acromegaly	acromegaly	NOUN
iajs-3387	162	38	register	register	NOUN
iajs-3387	162	39	.	.	PUNCT
iajs-3387	163	1	deutsche	deutsche	PROPN
iajs-3387	163	2	medizinische	medizinische	PROPN
iajs-3387	163	3	wochenschrift	wochenschrift	PROPN
iajs-3387	163	4	2023	2023	NUM
iajs-3387	163	5	,	,	PUNCT
iajs-3387	163	6	148(7	148(7	NUM
iajs-3387	163	7	)	)	PUNCT
iajs-3387	163	8	,	,	PUNCT
iajs-3387	163	9	380	380	NUM
iajs-3387	163	10	-	-	SYM
iajs-3387	163	11	385	385	NUM
iajs-3387	163	12	.	.	PUNCT
iajs-3387	164	1	https://doi.org/10.1055/a-1847-2553	https://doi.org/10.1055/a-1847-2553	PROPN
iajs-3387	164	2	.	.	PROPN
iajs-3387	165	1	11	11	NUM
iajs-3387	165	2	.	.	X
iajs-3387	166	1	lu	lu	PROPN
iajs-3387	166	2	,	,	PUNCT
iajs-3387	166	3	m.	m.	NOUN
iajs-3387	166	4	;	;	PUNCT
iajs-3387	166	5	flanagan	flanagan	PROPN
iajs-3387	166	6	,	,	PUNCT
iajs-3387	166	7	j.u	j.u	PROPN
iajs-3387	166	8	.	.	PROPN
iajs-3387	166	9	;	;	PUNCT
iajs-3387	166	10	langley	langley	PROPN
iajs-3387	166	11	,	,	PUNCT
iajs-3387	166	12	r.j	r.j	PROPN
iajs-3387	166	13	.	.	PROPN
iajs-3387	166	14	;	;	PUNCT
iajs-3387	166	15	hay	hay	PROPN
iajs-3387	166	16	,	,	PUNCT
iajs-3387	166	17	m.p	m.p	PROPN
iajs-3387	166	18	.	.	PROPN
iajs-3387	166	19	;	;	PUNCT
iajs-3387	166	20	perry	perry	PROPN
iajs-3387	166	21	,	,	PUNCT
iajs-3387	166	22	j.k	j.k	PROPN
iajs-3387	166	23	.	.	PUNCT
iajs-3387	166	24	targeting	target	VERB
iajs-3387	166	25	growth	growth	NOUN
iajs-3387	166	26	hormone	hormone	NOUN
iajs-3387	166	27	function	function	NOUN
iajs-3387	166	28	:	:	PUNCT
iajs-3387	166	29	strategies	strategy	NOUN
iajs-3387	166	30	and	and	CCONJ
iajs-3387	166	31	therapeutic	therapeutic	ADJ
iajs-3387	166	32	applications	application	NOUN
iajs-3387	166	33	.	.	PUNCT
iajs-3387	167	1	signal	signal	ADJ
iajs-3387	167	2	transduction	transduction	NOUN
iajs-3387	167	3	and	and	CCONJ
iajs-3387	167	4	targeted	target	VERB
iajs-3387	167	5	therapy	therapy	NOUN
iajs-3387	167	6	2019	2019	NUM
iajs-3387	167	7	,	,	PUNCT
iajs-3387	167	8	4(1	4(1	NOUN
iajs-3387	167	9	)	)	PUNCT
iajs-3387	167	10	,	,	PUNCT
iajs-3387	167	11	3	3	X
iajs-3387	167	12	.	.	PUNCT
iajs-3387	167	13	https://doi.org/10.1038/s41392-019-0036-y	https://doi.org/10.1038/s41392-019-0036-y	PROPN
iajs-3387	167	14	.	.	PUNCT
iajs-3387	168	1	12	12	NUM
iajs-3387	168	2	.	.	PUNCT
iajs-3387	169	1	ayuk	ayuk	PROPN
iajs-3387	169	2	,	,	PUNCT
iajs-3387	169	3	j.	j.	PROPN
iajs-3387	169	4	;	;	PUNCT
iajs-3387	169	5	sheppard	sheppard	PROPN
iajs-3387	169	6	,	,	PUNCT
iajs-3387	169	7	m.c	m.c	PROPN
iajs-3387	169	8	.	.	PROPN
iajs-3387	169	9	growth	growth	NOUN
iajs-3387	169	10	hormone	hormone	NOUN
iajs-3387	169	11	and	and	CCONJ
iajs-3387	169	12	its	its	PRON
iajs-3387	169	13	disorders	disorder	NOUN
iajs-3387	169	14	.	.	PUNCT
iajs-3387	170	1	postgraduate	postgraduate	PROPN
iajs-3387	170	2	medical	medical	ADJ
iajs-3387	170	3	journal	journal	PROPN
iajs-3387	170	4	2006	2006	NUM
iajs-3387	170	5	,	,	PUNCT
iajs-3387	170	6	82(963	82(963	NUM
iajs-3387	170	7	)	)	PUNCT
iajs-3387	170	8	,	,	PUNCT
iajs-3387	170	9	24	24	NUM
iajs-3387	170	10	-	-	SYM
iajs-3387	170	11	30	30	NUM
iajs-3387	170	12	.	.	PUNCT
iajs-3387	171	1	https://doi.org/10.1136/pgmj.2005.036087	https://doi.org/10.1136/pgmj.2005.036087	PROPN
iajs-3387	171	2	.	.	PROPN
iajs-3387	171	3	13	13	NUM
iajs-3387	171	4	.	.	PUNCT
iajs-3387	172	1	leroith	leroith	PROPN
iajs-3387	172	2	,	,	PUNCT
iajs-3387	172	3	d.	d.	PROPN
iajs-3387	172	4	;	;	PUNCT
iajs-3387	172	5	yakar	yakar	PRON
iajs-3387	172	6	,	,	PUNCT
iajs-3387	172	7	s.	s.	PROPN
iajs-3387	172	8	mechanisms	mechanism	NOUN
iajs-3387	172	9	of	of	ADP
iajs-3387	172	10	disease	disease	NOUN
iajs-3387	172	11	:	:	PUNCT
iajs-3387	172	12	metabolic	metabolic	NOUN
iajs-3387	172	13	effects	effect	NOUN
iajs-3387	172	14	of	of	ADP
iajs-3387	172	15	growth	growth	NOUN
iajs-3387	172	16	hormone	hormone	NOUN
iajs-3387	172	17	and	and	CCONJ
iajs-3387	172	18	insulinlike	insulinlike	NOUN
iajs-3387	172	19	growth	growth	NOUN
iajs-3387	172	20	factor	factor	NOUN
iajs-3387	172	21	1	1	NUM
iajs-3387	172	22	.	.	PUNCT
iajs-3387	173	1	nature	nature	NOUN
iajs-3387	173	2	clinical	clinical	ADJ
iajs-3387	173	3	practice	practice	NOUN
iajs-3387	173	4	endocrinology	endocrinology	NOUN
iajs-3387	173	5	&	&	CCONJ
iajs-3387	173	6	metabolism	metabolism	NOUN
iajs-3387	173	7	2007	2007	NUM
iajs-3387	173	8	,	,	PUNCT
iajs-3387	173	9	3(3	3(3	NUM
iajs-3387	173	10	)	)	PUNCT
iajs-3387	173	11	,	,	PUNCT
iajs-3387	173	12	302	302	NUM
iajs-3387	173	13	-	-	SYM
iajs-3387	173	14	310	310	NUM
iajs-3387	173	15	.	.	PUNCT
iajs-3387	173	16	https://doi.org/10.1038/ncpendmet0427	https://doi.org/10.1038/ncpendmet0427	NOUN
iajs-3387	173	17	.	.	PUNCT
iajs-3387	174	1	14	14	NUM
iajs-3387	174	2	.	.	X
iajs-3387	175	1	doessing	doessing	NOUN
iajs-3387	175	2	,	,	PUNCT
iajs-3387	175	3	s.	s.	PROPN
iajs-3387	175	4	;	;	PUNCT
iajs-3387	175	5	holm	holm	PROPN
iajs-3387	175	6	,	,	PUNCT
iajs-3387	175	7	l.	l.	PROPN
iajs-3387	175	8	;	;	PUNCT
iajs-3387	175	9	heinemeier	heinemeier	PROPN
iajs-3387	175	10	,	,	PUNCT
iajs-3387	175	11	k.m	k.m	PROPN
iajs-3387	175	12	.	.	PROPN
iajs-3387	175	13	;	;	PUNCT
iajs-3387	175	14	feldt	feldt	PROPN
iajs-3387	175	15	-	-	PUNCT
iajs-3387	175	16	rasmussen	rasmussen	PROPN
iajs-3387	175	17	,	,	PUNCT
iajs-3387	175	18	u.	u.	PROPN
iajs-3387	175	19	;	;	PUNCT
iajs-3387	175	20	schjerling	schjerling	NOUN
iajs-3387	175	21	,	,	PUNCT
iajs-3387	175	22	p.	p.	NOUN
iajs-3387	175	23	;	;	PUNCT
iajs-3387	175	24	qvortrup	qvortrup	NOUN
iajs-3387	175	25	,	,	PUNCT
iajs-3387	175	26	k.	k.	PROPN
iajs-3387	175	27	;	;	PUNCT
iajs-3387	176	1	larsen	larsen	PROPN
iajs-3387	176	2	,	,	PUNCT
iajs-3387	176	3	j.o	j.o	PROPN
iajs-3387	176	4	.	.	PROPN
iajs-3387	176	5	;	;	PUNCT
iajs-3387	176	6	nielsen	nielsen	PROPN
iajs-3387	176	7	,	,	PUNCT
iajs-3387	176	8	r.h	r.h	PROPN
iajs-3387	176	9	.	.	PROPN
iajs-3387	176	10	;	;	PUNCT
iajs-3387	176	11	flyvbjerg	flyvbjerg	PROPN
iajs-3387	176	12	,	,	PUNCT
iajs-3387	176	13	a.	a.	NOUN
iajs-3387	176	14	;	;	PUNCT
iajs-3387	176	15	kjaer	kjaer	NOUN
iajs-3387	176	16	,	,	PUNCT
iajs-3387	176	17	m.	m.	PROPN
iajs-3387	176	18	gh	gh	PROPN
iajs-3387	176	19	and	and	CCONJ
iajs-3387	176	20	igf1	igf1	PROPN
iajs-3387	176	21	levels	level	NOUN
iajs-3387	176	22	are	be	AUX
iajs-3387	176	23	positively	positively	ADV
iajs-3387	176	24	associated	associate	VERB
iajs-3387	176	25	with	with	ADP
iajs-3387	176	26	musculotendinous	musculotendinous	ADJ
iajs-3387	176	27	collagen	collagen	NOUN
iajs-3387	176	28	expression	expression	NOUN
iajs-3387	176	29	:	:	PUNCT
iajs-3387	176	30	experiments	experiment	NOUN
iajs-3387	176	31	in	in	ADP
iajs-3387	176	32	acromegalic	acromegalic	ADJ
iajs-3387	176	33	and	and	CCONJ
iajs-3387	176	34	gh	gh	PROPN
iajs-3387	176	35	deficiency	deficiency	NOUN
iajs-3387	176	36	patients	patient	NOUN
iajs-3387	176	37	.	.	PUNCT
iajs-3387	177	1	european	european	PROPN
iajs-3387	177	2	journal	journal	PROPN
iajs-3387	177	3	of	of	ADP
iajs-3387	177	4	endocrinology	endocrinology	NOUN
iajs-3387	177	5	2010	2010	NUM
iajs-3387	177	6	,	,	PUNCT
iajs-3387	177	7	163(6	163(6	NUM
iajs-3387	177	8	)	)	PUNCT
iajs-3387	177	9	,	,	PUNCT
iajs-3387	177	10	853	853	NUM
iajs-3387	177	11	-	-	SYM
iajs-3387	177	12	862	862	NUM
iajs-3387	177	13	.	.	PUNCT
iajs-3387	178	1	https://doi.org/10.1530/eje10-0818	https://doi.org/10.1530/eje10-0818	NOUN
iajs-3387	178	2	.	.	PUNCT
iajs-3387	179	1	15	15	NUM
iajs-3387	179	2	.	.	PUNCT
iajs-3387	179	3	tabur	tabur	PROPN
iajs-3387	179	4	,	,	PUNCT
iajs-3387	179	5	s.	s.	PROPN
iajs-3387	179	6	;	;	PUNCT
iajs-3387	179	7	sezen	sezen	PROPN
iajs-3387	179	8	,	,	PUNCT
iajs-3387	179	9	h.	h.	PROPN
iajs-3387	179	10	;	;	PUNCT
iajs-3387	179	11	korkmaz	korkmaz	PROPN
iajs-3387	179	12	,	,	PUNCT
iajs-3387	179	13	h.	h.	PROPN
iajs-3387	179	14	;	;	PUNCT
iajs-3387	179	15	ozkaya	ozkaya	PROPN
iajs-3387	179	16	,	,	PUNCT
iajs-3387	179	17	m.	m.	NOUN
iajs-3387	179	18	;	;	PUNCT
iajs-3387	179	19	akarsu	akarsu	PROPN
iajs-3387	179	20	,	,	PUNCT
iajs-3387	179	21	e.	e.	PROPN
iajs-3387	179	22	high	high	PROPN
iajs-3387	179	23	prolidase	prolidase	PROPN
iajs-3387	179	24	levels	level	NOUN
iajs-3387	179	25	may	may	AUX
iajs-3387	179	26	be	be	AUX
iajs-3387	179	27	a	a	DET
iajs-3387	179	28	marker	marker	NOUN
iajs-3387	179	29	of	of	ADP
iajs-3387	179	30	irreversible	irreversible	ADJ
iajs-3387	179	31	extracellular	extracellular	ADJ
iajs-3387	179	32	matrix	matrix	NOUN
iajs-3387	179	33	changes	change	NOUN
iajs-3387	179	34	in	in	ADP
iajs-3387	179	35	controlled	control	VERB
iajs-3387	179	36	acromegaly	acromegaly	NOUN
iajs-3387	179	37	patients	patient	NOUN
iajs-3387	179	38	?	?	PUNCT
iajs-3387	179	39	.	.	PUNCT
iajs-3387	180	1	experimental	experimental	ADJ
iajs-3387	180	2	and	and	CCONJ
iajs-3387	180	3	clinical	clinical	ADJ
iajs-3387	180	4	endocrinology	endocrinology	NOUN
iajs-3387	180	5	&	&	CCONJ
iajs-3387	180	6	diabetes	diabetes	NOUN
iajs-3387	180	7	2015	2015	NUM
iajs-3387	180	8	,	,	PUNCT
iajs-3387	180	9	17	17	NUM
iajs-3387	180	10	,	,	PUNCT
iajs-3387	180	11	82	82	NUM
iajs-3387	180	12	-	-	SYM
iajs-3387	180	13	6	6	NUM
iajs-3387	180	14	.	.	PUNCT
iajs-3387	181	1	https://doi.org/10.1055/s-0035-1564200	https://doi.org/10.1055/s-0035-1564200	PROPN
iajs-3387	181	2	.	.	PUNCT
iajs-3387	182	1	16	16	NUM
iajs-3387	182	2	.	.	PUNCT
iajs-3387	182	3	wątor	wątor	NOUN
iajs-3387	182	4	,	,	PUNCT
iajs-3387	182	5	e.	e.	PROPN
iajs-3387	182	6	;	;	PUNCT
iajs-3387	182	7	rutkiewicz	rutkiewicz	ADJ
iajs-3387	182	8	,	,	PUNCT
iajs-3387	182	9	m.	m.	NOUN
iajs-3387	182	10	;	;	PUNCT
iajs-3387	182	11	weiss	weiss	PROPN
iajs-3387	182	12	,	,	PUNCT
iajs-3387	182	13	m.s	m.s	PROPN
iajs-3387	182	14	.	.	PROPN
iajs-3387	182	15	;	;	PUNCT
iajs-3387	182	16	wilk	wilk	PROPN
iajs-3387	182	17	,	,	PUNCT
iajs-3387	182	18	p.	p.	NOUN
iajs-3387	182	19	co‐expression	co‐expression	NOUN
iajs-3387	182	20	with	with	ADP
iajs-3387	182	21	chaperones	chaperone	NOUN
iajs-3387	182	22	can	can	AUX
iajs-3387	182	23	affect	affect	VERB
iajs-3387	182	24	protein	protein	NOUN
iajs-3387	182	25	3d	3d	NOUN
iajs-3387	182	26	structure	structure	NOUN
iajs-3387	182	27	as	as	SCONJ
iajs-3387	182	28	exemplified	exemplify	VERB
iajs-3387	182	29	by	by	ADP
iajs-3387	182	30	loss‐of‐function	loss‐of‐function	NOUN
iajs-3387	182	31	variants	variant	NOUN
iajs-3387	182	32	of	of	ADP
iajs-3387	182	33	human	human	ADJ
iajs-3387	182	34	prolidase	prolidase	PROPN
iajs-3387	182	35	.	.	PUNCT
iajs-3387	183	1	febs	febs	NOUN
iajs-3387	183	2	letters	letter	NOUN
iajs-3387	183	3	2020	2020	NUM
iajs-3387	183	4	,	,	PUNCT
iajs-3387	183	5	594(18	594(18	NUM
iajs-3387	183	6	)	)	PUNCT
iajs-3387	183	7	,	,	PUNCT
iajs-3387	183	8	3045	3045	NUM
iajs-3387	183	9	-	-	SYM
iajs-3387	183	10	3056	3056	NUM
iajs-3387	183	11	.	.	PUNCT
iajs-3387	184	1	https://doi.org/10.1002/1873-3468	https://doi.org/10.1002/1873-3468	PROPN
iajs-3387	184	2	.	.	PUNCT
iajs-3387	185	1	17	17	NUM
iajs-3387	185	2	.	.	PUNCT
iajs-3387	186	1	abdulrahman	abdulrahman	PROPN
iajs-3387	186	2	,	,	PUNCT
iajs-3387	186	3	m.a	m.a	PROPN
iajs-3387	186	4	.	.	PROPN
iajs-3387	186	5	;	;	PUNCT
iajs-3387	186	6	jasim	jasim	PROPN
iajs-3387	186	7	,	,	PUNCT
iajs-3387	186	8	b.a	b.a	PROPN
iajs-3387	186	9	.	.	PROPN
iajs-3387	186	10	;	;	PUNCT
iajs-3387	186	11	al	al	PROPN
iajs-3387	186	12	-	-	PUNCT
iajs-3387	186	13	samaria	samaria	PROPN
iajs-3387	186	14	,	,	PUNCT
iajs-3387	186	15	a.m.f	a.m.f	NOUN
iajs-3387	186	16	.	.	PUNCT
iajs-3387	187	1	the	the	DET
iajs-3387	187	2	relationship	relationship	NOUN
iajs-3387	187	3	between	between	ADP
iajs-3387	187	4	the	the	PRON
iajs-3387	187	5	of	of	ADP
iajs-3387	187	6	prolidase	prolidase	NOUN
iajs-3387	187	7	activity	activity	NOUN
iajs-3387	187	8	and	and	CCONJ
iajs-3387	187	9	rheumatoid	rheumatoid	VERB
iajs-3387	187	10	arthritis	arthritis	NOUN
iajs-3387	187	11	.	.	PUNCT
iajs-3387	188	1	eurasian	eurasian	ADJ
iajs-3387	188	2	journal	journal	PROPN
iajs-3387	188	3	of	of	ADP
iajs-3387	188	4	biosciences	bioscience	NOUN
iajs-3387	188	5	2020	2020	NUM
iajs-3387	188	6	,	,	PUNCT
iajs-3387	188	7	14(2	14(2	NUM
iajs-3387	188	8	)	)	PUNCT
iajs-3387	188	9	,	,	PUNCT
iajs-3387	188	10	3045	3045	NUM
iajs-3387	188	11	.	.	PUNCT
iajs-3387	189	1	18	18	NUM
iajs-3387	189	2	.	.	X
iajs-3387	189	3	spodenkiewicz	spodenkiewicz	NOUN
iajs-3387	189	4	,	,	PUNCT
iajs-3387	189	5	m.	m.	NOUN
iajs-3387	189	6	;	;	PUNCT
iajs-3387	189	7	spodenkiewicz	spodenkiewicz	NOUN
iajs-3387	189	8	,	,	PUNCT
iajs-3387	189	9	m.	m.	NOUN
iajs-3387	189	10	;	;	PUNCT
iajs-3387	189	11	cleary	cleary	PROPN
iajs-3387	189	12	,	,	PUNCT
iajs-3387	189	13	m.	m.	NOUN
iajs-3387	189	14	;	;	PUNCT
iajs-3387	189	15	massier	massier	NOUN
iajs-3387	189	16	,	,	PUNCT
iajs-3387	189	17	m.	m.	NOUN
iajs-3387	189	18	;	;	PUNCT
iajs-3387	189	19	fitsialos	fitsialo	NOUN
iajs-3387	189	20	,	,	PUNCT
iajs-3387	189	21	g.	g.	PROPN
iajs-3387	189	22	;	;	PUNCT
iajs-3387	189	23	cottin	cottin	NOUN
iajs-3387	189	24	,	,	PUNCT
iajs-3387	189	25	v.	v.	PROPN
iajs-3387	189	26	;	;	PUNCT
iajs-3387	189	27	jouret	jouret	PROPN
iajs-3387	189	28	,	,	PUNCT
iajs-3387	189	29	g.	g.	PROPN
iajs-3387	189	30	;	;	PUNCT
iajs-3387	189	31	poirsier	poirsier	NOUN
iajs-3387	189	32	,	,	PUNCT
iajs-3387	189	33	c.	c.	PROPN
iajs-3387	189	34	;	;	PUNCT
iajs-3387	189	35	doco	doco	NOUN
iajs-3387	189	36	-	-	NOUN
iajs-3387	189	37	fenzy	fenzy	NOUN
iajs-3387	189	38	,	,	PUNCT
iajs-3387	189	39	m.	m.	NOUN
iajs-3387	189	40	;	;	PUNCT
iajs-3387	189	41	lèbre	lèbre	PROPN
iajs-3387	189	42	,	,	PUNCT
iajs-3387	189	43	a.s	a.s	PROPN
iajs-3387	189	44	.	.	PROPN
iajs-3387	189	45	clinical	clinical	ADJ
iajs-3387	189	46	genetics	genetic	NOUN
iajs-3387	189	47	of	of	ADP
iajs-3387	189	48	prolidase	prolidase	NOUN
iajs-3387	189	49	deficiency	deficiency	NOUN
iajs-3387	189	50	:	:	PUNCT
iajs-3387	189	51	an	an	DET
iajs-3387	189	52	updated	update	VERB
iajs-3387	189	53	review	review	NOUN
iajs-3387	189	54	.	.	PUNCT
iajs-3387	190	1	biology	biology	NOUN
iajs-3387	190	2	2020	2020	NUM
iajs-3387	190	3	,	,	PUNCT
iajs-3387	190	4	9(5	9(5	NUM
iajs-3387	190	5	)	)	PUNCT
iajs-3387	190	6	,	,	PUNCT
iajs-3387	190	7	108	108	NUM
iajs-3387	190	8	.	.	PUNCT
iajs-3387	191	1	https://doi.org/10.3390/biology9050108	https://doi.org/10.3390/biology9050108	NOUN
iajs-3387	191	2	.	.	PUNCT
iajs-3387	192	1	19	19	NUM
iajs-3387	192	2	.	.	X
iajs-3387	192	3	eni	eni	PROPN
iajs-3387	192	4	-	-	PUNCT
iajs-3387	192	5	aganga	aganga	PROPN
iajs-3387	192	6	,	,	PUNCT
iajs-3387	192	7	i.	i.	NOUN
iajs-3387	192	8	;	;	PUNCT
iajs-3387	192	9	lanaghan	lanaghan	PROPN
iajs-3387	192	10	,	,	PUNCT
iajs-3387	192	11	z.m	z.m	PROPN
iajs-3387	192	12	.	.	PROPN
iajs-3387	192	13	;	;	PUNCT
iajs-3387	192	14	balasubramaniam	balasubramaniam	PROPN
iajs-3387	192	15	,	,	PUNCT
iajs-3387	192	16	m.	m.	NOUN
iajs-3387	192	17	;	;	PUNCT
iajs-3387	192	18	dash	dash	NOUN
iajs-3387	192	19	,	,	PUNCT
iajs-3387	192	20	c.	c.	NOUN
iajs-3387	192	21	;	;	PUNCT
iajs-3387	192	22	pandhare	pandhare	NOUN
iajs-3387	192	23	,	,	PUNCT
iajs-3387	192	24	j.	j.	PROPN
iajs-3387	192	25	;	;	PUNCT
iajs-3387	192	26	prolidase	prolidase	PROPN
iajs-3387	192	27	:	:	PUNCT
iajs-3387	192	28	a	a	DET
iajs-3387	192	29	review	review	NOUN
iajs-3387	192	30	from	from	ADP
iajs-3387	192	31	discovery	discovery	NOUN
iajs-3387	192	32	to	to	ADP
iajs-3387	192	33	its	its	PRON
iajs-3387	192	34	role	role	NOUN
iajs-3387	192	35	in	in	ADP
iajs-3387	192	36	health	health	NOUN
iajs-3387	192	37	and	and	CCONJ
iajs-3387	192	38	disease	disease	NOUN
iajs-3387	192	39	.	.	PUNCT
iajs-3387	193	1	frontiers	frontier	NOUN
iajs-3387	193	2	in	in	ADP
iajs-3387	193	3	molecular	molecular	ADJ
iajs-3387	193	4	biosciences	bioscience	NOUN
iajs-3387	193	5	2021	2021	NUM
iajs-3387	193	6	,	,	PUNCT
iajs-3387	193	7	8	8	NUM
iajs-3387	193	8	,	,	PUNCT
iajs-3387	193	9	723003	723003	NUM
iajs-3387	193	10	.	.	PUNCT
iajs-3387	194	1	https://doi.org/10.3389/fmolb.2021.723003	https://doi.org/10.3389/fmolb.2021.723003	NOUN
iajs-3387	194	2	.	.	NOUN
iajs-3387	194	3	20	20	NUM
iajs-3387	194	4	.	.	PUNCT
iajs-3387	194	5	wassenaar	wassenaar	NOUN
iajs-3387	194	6	,	,	PUNCT
iajs-3387	194	7	m.j	m.j	PROPN
iajs-3387	194	8	.	.	PROPN
iajs-3387	194	9	;	;	PUNCT
iajs-3387	194	10	biermasz	biermasz	VERB
iajs-3387	194	11	,	,	PUNCT
iajs-3387	194	12	n.r	n.r	PROPN
iajs-3387	194	13	.	.	PROPN
iajs-3387	194	14	;	;	PUNCT
iajs-3387	194	15	van	van	PROPN
iajs-3387	194	16	duinen	duinen	PROPN
iajs-3387	194	17	,	,	PUNCT
iajs-3387	194	18	n.	n.	NOUN
iajs-3387	194	19	;	;	PUNCT
iajs-3387	194	20	van	van	PROPN
iajs-3387	194	21	der	der	PROPN
iajs-3387	194	22	klaauw	klaauw	PROPN
iajs-3387	194	23	,	,	PUNCT
iajs-3387	194	24	a.a	a.a	PROPN
iajs-3387	194	25	.	.	PROPN
iajs-3387	194	26	;	;	PUNCT
iajs-3387	194	27	pereira	pereira	PROPN
iajs-3387	194	28	,	,	PUNCT
iajs-3387	194	29	a.m	a.m	PROPN
iajs-3387	194	30	,	,	PUNCT
iajs-3387	194	31	;	;	PUNCT
iajs-3387	194	32	roelfsema	roelfsema	PROPN
iajs-3387	194	33	,	,	PUNCT
iajs-3387	194	34	f.	f.	PROPN
iajs-3387	194	35	;	;	PUNCT
iajs-3387	194	36	smit	smit	PROPN
iajs-3387	194	37	,	,	PUNCT
iajs-3387	194	38	j.w	j.w	PROPN
iajs-3387	194	39	.	.	PROPN
iajs-3387	194	40	;	;	PUNCT
iajs-3387	194	41	kroon	kroon	PROPN
iajs-3387	194	42	,	,	PUNCT
iajs-3387	194	43	h.m	h.m	PROPN
iajs-3387	194	44	.	.	PROPN
iajs-3387	194	45	;	;	PUNCT
iajs-3387	194	46	kloppenburg	kloppenburg	PROPN
iajs-3387	194	47	,	,	PUNCT
iajs-3387	194	48	m.	m.	NOUN
iajs-3387	194	49	;	;	PUNCT
iajs-3387	194	50	romijn	romijn	PROPN
iajs-3387	194	51	,	,	PUNCT
iajs-3387	194	52	j.a	j.a	PROPN
iajs-3387	194	53	.	.	PROPN
iajs-3387	194	54	high	high	ADJ
iajs-3387	194	55	prevalence	prevalence	NOUN
iajs-3387	194	56	of	of	ADP
iajs-3387	194	57	arthropathy	arthropathy	ADJ
iajs-3387	194	58	,	,	PUNCT
iajs-3387	194	59	according	accord	VERB
iajs-3387	194	60	to	to	ADP
iajs-3387	194	61	the	the	DET
iajs-3387	194	62	definitions	definition	NOUN
iajs-3387	194	63	of	of	ADP
iajs-3387	194	64	radiological	radiological	ADJ
iajs-3387	194	65	and	and	CCONJ
iajs-3387	194	66	clinical	clinical	ADJ
iajs-3387	194	67	osteoarthritis	osteoarthritis	NOUN
iajs-3387	194	68	,	,	PUNCT
iajs-3387	194	69	in	in	ADP
iajs-3387	194	70	patients	patient	NOUN
iajs-3387	194	71	with	with	ADP
iajs-3387	194	72	long	long	ADJ
iajs-3387	194	73	-	-	PUNCT
iajs-3387	194	74	term	term	NOUN
iajs-3387	194	75	cure	cure	NOUN
iajs-3387	194	76	of	of	ADP
iajs-3387	194	77	acromegaly	acromegaly	NOUN
iajs-3387	194	78	:	:	PUNCT
iajs-3387	194	79	european	european	PROPN
iajs-3387	194	80	journal	journal	PROPN
iajs-3387	194	81	of	of	ADP
iajs-3387	194	82	endocrinology	endocrinology	NOUN
iajs-3387	194	83	2009	2009	NUM
iajs-3387	194	84	,	,	PUNCT
iajs-3387	194	85	160(3	160(3	NUM
iajs-3387	194	86	)	)	PUNCT
iajs-3387	194	87	,	,	PUNCT
iajs-3387	194	88	357	357	NUM
iajs-3387	194	89	-	-	SYM
iajs-3387	194	90	365	365	NUM
iajs-3387	194	91	.	.	PUNCT
iajs-3387	195	1	https://doi.org/10.1530/eje-08-0845	https://doi.org/10.1530/eje-08-0845	NOUN
iajs-3387	195	2	.	.	PROPN
iajs-3387	195	3	21	21	NUM
iajs-3387	195	4	.	.	PUNCT
iajs-3387	195	5	giustina	giustina	PROPN
iajs-3387	195	6	,	,	PUNCT
iajs-3387	195	7	a.	a.	NOUN
iajs-3387	195	8	;	;	PUNCT
iajs-3387	195	9	mazziotti	mazziotti	PROPN
iajs-3387	195	10	,	,	PUNCT
iajs-3387	195	11	g.	g.	PROPN
iajs-3387	195	12	;	;	PUNCT
iajs-3387	195	13	canalis	canalis	PROPN
iajs-3387	195	14	,	,	PUNCT
iajs-3387	195	15	e.	e.	PROPN
iajs-3387	195	16	growth	growth	PROPN
iajs-3387	195	17	hormone	hormone	NOUN
iajs-3387	195	18	,	,	PUNCT
iajs-3387	195	19	insulin	insulin	NOUN
iajs-3387	195	20	-	-	PUNCT
iajs-3387	195	21	like	like	ADJ
iajs-3387	195	22	growth	growth	NOUN
iajs-3387	195	23	factors	factor	NOUN
iajs-3387	195	24	,	,	PUNCT
iajs-3387	195	25	and	and	CCONJ
iajs-3387	195	26	the	the	DET
iajs-3387	195	27	skeleton	skeleton	NOUN
iajs-3387	195	28	.	.	PUNCT
iajs-3387	196	1	endocrine	endocrine	ADJ
iajs-3387	196	2	reviews	review	NOUN
iajs-3387	196	3	2008	2008	NUM
iajs-3387	196	4	,	,	PUNCT
iajs-3387	196	5	29(5	29(5	NUM
iajs-3387	196	6	)	)	PUNCT
iajs-3387	196	7	,	,	PUNCT
iajs-3387	196	8	535	535	NUM
iajs-3387	196	9	-	-	SYM
iajs-3387	196	10	559	559	NUM
iajs-3387	196	11	.	.	PUNCT
iajs-3387	197	1	https://doi.org/10.1210/er.2007-0036	https://doi.org/10.1210/er.2007-0036	NOUN
iajs-3387	197	2	.	.	PUNCT
iajs-3387	198	1	22	22	NUM
iajs-3387	198	2	.	.	PUNCT
iajs-3387	199	1	doessing	doessing	NOUN
iajs-3387	199	2	,	,	PUNCT
iajs-3387	199	3	s.	s.	PROPN
iajs-3387	199	4	;	;	PUNCT
iajs-3387	199	5	holm	holm	PROPN
iajs-3387	199	6	,	,	PUNCT
iajs-3387	199	7	l.	l.	PROPN
iajs-3387	199	8	;	;	PUNCT
iajs-3387	199	9	heinemeier	heinemeier	PROPN
iajs-3387	199	10	,	,	PUNCT
iajs-3387	199	11	k.m	k.m	PROPN
iajs-3387	199	12	.	.	PROPN
iajs-3387	199	13	;	;	PUNCT
iajs-3387	199	14	feldt	feldt	PROPN
iajs-3387	199	15	-	-	PUNCT
iajs-3387	199	16	rasmussen	rasmussen	PROPN
iajs-3387	199	17	,	,	PUNCT
iajs-3387	199	18	u.	u.	PROPN
iajs-3387	199	19	;	;	PUNCT
iajs-3387	199	20	schjerling	schjerling	NOUN
iajs-3387	199	21	,	,	PUNCT
iajs-3387	199	22	p.	p.	NOUN
iajs-3387	199	23	;	;	PUNCT
iajs-3387	199	24	qvortrup	qvortrup	NOUN
iajs-3387	199	25	,	,	PUNCT
iajs-3387	199	26	k.	k.	PROPN
iajs-3387	199	27	;	;	PUNCT
iajs-3387	200	1	larsen	larsen	PROPN
iajs-3387	200	2	,	,	PUNCT
iajs-3387	200	3	j.o	j.o	PROPN
iajs-3387	200	4	.	.	PROPN
iajs-3387	200	5	;	;	PUNCT
iajs-3387	200	6	nielsen	nielsen	PROPN
iajs-3387	200	7	,	,	PUNCT
iajs-3387	200	8	r.h	r.h	PROPN
iajs-3387	200	9	.	.	PROPN
iajs-3387	200	10	;	;	PUNCT
iajs-3387	200	11	flyvbjerg	flyvbjerg	PROPN
iajs-3387	200	12	,	,	PUNCT
iajs-3387	200	13	a.	a.	NOUN
iajs-3387	200	14	;	;	PUNCT
iajs-3387	200	15	kjaer	kjaer	NOUN
iajs-3387	200	16	,	,	PUNCT
iajs-3387	200	17	m.	m.	PROPN
iajs-3387	200	18	gh	gh	PROPN
iajs-3387	200	19	and	and	CCONJ
iajs-3387	200	20	igf1	igf1	PROPN
iajs-3387	200	21	levels	level	NOUN
iajs-3387	200	22	are	be	AUX
iajs-3387	200	23	positively	positively	ADV
iajs-3387	200	24	associated	associate	VERB
iajs-3387	200	25	with	with	ADP
iajs-3387	200	26	musculotendinous	musculotendinous	ADJ
iajs-3387	200	27	collagen	collagen	NOUN
iajs-3387	200	28	expression	expression	NOUN
iajs-3387	200	29	:	:	PUNCT
iajs-3387	200	30	experiments	experiment	NOUN
iajs-3387	200	31	in	in	ADP
iajs-3387	200	32	acromegalic	acromegalic	ADJ
iajs-3387	200	33	and	and	CCONJ
iajs-3387	200	34	gh	gh	PROPN
iajs-3387	200	35	deficiency	deficiency	NOUN
iajs-3387	200	36	patients	patient	NOUN
iajs-3387	200	37	.	.	PUNCT
iajs-3387	201	1	european	european	PROPN
iajs-3387	201	2	journal	journal	PROPN
iajs-3387	201	3	of	of	ADP
iajs-3387	201	4	endocrinology	endocrinology	NOUN
iajs-3387	201	5	2010	2010	NUM
iajs-3387	201	6	,	,	PUNCT
iajs-3387	201	7	163(6	163(6	NUM
iajs-3387	201	8	)	)	PUNCT
iajs-3387	201	9	,	,	PUNCT
iajs-3387	201	10	853	853	NUM
iajs-3387	201	11	-	-	SYM
iajs-3387	201	12	862	862	NUM
iajs-3387	201	13	.	.	PUNCT
iajs-3387	202	1	https://doi.org/10.1530/eje-10818	https://doi.org/10.1530/eje-10818	NUM
iajs-3387	202	2	.	.	PUNCT
iajs-3387	203	1	23	23	NUM
iajs-3387	203	2	.	.	PUNCT
iajs-3387	203	3	wassenaar	wassenaar	NOUN
iajs-3387	203	4	,	,	PUNCT
iajs-3387	203	5	m.j	m.j	PROPN
iajs-3387	203	6	.	.	PROPN
iajs-3387	203	7	;	;	PUNCT
iajs-3387	203	8	cazemier	cazemier	ADV
iajs-3387	203	9	,	,	PUNCT
iajs-3387	203	10	m.	m.	NOUN
iajs-3387	203	11	;	;	PUNCT
iajs-3387	203	12	biermasz	biermasz	NOUN
iajs-3387	203	13	,	,	PUNCT
iajs-3387	203	14	n.r	n.r	PROPN
iajs-3387	203	15	.	.	PROPN
iajs-3387	203	16	;	;	PUNCT
iajs-3387	203	17	pereira	pereira	PROPN
iajs-3387	203	18	,	,	PUNCT
iajs-3387	203	19	a.m.	a.m.	ADV
iajs-3387	203	20	;	;	PUNCT
iajs-3387	203	21	roelfsema	roelfsema	PROPN
iajs-3387	203	22	,	,	PUNCT
iajs-3387	203	23	f.	f.	PROPN
iajs-3387	203	24	;	;	PUNCT
iajs-3387	203	25	smit	smit	PROPN
iajs-3387	203	26	,	,	PUNCT
iajs-3387	203	27	j.w	j.w	PROPN
iajs-3387	203	28	.	.	PROPN
iajs-3387	203	29	;	;	PUNCT
iajs-3387	203	30	hommes	homme	NOUN
iajs-3387	203	31	,	,	PUNCT
iajs-3387	203	32	d.w	d.w	PROPN
iajs-3387	203	33	.	.	PROPN
iajs-3387	203	34	;	;	PUNCT
iajs-3387	203	35	felt	feel	VERB
iajs-3387	203	36	-	-	PUNCT
iajs-3387	203	37	bersma	bersma	NOUN
iajs-3387	203	38	,	,	PUNCT
iajs-3387	203	39	r.j	r.j	PROPN
iajs-3387	203	40	.	.	PROPN
iajs-3387	203	41	;	;	PUNCT
iajs-3387	203	42	romijn	romijn	PROPN
iajs-3387	203	43	,	,	PUNCT
iajs-3387	203	44	j.a	j.a	PROPN
iajs-3387	203	45	.	.	PROPN
iajs-3387	203	46	acromegaly	acromegaly	PROPN
iajs-3387	203	47	is	be	AUX
iajs-3387	203	48	associated	associate	VERB
iajs-3387	203	49	with	with	ADP
iajs-3387	203	50	an	an	DET
iajs-3387	203	51	increased	increase	VERB
iajs-3387	203	52	prevalence	prevalence	NOUN
iajs-3387	203	53	of	of	ADP
iajs-3387	203	54	colonic	colonic	ADJ
iajs-3387	203	55	diverticula	diverticula	NOUN
iajs-3387	203	56	:	:	PUNCT
iajs-3387	203	57	a	a	DET
iajs-3387	203	58	case	case	NOUN
iajs-3387	203	59	-	-	PUNCT
iajs-3387	203	60	control	control	NOUN
iajs-3387	203	61	study	study	NOUN
iajs-3387	203	62	.	.	PUNCT
iajs-3387	204	1	the	the	DET
iajs-3387	204	2	journal	journal	NOUN
iajs-3387	204	3	of	of	ADP
iajs-3387	204	4	clinical	clinical	ADJ
iajs-3387	204	5	endocrinology	endocrinology	NOUN
iajs-3387	204	6	&	&	CCONJ
iajs-3387	204	7	metabolism	metabolism	NOUN
iajs-3387	204	8	2010	2010	NUM
iajs-3387	204	9	,	,	PUNCT
iajs-3387	204	10	95(5	95(5	NUM
iajs-3387	204	11	)	)	PUNCT
iajs-3387	204	12	,	,	PUNCT
iajs-3387	204	13	2073	2073	NUM
iajs-3387	204	14	-	-	SYM
iajs-3387	204	15	9	9	NUM
iajs-3387	204	16	.	.	PUNCT
iajs-3387	204	17	https://doi.org/10.1210/jc.2009-1714	https://doi.org/10.1210/jc.2009-1714	NOUN
iajs-3387	204	18	.	.	PUNCT
iajs-3387	205	1	https://doi.org/10.1038/nrendo.2014.21	https://doi.org/10.1038/nrendo.2014.21	PROPN
iajs-3387	205	2	https://doi.org/10.1055/a-1847-2553	https://doi.org/10.1055/a-1847-2553	PROPN
iajs-3387	205	3	https://doi.org/10.1038/s41392-019-0036-y	https://doi.org/10.1038/s41392-019-0036-y	PROPN
iajs-3387	205	4	https://doi.org/10.1136/pgmj.2005.036087	https://doi.org/10.1136/pgmj.2005.036087	PROPN
iajs-3387	205	5	https://doi.org/10.1038/ncpendmet0427	https://doi.org/10.1038/ncpendmet0427	VERB
iajs-3387	205	6	https://doi.org/10.1530/eje-10-0818	https://doi.org/10.1530/eje-10-0818	ADP
iajs-3387	205	7	https://doi.org/10.1530/eje-10-0818	https://doi.org/10.1530/eje-10-0818	ADP
iajs-3387	205	8	https://doi.org/10.1055/s-0035-1564200	https://doi.org/10.1055/s-0035-1564200	PROPN
iajs-3387	205	9	https://doi.org/10.1002/1873-3468	https://doi.org/10.1002/1873-3468	PROPN
iajs-3387	205	10	https://doi.org/10.3390/biology9050108	https://doi.org/10.3390/biology9050108	NOUN
iajs-3387	205	11	https://doi.org/10.3389/fmolb.2021.723003	https://doi.org/10.3389/fmolb.2021.723003	PROPN
iajs-3387	205	12	https://doi.org/10.1530/eje-08-0845	https://doi.org/10.1530/eje-08-0845	PRON
iajs-3387	205	13	https://doi.org/10.1210/er.2007-0036	https://doi.org/10.1210/er.2007-0036	NOUN
iajs-3387	205	14	https://doi.org/10.1530/eje-1-0818	https://doi.org/10.1530/eje-1-0818	NUM
iajs-3387	205	15	https://doi.org/10.1530/eje-1-0818	https://doi.org/10.1530/eje-1-0818	NUM
iajs-3387	205	16	https://doi.org/10.1210/jc.2009-1714	https://doi.org/10.1210/jc.2009-1714	NOUN
iajs-3387	205	17	ihjpas	ihjpa	NOUN
iajs-3387	205	18	.	.	PUNCT
iajs-3387	206	1	2024	2024	NUM
iajs-3387	206	2	,	,	PUNCT
iajs-3387	206	3	37(4	37(4	PROPN
iajs-3387	206	4	)	)	PUNCT
iajs-3387	206	5	262	262	NUM
iajs-3387	206	6	24	24	NUM
iajs-3387	206	7	.	.	PUNCT
iajs-3387	207	1	horoz	horoz	ADJ
iajs-3387	207	2	,	,	PUNCT
iajs-3387	207	3	m.	m.	NOUN
iajs-3387	207	4	;	;	PUNCT
iajs-3387	207	5	aslan	aslan	PROPN
iajs-3387	207	6	,	,	PUNCT
iajs-3387	207	7	m.	m.	NOUN
iajs-3387	207	8	;	;	PUNCT
iajs-3387	207	9	bolukbas	bolukbas	PROPN
iajs-3387	207	10	,	,	PUNCT
iajs-3387	207	11	f.f	f.f	PROPN
iajs-3387	207	12	.	.	PROPN
iajs-3387	207	13	;	;	PUNCT
iajs-3387	207	14	bolukbas	bolukbas	PROPN
iajs-3387	207	15	,	,	PUNCT
iajs-3387	207	16	c.	c.	PROPN
iajs-3387	207	17	;	;	PUNCT
iajs-3387	207	18	nazligul	nazligul	PROPN
iajs-3387	207	19	,	,	PUNCT
iajs-3387	207	20	y.	y.	PROPN
iajs-3387	207	21	;	;	PUNCT
iajs-3387	207	22	celik	celik	PROPN
iajs-3387	207	23	,	,	PUNCT
iajs-3387	207	24	h.	h.	PROPN
iajs-3387	207	25	;	;	PUNCT
iajs-3387	207	26	aksoy	aksoy	PROPN
iajs-3387	207	27	,	,	PUNCT
iajs-3387	207	28	n.	n.	PROPN
iajs-3387	207	29	serum	serum	PROPN
iajs-3387	207	30	prolidase	prolidase	NOUN
iajs-3387	207	31	enzyme	enzyme	NOUN
iajs-3387	207	32	activity	activity	NOUN
iajs-3387	207	33	and	and	CCONJ
iajs-3387	207	34	its	its	PRON
iajs-3387	207	35	relation	relation	NOUN
iajs-3387	207	36	to	to	ADP
iajs-3387	207	37	histopathological	histopathological	ADJ
iajs-3387	207	38	findings	finding	NOUN
iajs-3387	207	39	in	in	ADP
iajs-3387	207	40	patients	patient	NOUN
iajs-3387	207	41	with	with	ADP
iajs-3387	207	42	non‐	non‐	ADJ
iajs-3387	207	43	alcoholic	alcoholic	ADJ
iajs-3387	207	44	steatohepatitis	steatohepatitis	NOUN
iajs-3387	207	45	.	.	PUNCT
iajs-3387	208	1	journal	journal	PROPN
iajs-3387	208	2	of	of	ADP
iajs-3387	208	3	clinical	clinical	ADJ
iajs-3387	208	4	laboratory	laboratory	NOUN
iajs-3387	208	5	analysis	analysis	NOUN
iajs-3387	208	6	2010	2010	NUM
iajs-3387	208	7	,	,	PUNCT
iajs-3387	208	8	24(3	24(3	NUM
iajs-3387	208	9	)	)	PUNCT
iajs-3387	208	10	,	,	PUNCT
iajs-3387	208	11	207	207	NUM
iajs-3387	208	12	-	-	SYM
iajs-3387	208	13	211	211	NUM
iajs-3387	208	14	.	.	PUNCT
iajs-3387	209	1	https://doi.org/10.1002/jcla.20334	https://doi.org/10.1002/jcla.20334	NOUN
iajs-3387	209	2	.	.	PUNCT
iajs-3387	210	1	25	25	NUM
iajs-3387	210	2	.	.	PUNCT
iajs-3387	210	3	valkusz	valkusz	PROPN
iajs-3387	210	4	,	,	PUNCT
iajs-3387	210	5	z.	z.	PROPN
iajs-3387	210	6	;	;	PUNCT
iajs-3387	210	7	tóth	tóth	NOUN
iajs-3387	210	8	,	,	PUNCT
iajs-3387	210	9	m.	m.	NOUN
iajs-3387	210	10	;	;	PUNCT
iajs-3387	210	11	boda	boda	PROPN
iajs-3387	210	12	,	,	PUNCT
iajs-3387	210	13	j.	j.	PROPN
iajs-3387	210	14	;	;	PUNCT
iajs-3387	210	15	nagy	nagy	PROPN
iajs-3387	210	16	,	,	PUNCT
iajs-3387	210	17	e.	e.	PROPN
iajs-3387	210	18	;	;	PUNCT
iajs-3387	210	19	julesz	julesz	PROPN
iajs-3387	210	20	,	,	PUNCT
iajs-3387	210	21	j.	j.	PROPN
iajs-3387	210	22	the	the	DET
iajs-3387	210	23	importance	importance	NOUN
iajs-3387	210	24	of	of	ADP
iajs-3387	210	25	early	early	ADJ
iajs-3387	210	26	diagnosis	diagnosis	NOUN
iajs-3387	210	27	of	of	ADP
iajs-3387	210	28	acromegaly	acromegaly	PROPN
iajs-3387	210	29	.	.	PUNCT
iajs-3387	211	1	orvosi	orvosi	NOUN
iajs-3387	211	2	hetilap	hetilap	VERB
iajs-3387	211	3	2011	2011	NUM
iajs-3387	211	4	,	,	PUNCT
iajs-3387	211	5	152(18	152(18	NUM
iajs-3387	211	6	)	)	PUNCT
iajs-3387	211	7	,	,	PUNCT
iajs-3387	211	8	696	696	NUM
iajs-3387	211	9	-	-	SYM
iajs-3387	211	10	702	702	NUM
iajs-3387	211	11	.	.	PUNCT
iajs-3387	211	12	https://doi.org/10.1556/oh.2011.29109	https://doi.org/10.1556/oh.2011.29109	VERB
iajs-3387	211	13	.	.	PUNCT
iajs-3387	212	1	26	26	NUM
iajs-3387	212	2	.	.	PUNCT
iajs-3387	213	1	karna	karna	PROPN
iajs-3387	213	2	,	,	PUNCT
iajs-3387	213	3	e.	e.	PROPN
iajs-3387	213	4	;	;	PUNCT
iajs-3387	213	5	pałka	pałka	PROPN
iajs-3387	213	6	,	,	PUNCT
iajs-3387	213	7	j.	j.	PROPN
iajs-3387	213	8	;	;	PUNCT
iajs-3387	213	9	wołczyński	wołczyński	PROPN
iajs-3387	213	10	,	,	PUNCT
iajs-3387	213	11	s.	s.	PROPN
iajs-3387	213	12	doxycycline	doxycycline	NOUN
iajs-3387	213	13	-	-	PUNCT
iajs-3387	213	14	induced	induce	VERB
iajs-3387	213	15	inhibition	inhibition	NOUN
iajs-3387	213	16	of	of	ADP
iajs-3387	213	17	prolidase	prolidase	NOUN
iajs-3387	213	18	activity	activity	NOUN
iajs-3387	213	19	in	in	ADP
iajs-3387	213	20	human	human	ADJ
iajs-3387	213	21	skin	skin	NOUN
iajs-3387	213	22	fibroblasts	fibroblast	NOUN
iajs-3387	213	23	and	and	CCONJ
iajs-3387	213	24	its	its	PRON
iajs-3387	213	25	involvement	involvement	NOUN
iajs-3387	213	26	in	in	ADP
iajs-3387	213	27	impaired	impaired	ADJ
iajs-3387	213	28	collagen	collagen	NOUN
iajs-3387	213	29	biosynthesis	biosynthesis	NOUN
iajs-3387	213	30	.	.	PUNCT
iajs-3387	214	1	european	european	ADJ
iajs-3387	214	2	journal	journal	PROPN
iajs-3387	214	3	of	of	ADP
iajs-3387	214	4	pharmacology	pharmacology	NOUN
iajs-3387	214	5	2001	2001	NUM
iajs-3387	214	6	,	,	PUNCT
iajs-3387	214	7	430(1	430(1	NUM
iajs-3387	214	8	)	)	PUNCT
iajs-3387	214	9	,	,	PUNCT
iajs-3387	214	10	25	25	NUM
iajs-3387	214	11	-	-	SYM
iajs-3387	214	12	31	31	NUM
iajs-3387	214	13	.	.	PUNCT
iajs-3387	215	1	https://doi.org/10.1016/s0014-2999(01)01372-3	https://doi.org/10.1016/s0014-2999(01)01372-3	NOUN
iajs-3387	215	2	.	.	PUNCT
iajs-3387	216	1	27	27	NUM
iajs-3387	216	2	.	.	PUNCT
iajs-3387	216	3	panahi	panahi	PROPN
iajs-3387	216	4	,	,	PUNCT
iajs-3387	216	5	y.	y.	PROPN
iajs-3387	216	6	;	;	PUNCT
iajs-3387	216	7	alishiri	alishiri	PROPN
iajs-3387	216	8	,	,	PUNCT
iajs-3387	216	9	g.h	g.h	PROPN
iajs-3387	216	10	.	.	PROPN
iajs-3387	216	11	;	;	PUNCT
iajs-3387	216	12	parvin	parvin	PROPN
iajs-3387	216	13	,	,	PUNCT
iajs-3387	216	14	s.	s.	PROPN
iajs-3387	216	15	;	;	PUNCT
iajs-3387	216	16	sahebkar	sahebkar	PROPN
iajs-3387	216	17	,	,	PUNCT
iajs-3387	216	18	a.	a.	NOUN
iajs-3387	216	19	mitigation	mitigation	NOUN
iajs-3387	216	20	of	of	ADP
iajs-3387	216	21	systemic	systemic	ADJ
iajs-3387	216	22	oxidative	oxidative	ADJ
iajs-3387	216	23	stress	stress	NOUN
iajs-3387	216	24	by	by	ADP
iajs-3387	216	25	curcuminoids	curcuminoid	NOUN
iajs-3387	216	26	in	in	ADP
iajs-3387	216	27	osteoarthritis	osteoarthritis	PROPN
iajs-3387	216	28	.	.	PUNCT
iajs-3387	217	1	journal	journal	PROPN
iajs-3387	217	2	of	of	ADP
iajs-3387	217	3	dietary	dietary	ADJ
iajs-3387	217	4	supplements	supplement	NOUN
iajs-3387	217	5	2016	2016	NUM
iajs-3387	217	6	,	,	PUNCT
iajs-3387	217	7	13(2	13(2	PROPN
iajs-3387	217	8	)	)	PUNCT
iajs-3387	217	9	,	,	PUNCT
iajs-3387	217	10	209	209	NUM
iajs-3387	217	11	-	-	SYM
iajs-3387	217	12	220	220	NUM
iajs-3387	217	13	.	.	PUNCT
iajs-3387	218	1	https://doi.org/10.3109/19390211.2015.1008611	https://doi.org/10.3109/19390211.2015.1008611	NOUN
iajs-3387	218	2	.	.	PUNCT
iajs-3387	219	1	28	28	NUM
iajs-3387	219	2	.	.	PUNCT
iajs-3387	219	3	nishizawa	nishizawa	PROPN
iajs-3387	219	4	,	,	PUNCT
iajs-3387	219	5	h.	h.	PROPN
iajs-3387	219	6	;	;	PUNCT
iajs-3387	219	7	handayaningsih	handayaningsih	PROPN
iajs-3387	219	8	,	,	PUNCT
iajs-3387	219	9	a.e	a.e	PROPN
iajs-3387	219	10	.	.	PROPN
iajs-3387	219	11	;	;	PUNCT
iajs-3387	219	12	iguchi	iguchi	ADJ
iajs-3387	219	13	,	,	PUNCT
iajs-3387	219	14	g.	g.	PROPN
iajs-3387	219	15	;	;	PUNCT
iajs-3387	219	16	cho	cho	PROPN
iajs-3387	219	17	,	,	PUNCT
iajs-3387	219	18	y.	y.	PROPN
iajs-3387	219	19	;	;	PUNCT
iajs-3387	219	20	takahashi	takahashi	PROPN
iajs-3387	219	21	,	,	PUNCT
iajs-3387	219	22	m.	m.	NOUN
iajs-3387	219	23	;	;	PUNCT
iajs-3387	219	24	yamamoto	yamamoto	NOUN
iajs-3387	219	25	,	,	PUNCT
iajs-3387	219	26	m.	m.	NOUN
iajs-3387	219	27	;	;	PUNCT
iajs-3387	219	28	suda	suda	PROPN
iajs-3387	219	29	,	,	PUNCT
iajs-3387	219	30	k.	k.	PROPN
iajs-3387	219	31	;	;	PUNCT
iajs-3387	219	32	kasahara	kasahara	PROPN
iajs-3387	219	33	,	,	PUNCT
iajs-3387	219	34	k.	k.	PROPN
iajs-3387	219	35	;	;	PUNCT
iajs-3387	219	36	hakuno	hakuno	PROPN
iajs-3387	219	37	,	,	PUNCT
iajs-3387	219	38	f.	f.	PROPN
iajs-3387	219	39	;	;	PUNCT
iajs-3387	219	40	yamanouchi	yamanouchi	PROPN
iajs-3387	219	41	,	,	PUNCT
iajs-3387	219	42	k.	k.	PROPN
iajs-3387	219	43	;	;	PUNCT
iajs-3387	219	44	nishihara	nishihara	NOUN
iajs-3387	219	45	,	,	PUNCT
iajs-3387	219	46	m.	m.	NOUN
iajs-3387	219	47	enhanced	enhance	VERB
iajs-3387	219	48	oxidative	oxidative	ADJ
iajs-3387	219	49	stress	stress	NOUN
iajs-3387	219	50	in	in	ADP
iajs-3387	219	51	ghtransgenic	ghtransgenic	ADJ
iajs-3387	219	52	rat	rat	NOUN
iajs-3387	219	53	and	and	CCONJ
iajs-3387	219	54	acromegaly	acromegaly	NOUN
iajs-3387	219	55	in	in	ADP
iajs-3387	219	56	humans	human	NOUN
iajs-3387	219	57	.	.	PUNCT
iajs-3387	220	1	growth	growth	NOUN
iajs-3387	220	2	hormone	hormone	PROPN
iajs-3387	220	3	&	&	CCONJ
iajs-3387	220	4	igf	igf	PROPN
iajs-3387	220	5	research	research	PROPN
iajs-3387	220	6	2012	2012	NUM
iajs-3387	220	7	,	,	PUNCT
iajs-3387	220	8	22(2	22(2	NUM
iajs-3387	220	9	)	)	PUNCT
iajs-3387	220	10	,	,	PUNCT
iajs-3387	220	11	64	64	NUM
iajs-3387	220	12	-	-	SYM
iajs-3387	220	13	68	68	NUM
iajs-3387	220	14	.	.	PUNCT
iajs-3387	221	1	https://doi.org/10.3109/19390211.2015.1008611	https://doi.org/10.3109/19390211.2015.1008611	NOUN
iajs-3387	221	2	.	.	PUNCT
iajs-3387	222	1	29	29	NUM
iajs-3387	222	2	.	.	PUNCT
iajs-3387	223	1	anagnostis	anagnostis	PROPN
iajs-3387	223	2	,	,	PUNCT
iajs-3387	223	3	p.	p.	PROPN
iajs-3387	223	4	;	;	PUNCT
iajs-3387	223	5	efstathiadou	efstathiadou	PROPN
iajs-3387	223	6	,	,	PUNCT
iajs-3387	223	7	z.a	z.a	PROPN
iajs-3387	223	8	.	.	PROPN
iajs-3387	223	9	;	;	PUNCT
iajs-3387	223	10	gougoura	gougoura	NOUN
iajs-3387	223	11	,	,	PUNCT
iajs-3387	223	12	s.	s.	PROPN
iajs-3387	223	13	;	;	PUNCT
iajs-3387	223	14	polyzos	polyzos	PROPN
iajs-3387	223	15	,	,	PUNCT
iajs-3387	223	16	s.a	s.a	PROPN
iajs-3387	223	17	.	.	PROPN
iajs-3387	223	18	;	;	PUNCT
iajs-3387	223	19	karathanasi	karathanasi	PROPN
iajs-3387	223	20	,	,	PUNCT
iajs-3387	223	21	e.	e.	PROPN
iajs-3387	223	22	;	;	PUNCT
iajs-3387	223	23	dritsa	dritsa	NOUN
iajs-3387	223	24	,	,	PUNCT
iajs-3387	223	25	p.	p.	PROPN
iajs-3387	223	26	;	;	PUNCT
iajs-3387	223	27	kita	kita	PROPN
iajs-3387	223	28	,	,	PUNCT
iajs-3387	223	29	m.	m.	NOUN
iajs-3387	223	30	;	;	PUNCT
iajs-3387	223	31	koukoulis	koukoulis	PROPN
iajs-3387	223	32	,	,	PUNCT
iajs-3387	223	33	g.n	g.n	PROPN
iajs-3387	223	34	.	.	PROPN
iajs-3387	223	35	oxidative	oxidative	ADJ
iajs-3387	223	36	stress	stress	NOUN
iajs-3387	223	37	and	and	CCONJ
iajs-3387	223	38	reduced	reduce	VERB
iajs-3387	223	39	antioxidative	antioxidative	ADJ
iajs-3387	223	40	status	status	NOUN
iajs-3387	223	41	,	,	PUNCT
iajs-3387	223	42	along	along	ADP
iajs-3387	223	43	with	with	ADP
iajs-3387	223	44	endothelial	endothelial	ADJ
iajs-3387	223	45	dysfunction	dysfunction	NOUN
iajs-3387	223	46	in	in	ADP
iajs-3387	223	47	acromegaly	acromegaly	PROPN
iajs-3387	223	48	.	.	PUNCT
iajs-3387	224	1	hormone	hormone	NOUN
iajs-3387	224	2	and	and	CCONJ
iajs-3387	224	3	metabolic	metabolic	NOUN
iajs-3387	224	4	research	research	NOUN
iajs-3387	224	5	2013	2013	NUM
iajs-3387	224	6	,	,	PUNCT
iajs-3387	224	7	45(04	45(04	NUM
iajs-3387	224	8	)	)	PUNCT
iajs-3387	224	9	,	,	PUNCT
iajs-3387	224	10	314	314	NUM
iajs-3387	224	11	-	-	SYM
iajs-3387	224	12	318	318	NUM
iajs-3387	224	13	.	.	PUNCT
iajs-3387	225	1	https://doi.org/10.1055/s-0032-1323765	https://doi.org/10.1055/s-0032-1323765	PROPN
iajs-3387	225	2	.	.	PUNCT
iajs-3387	226	1	30	30	NUM
iajs-3387	226	2	.	.	PUNCT
iajs-3387	227	1	claessen	claessen	PROPN
iajs-3387	227	2	,	,	PUNCT
iajs-3387	227	3	k.m	k.m	PROPN
iajs-3387	227	4	.	.	PROPN
iajs-3387	227	5	;	;	PUNCT
iajs-3387	228	1	ramautar	ramautar	PROPN
iajs-3387	228	2	,	,	PUNCT
iajs-3387	228	3	s.r	s.r	PROPN
iajs-3387	228	4	.	.	PROPN
iajs-3387	228	5	;	;	PUNCT
iajs-3387	228	6	pereira	pereira	PROPN
iajs-3387	228	7	,	,	PUNCT
iajs-3387	228	8	a.m.	a.m.	ADV
iajs-3387	228	9	;	;	PUNCT
iajs-3387	228	10	smit	smit	PROPN
iajs-3387	228	11	,	,	PUNCT
iajs-3387	228	12	j.w	j.w	PROPN
iajs-3387	228	13	.	.	PROPN
iajs-3387	228	14	;	;	PUNCT
iajs-3387	228	15	roelfsema	roelfsema	PROPN
iajs-3387	228	16	,	,	PUNCT
iajs-3387	228	17	f.	f.	PROPN
iajs-3387	228	18	;	;	PUNCT
iajs-3387	228	19	romijn	romijn	PROPN
iajs-3387	228	20	,	,	PUNCT
iajs-3387	228	21	j.a	j.a	PROPN
iajs-3387	228	22	.	.	PROPN
iajs-3387	228	23	;	;	PUNCT
iajs-3387	228	24	kroon	kroon	PROPN
iajs-3387	228	25	,	,	PUNCT
iajs-3387	228	26	h.m	h.m	PROPN
iajs-3387	228	27	.	.	PROPN
iajs-3387	228	28	;	;	PUNCT
iajs-3387	228	29	kloppenburg	kloppenburg	PROPN
iajs-3387	228	30	,	,	PUNCT
iajs-3387	228	31	m.	m.	NOUN
iajs-3387	228	32	;	;	PUNCT
iajs-3387	228	33	biermasz	biermasz	NOUN
iajs-3387	228	34	,	,	PUNCT
iajs-3387	228	35	n.r	n.r	PROPN
iajs-3387	228	36	.	.	PROPN
iajs-3387	228	37	progression	progression	NOUN
iajs-3387	228	38	of	of	ADP
iajs-3387	228	39	acromegalic	acromegalic	ADV
iajs-3387	228	40	arthropathy	arthropathy	ADJ
iajs-3387	228	41	despite	despite	SCONJ
iajs-3387	228	42	longterm	longterm	ADJ
iajs-3387	228	43	biochemical	biochemical	ADJ
iajs-3387	228	44	control	control	NOUN
iajs-3387	228	45	.	.	PUNCT
iajs-3387	229	1	european	european	ADJ
iajs-3387	229	2	journal	journal	PROPN
iajs-3387	229	3	of	of	ADP
iajs-3387	229	4	endocrinology	endocrinology	NOUN
iajs-3387	229	5	2012	2012	NUM
iajs-3387	229	6	,	,	PUNCT
iajs-3387	229	7	167(2	167(2	NUM
iajs-3387	229	8	)	)	PUNCT
iajs-3387	229	9	,	,	PUNCT
iajs-3387	229	10	235	235	NUM
iajs-3387	229	11	-	-	SYM
iajs-3387	229	12	244	244	NUM
iajs-3387	229	13	.	.	PUNCT
iajs-3387	230	1	https://doi.org/10.1530/eje-12-0147	https://doi.org/10.1530/eje-12-0147	PROPN
iajs-3387	230	2	.	.	PROPN
iajs-3387	230	3	31	31	NUM
iajs-3387	230	4	.	.	PUNCT
iajs-3387	231	1	claessen	claessen	PROPN
iajs-3387	231	2	,	,	PUNCT
iajs-3387	231	3	k.m	k.m	PROPN
iajs-3387	231	4	.	.	PROPN
iajs-3387	231	5	;	;	PUNCT
iajs-3387	231	6	ramautar	ramautar	PROPN
iajs-3387	231	7	,	,	PUNCT
iajs-3387	231	8	s.r	s.r	PROPN
iajs-3387	231	9	.	.	PROPN
iajs-3387	231	10	;	;	PUNCT
iajs-3387	231	11	pereira	pereira	PROPN
iajs-3387	231	12	,	,	PUNCT
iajs-3387	231	13	a.m.	a.m.	ADV
iajs-3387	231	14	;	;	PUNCT
iajs-3387	231	15	romijn	romijn	PROPN
iajs-3387	231	16	,	,	PUNCT
iajs-3387	231	17	j.a	j.a	PROPN
iajs-3387	231	18	.	.	PROPN
iajs-3387	231	19	;	;	PUNCT
iajs-3387	231	20	kroon	kroon	PROPN
iajs-3387	231	21	,	,	PUNCT
iajs-3387	231	22	h.m	h.m	PROPN
iajs-3387	231	23	.	.	PROPN
iajs-3387	231	24	;	;	PUNCT
iajs-3387	231	25	kloppenburg	kloppenburg	PROPN
iajs-3387	231	26	,	,	PUNCT
iajs-3387	231	27	m.	m.	NOUN
iajs-3387	231	28	;	;	PUNCT
iajs-3387	231	29	biermasz	biermasz	NOUN
iajs-3387	231	30	,	,	PUNCT
iajs-3387	231	31	n.r	n.r	PROPN
iajs-3387	231	32	.	.	PROPN
iajs-3387	231	33	increased	increase	VERB
iajs-3387	231	34	clinical	clinical	ADJ
iajs-3387	231	35	symptoms	symptom	NOUN
iajs-3387	231	36	of	of	ADP
iajs-3387	231	37	acromegalic	acromegalic	ADV
iajs-3387	231	38	arthropathy	arthropathy	ADJ
iajs-3387	231	39	in	in	ADP
iajs-3387	231	40	patients	patient	NOUN
iajs-3387	231	41	with	with	ADP
iajs-3387	231	42	longterm	longterm	ADJ
iajs-3387	231	43	disease	disease	NOUN
iajs-3387	231	44	control	control	NOUN
iajs-3387	231	45	:	:	PUNCT
iajs-3387	231	46	a	a	DET
iajs-3387	231	47	prospective	prospective	ADJ
iajs-3387	231	48	follow	follow	NOUN
iajs-3387	231	49	-	-	PUNCT
iajs-3387	231	50	up	up	ADP
iajs-3387	231	51	study	study	NOUN
iajs-3387	231	52	.	.	PUNCT
iajs-3387	232	1	pituitary	pituitary	ADJ
iajs-3387	232	2	2014	2014	NUM
iajs-3387	232	3	,	,	PUNCT
iajs-3387	232	4	17	17	NUM
iajs-3387	232	5	,	,	PUNCT
iajs-3387	232	6	44	44	NUM
iajs-3387	232	7	-	-	SYM
iajs-3387	232	8	52	52	NUM
iajs-3387	232	9	.	.	PUNCT
iajs-3387	233	1	https://doi.org/10.1007/s11102-013-0464-6	https://doi.org/10.1007/s11102-013-0464-6	PROPN
iajs-3387	233	2	.	.	PUNCT
iajs-3387	234	1	https://doi.org/10.1002/jcla.20334	https://doi.org/10.1002/jcla.20334	NOUN
iajs-3387	234	2	https://doi.org/10.1556/oh.2011.29109	https://doi.org/10.1556/oh.2011.29109	VERB
iajs-3387	234	3	https://doi.org/10.1016/s0014-2999(01)01372-3	https://doi.org/10.1016/s0014-2999(01)01372-3	PROPN
iajs-3387	234	4	https://doi.org/10.3109/19390211.2015.1008611	https://doi.org/10.3109/19390211.2015.1008611	PUNCT
iajs-3387	234	5	https://doi.org/10.3109/19390211.2015.1008611	https://doi.org/10.3109/19390211.2015.1008611	PUNCT
iajs-3387	235	1	https://doi.org/10.1055/s-0032-1323765	https://doi.org/10.1055/s-0032-1323765	PROPN
iajs-3387	235	2	https://doi.org/10.1530/eje-12-0147	https://doi.org/10.1530/eje-12-0147	PROPN
iajs-3387	235	3	https://doi.org/10.1007/s11102-013-0464-6	https://doi.org/10.1007/s11102-013-0464-6	PROPN